<SEC-DOCUMENT>0001213900-19-012981.txt : 20190717
<SEC-HEADER>0001213900-19-012981.hdr.sgml : 20190717
<ACCEPTANCE-DATETIME>20190717162024
ACCESSION NUMBER:		0001213900-19-012981
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20190717
DATE AS OF CHANGE:		20190717

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Immuron Ltd
		CENTRAL INDEX KEY:			0001660046
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-230762
		FILM NUMBER:		19959351

	BUSINESS ADDRESS:	
		STREET 1:		62 LYGON STREET
		STREET 2:		LEVEL 3
		CITY:			CARLTON, VICTORIA
		STATE:			C3
		ZIP:			3053
		BUSINESS PHONE:		61 03 9824 5254

	MAIL ADDRESS:	
		STREET 1:		62 LYGON STREET
		STREET 2:		LEVEL 3
		CITY:			CARLTON, VICTORIA
		STATE:			C3
		ZIP:			3053
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>f424b5071619b_immuronlimit.htm
<DESCRIPTION>PROSPECTUS SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Filed Pursuant to Rule 424(b)(5)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><B>Registration
No. 333-<FONT STYLE="background-color: white">230762</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PROSPECTUS SUPPLEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(To the Prospectus dated April 17, 2019)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>339,130 American Depositary Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Representing 13,565,200 Ordinary Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>IMMURON
    LIMITED</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are offering 339,130 <FONT STYLE="background-color: white">American
Depositary Shares (&ldquo;ADSs&rdquo;), each representing 40 </FONT>ordinary shares, no par value (&ldquo;ordinary shares&rdquo;),
pursuant to this prospectus supplement and the accompanying prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">ADSs
representing our ordinary shares and warrants to purchase ADSs (&ldquo;ADS Warrants&rdquo;) are listed on The Nasdaq Capital Market
under the symbols &ldquo;IMRN&rdquo; and &ldquo;IMRNW,&rdquo; respectively. On July 16, 2019, the last reported price of the ADSs
and ADS Warrants on The Nasdaq Capital Market was $4.30&nbsp;per ADS and $1.64&nbsp;per ADS Warrant, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Our
ordinary shares are currently listed on the Australian Securities Exchange (&ldquo;ASX&rdquo;) under the symbol &ldquo;IMC&rdquo;.
On July 16, 2019, the last reported price of our ordinary shares on the ASX was A$0.145 per ordinary share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The aggregate market value of our
outstanding ordinary shares held by non-affiliates as of the date of this prospectus supplement was approximately
$18,059,334, based on 163,215,706 ordinary shares outstanding as of the date of this prospectus supplement, of which
137,857,509 were held by non-affiliates, and a price per ordinary share of A$0.19 based on the closing sale price of our
ordinary shares on the ASX on May 23, 2019. During the 12 calendar month period that ends on, and includes, the date of this
prospectus supplement, we have sold securities with an aggregate market value of $2,000,000 pursuant to General Instruction
I.B.5 of Form&nbsp;F-3. <FONT STYLE="background-color: white">In no event will we sell our ordinary shares in a primary public
offering with a value&nbsp;exceeding&nbsp;one-third&nbsp;of&nbsp;our public float in any 12 calendar month period so long as
our public float remains below $75.0&nbsp;million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investing in the ADSs involves a high
degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page S-3 of this prospectus for a discussion of information that should
be considered in connection with an investment in these securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Neither the Securities and Exchange
Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; padding-left: 9pt; text-indent: -9pt; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per ADS</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 76%; padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public offering price</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right">4.00</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right">1,356,520</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriter discounts and commissions <SUP>(1)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right">0.28</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right">94,956</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds to us, before expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right">3.72</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right">1,261,564</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) Underwriting discounts and commissions
do not include a non-accountable expense allowance equal to 1% of the gross proceeds of this offering payable to ThinkEquity, a
division of Fordham Financial Management, Inc., the representative of the underwriters. We refer you to &ldquo;Underwriting&rdquo;
beginning on page S-22 for additional information regarding underwriters&rsquo; compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have granted the representative of
the underwriters an over-allotment option to purchase up to an additional 50,869 ADSs from us at the public offering price,
less the underwriting discounts and commissions, within 45 days from the date of this prospectus supplement to cover
over-allotments, if any. If the representative of the underwriters exercises its over-allotment option in full, the total
underwriting discounts and commissions payable will be $109,200, and the total proceeds to us, before expenses, will be
$1,450,796.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect to deliver the ADSs to purchasers
on or about July 19, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ThinkEquity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>a division of Fordham Financial Management,
Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus supplement
is July 16, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><IMG SRC="image_002.jpg" ALT="" STYLE="width: 820px; height: 398px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Prospectus Supplement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 90%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 10%; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PAGE</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#ps_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT THIS PROSPECTUS SUPPLEMENT</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-ii</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#ps_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRESENTATION OF FINANCIAL INFORMATION</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-ii</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#ps_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-iii</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#ps_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUPPLEMENT SUMMARY</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-1</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#ps_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-3</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#ps_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-4</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#ps_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIVIDEND POLICY</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-5</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#ps_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAPITALIZATION</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-5</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#ps_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DILUTION</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-6</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#ps_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MANAGEMENT</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-7</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#ps_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF THE SECURITIES WE ARE OFFERING</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-9</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#ps_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TAXATION</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-15</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#ps_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNDERWRITING</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-22</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#ps_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-26</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#ps_015"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-26</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#ps_016"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-26</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#ps_017"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION BY REFERENCE</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>S-26</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Prospectus</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="width: 10%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUMMARY</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAPITALIZATION AND INDEBTEDNESS</FONT></A></TD>
    <TD STYLE="text-align: center">5</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="text-align: center">5</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF SHARE CAPITAL AND CONSTITUTION</FONT></A></TD>
    <TD STYLE="text-align: center">5</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF AMERICAN DEPOSITARY SHARES</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF PREFERENCE SHARES</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF WARRANTS</FONT></A></TD>
    <TD STYLE="text-align: center">19</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF UNITS</FONT></A></TD>
    <TD STYLE="text-align: center">20</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TAXATION</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPENSES</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_015"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_016"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_017"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ENFORCEMENT OF CIVIL LIABILITIES</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_018"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_019"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_001"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white; text-align: justify">This document
is in two parts. The first part is this prospectus supplement, which describes the terms of this offering of ADSs and supplements
information contained in the accompanying prospectus and the documents incorporated by reference into the accompanying prospectus.
The second part is the accompanying prospectus, which gives more general information about us and the securities we may offer from
time to time under our registration statement on Form&nbsp;F-3.&nbsp;To the extent there is a conflict between the information
contained in this prospectus supplement, on the one hand, and the information contained in the accompanying prospectus or any document
incorporated by reference therein, on the other hand, the information in this prospectus supplement shall prevail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white; text-align: justify">You should read
both this prospectus supplement and the accompanying prospectus, together with additional information described below under the
heading &ldquo;Where You Can Find More Information,&rdquo; before purchasing any of the ADSs. This prospectus supplement does not
contain all of the information included in the registration statement. For a more complete understanding of the offering of the
ADSs, you should refer to the registration statement, including the exhibits. You may access the registration statement, exhibits
and other reports we file with the SEC on the SEC&rsquo;s website. More information regarding how you can access this and other
information is included under the heading &ldquo;Where You Can Find More Information&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white; text-align: justify">The information
in this prospectus supplement is accurate as of the date on the front cover of this prospectus supplement, and the information
in any free writing prospectus that we may provide you in connection with this offering is accurate only as of the date of that
free writing prospectus. Neither the delivery of this prospectus supplement nor the sale of any securities means that information
contained in this prospectus supplement is correct after the date of this prospectus supplement or as of any other date. To the
extent there is any conflict between the information contained in this prospectus supplement and the accompanying prospectus, you
should rely on the information in the prospectus supplement, provided that if any statement in one of these documents is inconsistent
with a statement in another document having a later date, the statement in the document having the later date modifies or supersedes
the earlier statement. Any information incorporated by reference is only accurate as of the date of the document incorporated by
reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">Unless otherwise
indicated or the context implies otherwise:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;ADSs&rdquo;
refers to American depositary shares, each of which represents forty (40)&nbsp;ordinary shares;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;ASX&rdquo;
refers to the Australian Securities Exchange, where our ordinary shares are listed;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;A$&rdquo;
or &ldquo;Australian dollars&rdquo; refers to the legal currency of Australia;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;IFRS&rdquo;
refers to the International Financial Reporting Standards as issued by the International Accounting Standards Board, or IASB;
and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Immuron,&rdquo;
&ldquo;we,&rdquo; &ldquo;us&rdquo; or &ldquo;our&rdquo; refer to Immuron Limited, an Australian corporation, and its subsidiaries.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white; text-align: justify">All references
to &ldquo;$&rdquo;, &ldquo;US$&rdquo; and &ldquo;U.S. dollar&rdquo; in this prospectus supplement and the accompanying prospectus
refer to United States dollars. Except as otherwise stated, all monetary amounts in this prospectus supplement and the accompanying
prospectus are presented in United States dollars. Unless otherwise indicated, the consolidated financial statements and related
notes included, or incorporated by reference, in this prospectus supplement and the accompanying prospectus have been prepared
in accordance with Australian Accounting Standards and also comply with IFRS, which differs in certain significant respects from
Generally Accepted Accounting Principles in the United States. Our fiscal year ends on June&nbsp;30 of each year. References to
&ldquo;fiscal 2018&rdquo; mean the&nbsp;12-month&nbsp;period ended June&nbsp;30, 2018 and other fiscal years are referred to in
a corresponding manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; background-color: white"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><A NAME="ps_002"></A><B>PRESENTATION
OF FINANCIAL INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our financial information
is presented in Australian dollars. For the convenience of the reader, in this prospectus, unless otherwise indicated, translations
from Australian dollars into U.S. dollars were made at the rate of A$1.00 to US$0.7046, which was exchange rate as quoted by the
Federal Reserve Bank of New York on December 31, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have made rounding
adjustments to some of the figures included in this prospectus supplement. Accordingly, numerical figures shown as totals in some
tables may not be an arithmetic aggregation of the figures that preceded them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_003"></A>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus supplement
and the accompanying prospectus, including the documents that we incorporate by reference, contain forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities
Exchange Act of 1934, as amended, or the Exchange Act. <FONT STYLE="background-color: white">All statements, other than statements
of historical facts, contained in this </FONT>prospectus supplement and any accompanying prospectus<FONT STYLE="background-color: white">,
including statements regarding our future results of operations and financial position, business strategy, prospective products,
product approvals, research and development costs, timing and likelihood of success, plans and objectives of management for future
operations, and future results of current and anticipated products, are forward-looking statements. These statements relate to
future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors which
may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements
expressed or implied by the forward-looking statements. The words &ldquo;anticipate,&rdquo; &ldquo;assume,&rdquo; &ldquo;believe,&rdquo;
&ldquo;contemplate,&rdquo; &ldquo;continue,&rdquo; &ldquo;could,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;goal,&rdquo;
&ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;might,&rdquo; &ldquo;objective,&rdquo; &ldquo;plan,&rdquo; &ldquo;potential,&rdquo;
&ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;positioned,&rdquo; &ldquo;seek,&rdquo; &ldquo;should,&rdquo; &ldquo;target,&rdquo;
&ldquo;will,&rdquo; &ldquo;would,&rdquo; or the negative of these terms or other similar expressions are intended to identify forward-looking
statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are based
on current expectations, estimates, forecasts and projections about our business and the industry in which we operate and management&rsquo;s
beliefs and assumptions, are not guarantees of future performance or development and involve known and unknown risks, uncertainties
and other factors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Actual results or events
could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. As a result,
any or all of our forward-looking statements in this prospectus supplement and the accompanying prospectus may turn out to be inaccurate.
We have included important factors in the cautionary statements included in this prospectus supplement and the accompanying prospectus,
particularly in the sections of this prospectus supplement and the accompanying prospectus titled &ldquo;Risk Factors,&rdquo; that
we believe could cause actual results or events to differ materially from the forward-looking statements that we make. We may not
actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue
reliance on our forward-looking statements. Moreover, we operate in a highly competitive and rapidly changing environment in which
new risks often emerge. It is not possible for our management to predict all risks, nor can we assess the impact of all factors
on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from
those contained in any forward-looking statements we may make. Our forward-looking statements do not reflect the potential impact
of any future acquisitions, mergers, dispositions, joint ventures or investments we may make.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should read this
prospectus supplement and the accompanying prospectus and the documents that we reference in this prospectus and have filed as
exhibits to the registration statement of which this prospectus is a part completely and with the understanding that our actual
future results may be materially different from what we expect. The forward-looking statements contained in this prospectus supplement
and the accompanying prospectus are made as of the date on the front cover of this prospectus supplement or such accompanying prospectus
only, and we do not assume any obligation to update any forward-looking statements except as required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5pt; padding-left: 5pt; border: Black 1.5pt solid; width: 99%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_004"></A>PROSPECTUS SUPPLEMENT SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This summary highlights information
contained elsewhere or incorporated by reference into this prospectus supplement and the accompanying prospectus. This summary
does not contain all of the information that you should consider before deciding to invest in our securities. You should read this
entire prospectus supplement and the accompanying prospectus carefully, including the &ldquo;Risk Factors&rdquo; section contained
in this prospectus supplement and our consolidated financial statements and the related notes and the other documents incorporated
by reference into this prospectus supplement and in the accompanying prospectus. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a commercial
and clinical-stage biopharmaceutical company with a proprietary technology platform focused on the development and commercialization
of a novel class of specifically targeted polyclonal antibodies that we believe can address significant unmet medical needs. Our
oral polyclonal antibodies offer delivery within the gastrointestinal (GI) tract and essentially do not cross into the bloodstream,
potentially leading to much improved safety and tolerability, without sacrificing efficacy. We believe that our two lead drug candidates,
IMM-124E and IMM-529 currently in clinical development, have the potential to transform the existing medical care paradigms for
travelers&rsquo; diarrhea, and for&nbsp;<I>C. difficile</I>&nbsp;infections, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently market
our flagship commercial product Travelan<SUP>&reg;</SUP> in Australia, where it is a listed medicine on the Australian Register
for Therapeutic Goods, as an over-the-counter product indicated to reduce the risk of travelers&rsquo; diarrhea. We also market
Travelan<SUP>&reg;</SUP> in Canada where it is licensed as a natural health product indicated to reduce the risk of travelers&rsquo;
diarrhea, and presently market Travelan<SUP>&reg;</SUP> in the U.S. as a dietary supplement for digestive tract protection. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On July 16, 2019, we announced
sales results for the year ended June 30, 2019 (&ldquo;FY19&rdquo;) for our commercially available products, including Travelan&reg;.
Travelan&reg; sales experienced considerable growth in North America in FY19 as revenue increased by 52%, and reached $1.16M AUD.
In the United States, Travelan&reg; FY19 revenue exceeded the $1M AUD milestone for the first time, as sales grew by 32% YoY to
$1.02M AUD. Global Immuron revenue grew by 29% YoY in FY19, reaching $2.6M AUD.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The data presented above reflects our preliminary estimates
based solely upon information available to us as of the date of this prospectus supplement, and is not a comprehensive statement
of our financial results or position as of June 30, 2019. Such results are subject to the completion of our closing procedures.
You should not place undue reliance upon our preliminary estimates. For example, during the course of the preparation of our financial
statements and related notes for the year ended June 30, 2019, additional items that would require material adjustments to be made
to the preliminary estimated financial information presented above may be identified. There can be no assurance that these estimates
will be realized, and estimates are subject to risks and uncertainties, many of which are not within our control.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that IMM-124E
(which contains the same active pharmaceutical ingredient as Travelan<SUP>&reg;</SUP>) has great potential in preventing travelers&rsquo;
diarrhea, and we are accordingly planning to focus clinical development of this drug candidate through an FDA 505(b)(2) pathway
to an approval specifically for prevention of travelers&rsquo; diarrhea. IMM-124E is also in two NIH sponsored Phase 2 clinical
trials to treat alcoholic steatohepatitis (ASH) and pediatric nonalcoholic fatty liver disease (NAFLD), respectively. The ASH trial
has completed enrollment, and release of top-line data by the NIH is expected sometime in the third quarter of 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are also looking
to refocus the present ex-U.S. clinical program for IMM-529 which is presently evaluating IMM-529 in&nbsp;<I>C. difficile</I> patients
to specifically evaluate patients with recurrent&nbsp;<I>C. difficile&nbsp;</I>infections where present-day standard-of-care antibiotics
typically lead to considerable rates of recurrence. To do this, we plan to file an IND with FDA in 2020 for clinical development
of IMM-529 specifically to treat patients with recurrent&nbsp;<I>C. difficile</I>, currently an unmet medical need.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Immuron Limited was
incorporated under the laws of Australia in 1994 and has been listed on the ASX since April 30, 1999. Our principal executive office
is located at Level 3, 62 Lygon Street, Carlton South, Victoria, Australia 3053 and our telephone number is +61 (0)3 9824 5254.
Our website address is www.immuron.com. Information on our website and the websites linked to it do not constitute a part of this
prospectus supplement and the accompanying prospectus. Our agent for service of process in the United States is Puglisi &amp; Associates,
850 Library Avenue, Suite 204, Newark, DE 19711.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5pt; padding-left: 5pt; border: Black 1.5pt solid; width: 99%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE OFFERING </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="width: 20%; padding-left: 9pt; text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 79%">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADSs offered by us</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">339,130 ADSs</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 9pt; text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares to be outstanding immediately after this offering</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">176,780,906 <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    shares (including ordinary shares represented by ADSs)<SUP>(1)</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 9pt; text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADSs</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Each ADS represents 40 ordinary shares. The depositary (as identified below) is the holder of the ordinary shares underlying the ADSs and ADS holders have the rights provided in the deposit agreement among us, the depositary and holders and beneficial owners of ADSs from time to time. To better understand the terms of the ADSs, please see &ldquo;Description of the Securities We Are Offering.&rdquo;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 9pt; text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depositary</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Bank of New York Mellon</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 9pt; text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of proceeds</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We currently intend to use the net proceeds from the sale of the securities under this prospectus supplement to support a variety of non-clinical activities, including animal toxicology studies, manufacture of active pharmaceutical ingredient, development of supporting analytical assays and regulatory activities in connection with the development of our two clinical candidates, IMM-124E and IMM-529. In addition, we expect to use a portion of the net proceeds for our anticipated clinical trial with IMM-124E to prevent travelers&rsquo; diarrhea and working capital. We may also use a portion of the net proceeds from this offering to in-license, acquire or invest in complementary businesses, technologies, products or assets. However, we have no current commitments or obligations to do so. See &ldquo;Use of Proceeds&rdquo;.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 9pt; text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk factors</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See &ldquo;Risk Factors&rdquo; beginning on page&nbsp;S-3 of this prospectus supplement and other information included or incorporated by reference into this prospectus supplement and the accompanying prospectus for a discussion of factors you should carefully consider before investing in our securities.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 9pt; text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq Capital Market Symbol</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">ADSs and ADS Warrants are listed on The Nasdaq Capital Market under the symbols &ldquo;IMRN&rdquo; and &ldquo;IMRNW,&rdquo; respectively. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) The number of shares of ordinary shares outstanding after
this offering is based on 163,215,706 ordinary shares (including ordinary shares represented by ADSs) outstanding as of June 30,
2019, and excludes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an aggregate of 44,823,800 ordinary shares issuable upon the exercise of options at exercise prices of between $0.33 and $1.37 per ordinary share; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,760,000 ordinary shares issuable upon exercise of warrants at an exercise price of $0.176 per ordinary share.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">Unless otherwise indicated, this
prospectus supplement reflects and assumes the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no exercise of the representative of the underwriters&rsquo; over-allotment option; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no exercise of the Underwriter&rsquo;s Warrants;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_005"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>An investment in the ADSs involves a
high degree of risk. Prior to making a decision about investing in these securities, you should carefully consider the specific
risks, uncertainties and assumptions discussed under <FONT STYLE="background-color: white">the heading &ldquo;Risk Factors&rdquo;
included in our most recent Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577418011717/s113211_20f.htm">Form&nbsp;20-F</A>&nbsp;for the fiscal year ended June 30, 2018, </FONT>all of which are
incorporated herein by reference, and may be amended, supplemented or superseded from time to time by other reports we file with
the SEC in the future. Our business, financial condition or results of operations could be materially adversely affected by any
of these risks which cause you to lose all or part of your investment in the offered securities. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Risks Related to the Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>We will have broad discretion in
how we use the proceeds, and we may use the proceeds in ways with which you and other shareholders may disagree.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white; text-align: justify">We intend to use
the net proceeds from this offering <FONT STYLE="background-color: white">to support a variety of non-clinical activities, including
animal toxicology studies, manufacture of active pharmaceutical ingredient, development of supporting analytical assays and regulatory
activities in connection with the development of our two clinical candidates, IMM-124E and IMM-529. In addition, we expect to use
a portion of the net proceeds for our anticipated clinical trial with IMM-124E to prevent travelers&rsquo; diarrhea and working
capital. We may also use a portion of the net proceeds from this offering to in-license, acquire or invest in complementary businesses,
technologies, products or assets. However, we have no current commitments or obligations to do so.</FONT> Pending these uses, our
management will have broad discretion in the application of the proceeds from this offering and could spend the proceeds in ways
that do not necessarily improve our operating results or enhance the value of our ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We will need to raise additional capital
to meet our business requirements in the future, which is likely to be challenging, could be highly dilutive and may cause the
market price of our securities to decline.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to meet our
business objectives, we will need to raise additional capital, which may not be available on reasonable terms, or at all. We anticipate
that, if we raise such additional capital, we will use such additional capital to accomplish the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">finance our current operating expenses;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">finance our clinical trials;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">pursue growth opportunities;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">hire and retain qualified management and key employees;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">respond to competitive pressures;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">comply with regulatory requirements; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">maintain compliance with applicable laws.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent that
we raise additional capital through the sale of equity or convertible debt securities, the issuance of such securities could result
in substantial dilution for our current stockholders. The terms of any securities issued by us in future capital transactions may
be more favorable to new investors, and may include preferences, superior voting rights and the issuance of warrants or other derivative
securities, which may have a further dilutive effect on the holders of any of our securities then-outstanding. We may issue additional
ordinary shares or securities convertible into or exchangeable or exercisable for our ordinary shares in connection with hiring
or retaining personnel, option or warrant exercises, future acquisitions or future placements of our securities for capital-raising
or other business purposes. The issuance of additional securities, whether equity or debt, by us, or the possibility of such issuance,
may cause the market price of our securities to decline and existing stockholders may not agree with our financing plans or the
terms of such financings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any additional debt
or equity financing that we may need may not be available on terms favorable to us, or at all. If we are unable to obtain such
additional financing on a timely basis, we may have to curtail or cease our business operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>You will experience immediate and
substantial dilution in the net tangible book value per share of the ADSs you purchase.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Since the
offering price per share of the ADSs being offered is substantially higher than the net tangible book value per share of
ADSs, you will suffer substantial dilution in the net tangible book value of the ADSs you purchase in this offering. Based on
the public offering price of $4.00 per ADS, if you purchase ADSs in this offering, you will suffer immediate and substantial
dilution of approximately $0.06 per share ($2.27 per ADS) in the net tangible book value of the ADSs. See the section entitled
&ldquo;Dilution&rdquo; on page&nbsp;S-6 of this prospectus supplement for a more detailed discussion of the dilution you will
incur if you purchase ADSs in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If we are classified as a &ldquo;passive
foreign investment company,&rdquo; then our U.S. shareholders could suffer adverse tax consequences as a result.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Generally, if, for
any taxable year, at least 75% of our gross income is passive income (including our pro rata share of the gross income of our 25%
or more owned corporate subsidiaries) or at least 50% of the average quarterly value of our gross assets (including our pro rata
share of the gross assets of our 25% or more owned corporate subsidiaries) is attributable to assets that produce passive income
or are held for the production of passive income, including cash, we would be characterized as a passive foreign investment company,
or PFIC, for U.S. federal income tax purposes. For purposes of these tests, passive income includes dividends, interest, and gains
from the sale or exchange of investment property and rents and royalties other than rents and royalties which are received from
unrelated parties in connection with the active conduct of a trade or business. If we are characterized as a PFIC, a U.S. holder
of our ordinary shares or the ADSs may suffer adverse tax consequences, including having gains recognized on the sale of our ordinary
shares or ADSs treated as ordinary income, rather than capital gain, the loss of the preferential rate applicable to dividends
received on our ordinary shares or the ADSs by individuals who are U.S. holders, and having interest charges added to their tax
on distributions from us and on gains from the sale of our ordinary shares or the ADSs. See &ldquo;Taxation.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_006"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We estimate that the
net proceeds to us from our issuance and sale of ADSs in this offering will be approximately $1.1 million, after deducting
underwriting discounts and commissions and estimated offering expenses payable by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We intend to use the
net proceeds from this offering <FONT STYLE="background-color: white">to support a variety of non-clinical activities, including
animal toxicology studies, manufacture of active pharmaceutical ingredient, development of supporting analytical assays and regulatory
activities in connection with the development of our two clinical candidates, IMM-124E and IMM-529. In addition, we expect to use
a portion of the net proceeds for our anticipated clinical trial with IMM-124E to prevent travelers&rsquo; diarrhea and working
capital. We may also use a portion of the net proceeds from this offering to in-license, acquire or invest in complementary businesses,
technologies, products or assets. However, we have no current commitments or obligations to do so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This expected use of
our net proceeds from this offering represents our intentions based upon our current plans and business conditions, which could
change in the future as our plans and business conditions evolve. The amounts and timing of our actual expenditures may vary significantly
depending on numerous factors, including the progress of our commercialization effort, the progress of our product candidate development,
the status of and results from clinical trials and any unforeseen cash needs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result, our management
will retain broad discretion over the allocation of the net proceeds from this offering, and investors will be relying on the judgment
of our management regarding the application of the net proceeds from this offering. The timing and amount of our actual expenditures
will be based on many factors, including cash flows from operations and the anticipated growth of our business. Pending these uses,
we expect to invest the net proceeds in short-term, interest bearing obligations, certificates of deposit or direct or guaranteed
obligations of the United States. The goal with respect to the investment of these net proceeds is capital preservation and liquidity
so that such funds are readily available to fund our operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_007"></A>DIVIDEND POLICY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have never declared
or paid cash dividends on our ordinary shares. We currently intend to retain all available funds and any future earnings to support
our operations and to finance the growth and development of our business, and therefore do not anticipate paying any cash dividends
on our ordinary shares in the foreseeable future. Any future determination to declare cash dividends will be made at the discretion
of our board of directors, subject to compliance with applicable laws and covenants under our credit facilities, which may restrict
or limit our ability to pay dividends, and will depend on our financial condition, operating results, capital requirements, general
business conditions and other factors that our board of directors may deem relevant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_008"></A>CAPITALIZATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
sets forth our cash and cash equivalents and our capitalization as of December 31, 2018 presented in U.S. dollars:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on an actual basis; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on an as adjusted basis to give effect to the (i) sale of 500,000 ADSs at a public offering price of $4.00 per ADS in a public offering we completed in May 2019 and (ii) sale of 339,130 ADSs in this offering at a public offering price of $4.00 per ADS.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="white-space: nowrap; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As of December 31, 2018</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Actual</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As Adjusted</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,952,456</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><P STYLE="margin: 0pt 0">5,525,954</P>


</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Shareholders&rsquo; equity:</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued capital</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,178,623</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><P STYLE="margin: 0pt 0">43,752,121</P>


</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reserves</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,942,390</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><P STYLE="margin: 0pt 0">1,942,390</P>


</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated losses</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(38,064,556</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0pt 0">(38,064,556</P>


</TD>
    <TD STYLE="padding-bottom: 1.5pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total shareholders&rsquo; equity</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,056,097</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0pt 0">7,629,955</P>


</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total capitalization</FONT></TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,056,097</FONT></TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right"><P STYLE="margin: 0pt 0">7,629,955</P>


</TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table above excludes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an aggregate of 44,823,800 ordinary shares issuable upon the exercise of options at exercise prices of between $0.33 and $1.37 per ordinary share; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,760,000 ordinary shares issuable upon exercise of warrants at an exercise price of $0.176 per ordinary share.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_009"></A>DILUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you purchase ADSs
in this offering, your ownership interest in us will be diluted to the extent of the difference between the public offering price
per ADS you will pay in this offering and the pro forma net tangible book value per ADS after this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our historical net
tangible book value as of December 31, 2018, was approximately $5.06 million, corresponding to a net tangible book value of $0.035
per ordinary share or $1.41 per ADS (using the ratio of 40 ordinary shares to one ADS), as of such date. We calculate our historical
net tangible book value per share or per ADS by taking the amount of our total tangible assets, subtracting the amount of our total
liabilities, and then dividing the difference by the actual total number of ordinary shares or ADSs outstanding, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The as adjusted net tangible
book value per share as of December 31, 2018 was $0.04 per ordinary share or $1.73 per ADS (using the ratio of 40 ordinary shares
to one ADS). The as adjusted net tangible book value per share gives effect to the (i) sale of 500,000 ADSs at a public offering
price of $4.00 per ADS in a public offering we completed in May 2019 and (ii) sale and issuance of the ADSs in this offering at
an offering price of $4.00 per ADS, after deducting underwriting discounts and commissions and estimated offering expenses payable
by us.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The as adjusted net
tangible book value per share after the offering is calculated by dividing the net tangible book value of $7.63 million, by 176,780,906,
which is equal to our as adjusted issued and outstanding ordinary shares. The difference between the public offering price and
the as adjusted net tangible book value per share represents an immediate increase in the net tangible book value of $0.01 per
ordinary share or $0.31 per ADS to existing shareholders and immediate dilution of $0.06 per share, or $2.27 per ADS to new investors
purchasing the ADSs in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table illustrates this dilution
on an ADS basis:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%">Public offering price per ADS</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">4.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Actual net tangible book value per ADS as at December 31, 2018</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.41</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Increase in net tangible book value per ADS attributable
    to purchasers purchasing ADSs in the May 2019 public offering and this offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.31</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net tangible book value per ADS, as adjusted to give effect to this offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.73</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dilution per ADS to purchasers in this offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2.27</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_010"></A>MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">The
following table sets forth the names and ages of all of our directors and executive officers. Our board of directors is currently
comprised of seven members, who are elected annually to serve for one year or until their successor is duly elected and qualified,
or until their earlier resignation or removal. Executive officers serve at the discretion of the board of directors and are appointed
by the board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: bottom; width: 27%; border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="vertical-align: bottom; width: 6%; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: justify; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="vertical-align: bottom; width: 65%; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Roger Aston</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Executive Chairman</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Peter Anastasiou</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice Chairman</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Daniel Pollock</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Executive Director</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Stephen Anastasiou</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Executive Director</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prof. Ravi Savarirayan</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Executive Director</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Richard J. Berman</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Executive Director </FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary S. Jacob, Ph.D.</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Non-Executive Director</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Jerry Kanellos, Ph.D.</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Phillip Hains</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer and Secretary</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Mr. Peter Anastasiou and Mr. Stephen Anastasiou
are brothers. Other than such relationship, there are no family relationships among our directors and senior executives. &nbsp;Peter
Anastasiou is the Chairman of Grandlodge Capital Pty Ltd., one of our principal stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Roger Aston&nbsp;</I></B>has
been a member of our board of directors and the board&rsquo;s non-executive Chairman since March 2012. Dr. Aston is both a scientist
and a seasoned biotechnology entrepreneur, with a successful track record in both fields, and brings to the board more than 20
years&rsquo; experience in the pharmaceutical and biotech industries. Aspects of his experience include FDA and EU product registration,
clinical trials, global licensing agreements, fundraising through private placements, and a network of contacts within the pharmaceutical,
banking and stock broking sectors. Dr. Aston has had extensive experience on boards of many biopharmaceutical companies including
Directorships/Chairmanships with Clinuvel Limited (ASX:CUV), HalcyGen Limited (ASX:HGN), Ascent Pharma Health Limited (ASX:APH).
Dr. Aston is currently the Executive Chairman of Pharmaust Ltd (ASX:PAA), Director and Chairman of Regeneus Limited (ASX:RGS) and
ResApp Limited (ASX:RAP). During 2007 and 2008, Dr. Aston was a member of the AusIndustry Biological Committee advising the Industry
Research and Development Board. More recently, Dr. Aston was Executive Chairman of Mayne Pharma Group from 2009 to 2011 and CEO
of Mayne Pharma Group until 2012. Dr. Aston has also been a Director of IDT Limited (ASX:IDT), Cynata Limited (ASX:CYP), Calzada
Limited (now Polynovo Limited), Director and Chairman of Oncosil Medical Limited (ASX:OSL), and Biolife Limited (now Imugene ASX:IMU).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Peter Anastasiou</I></B>
has been a member of our board of directors and our Executive Vice Chairman since May 2015. Mr. Anastasiou is an entrepreneur and
investor with extensive experience in business both in Australia and overseas. Mr. Anastasiou was the founding Chairman of the
ACSI Group of Companies, which has owned and managed successful consumer companies such as SABCO, Britex Carpet Care, Rug Doctor
and Crystal Clear. Mr. Anastasiou also has a number of philanthropic interests including being a patron of the Identity Theatre
for men, a prior board member and supporter of the Indigenous Eye Health Unit at Melbourne University, a supporter of the John
Fawcett Foundation in Bali, and a founding investor and Director of Melbourne Victory Football Club.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Daniel Pollock&nbsp;</I></B>has
been a member of our board of directors since October 2012. Mr. Pollock is a lawyer admitted in both Scotland and Australia and
holding Practicing Certificates in both jurisdictions. He is a sole practitioner in his own legal firm based in Melbourne, Australia
which operates internationally and specializes in commercial law. He is also Executive Director and co-owner of Great Accommodation
P/L a property management business operating in Victoria.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Stephen Anastasiou&nbsp;</I></B>has
been a member of our board of directors since May 2013. Mr. Anastasiou has over 20 years&rsquo; experience in general management,
marketing and strategic planning within the healthcare industry. His breadth of experience incorporates medical diagnostics, pharmaceuticals,
hospital, dental and OTC products, with companies including the international pharmaceutical company Bristol - Myers Squibb. While
working with KPMG Peat Marwick as a management consultant, Mr. Anastasiou led project teams in a diverse range of market development
and strategic planning projects in both the public and private sector. He is also a director and shareholder of a number of unlisted
private companies, covering a variety of industry sectors that include healthcare and funds management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Professor Ravi
Savarirayan&nbsp;</I></B>was appointed as a non-executive director of our board on April 7, 2017. He is a consultant clinical geneticist
at the Victorian Clinical Genetics Services since August 1999, as well as Professor and Research Group Leader (Skeletal Biology
and Disease) at the Murdoch Children&rsquo;s Research Institute since September 2000. Mr. Savarirayan is a founding member of the
Skeletal Dysplasia Management Consortium since January 2011 and has been the Chair of the Specialist Advisory Committee in Clinical
Genetics, Royal Australasian College of Physicians since February 2009. He was president of the International Skeletal Dysplasia
Society from July 2009 to June 2011 and has been an invited member of several International Working Committees on Constitutional
Diseases of Bone. Mr. Savarirayan&rsquo;s primary research focus is on inherited disorders of the skeleton causing short stature,
arthritis and osteoporosis. He has published over 150 peer-reviewed articles, collaborating with peers from over 30 countries,
and has been on the editorial board of Human Mutation since January 2009, European Journal of Human Genetics since July 2007, American
Journal of Medical Genetics since December 2011 and Journal of Medical Genetics since June 2005. Mr. Savarirayan received his MBBS
from the University of Adelaide in 1990 and became a fellow of the Royal Australasian College of Physicians in December 1997. He
was certified as a specialist in clinical genetics from the Human Genetics Society of Australasia in 1998 and received his Doctor
of Medicine from the University of Melbourne in 2004, for his thesis &ldquo;Clinical and Molecular Studies in the Osteochondrodysplasias.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Mr. Richard J.
Berman&nbsp;</I></B>was<I>&nbsp;</I>appointed as a non-executive director effective July 1, 2018<B>.&nbsp;</B>Mr. Berman&rsquo;s
business career spans over 35 years of venture capital, senior management and merger &amp; acquisitions experience. Mr. Berman
is a well-respected and seasoned professional, senior executive and public company board member with extensive experience in many
business sectors including finance, technology, retail, bio-science and real estate. In the last five years, Mr. Berman was employed
under the following positions, director at Energy Smart Resources, Inc since2012, lead independent director of Cryoport, Inc. since2015,
and independent director of Catasys, Inc since 2017. Mr. Berman is also a director of three public healthcare companies: Advaxis,
Inc., Caladrius Biosciences, Inc., and Cryoport Inc. He has also served as a director or officer of more than a dozen public and
private companies. In 2016, he joined the advisory Board of Medifirst while in 2014, he was elected Chairman of MetaStat Inc. From
2006-2011, he was Chairman of National Investment Managers, a company with $12 billion in pension administration assets. From 2002
to 2010, he was a director of Nexmed Inc where he also served as Chairman/CEO in 2008 and 2009 (now called Apricus Biosciences,
Inc.). From 1998-2000, he was employed by Internet Commerce Corporation (now Easylink Services) as Chairman and CEO, and was a
director from 1998 to 2012. Previously, Mr. Berman worked at Goldman Sachs; was Senior Vice President of Bankers Trust Company,
where he started the M&amp;A and Leveraged Buyout Departments; created the largest battery company in the world in the 1980&rsquo;s
by merging Prestolite, General Battery and Exide to form Exide Technologies (XIDE); helped to create what is now Soho (NYC) by
developing five buildings; and advised on over $4 billion of M&amp;A transactions in over 300 deals. He is a past Director of the
Stern School of Business of NYU where he obtained his B.S. and MBA. degrees. He also has law degrees from Boston College and The
Hague Academy of International Law, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Gary S. Jacob</I></B>,
<B><I>Ph.D.</I></B> has served as our Chief Executive Officer since November 2018 and a director since April 2019. From July 2008
until December 2017, Dr. Jacob was President and Chief Executive Officer of Synergy Pharmaceuticals&nbsp;Inc., and he served as
its Chairman from September 2013 to December 2017. He served as Executive Chairman from December 2017 until October 2018. On December&nbsp;12,
2018, Synergy Pharmaceuticals Inc. filed a petition for relief under Chapter 11 of the U.S. Bankruptcy Code. Dr. Jacob has been
Chairman of ContraVir Pharmaceuticals,&nbsp;Inc. since May 2013. Dr. Jacob has been a director of Trovagene,&nbsp;Inc. since February
2009. Dr.&nbsp;Jacob served as Chief Executive Officer of Callisto Pharmaceuticals,&nbsp;Inc. from October 2004 until it was merged
into Synergy Pharmaceuticals&nbsp;Inc. in January 2013. Prior to 1999, Dr.&nbsp;Jacob served as a Monsanto Science Fellow, specializing
in the field of glycobiology, and from 1997 to 1998 was Director of Functional Genomics, Corporate Science&nbsp;&amp; Technology,
at Monsanto Company. Dr. Jacob earned a B.S. in Chemistry from the University of Missouri, St. Louis, and holds a Ph.D. in Biochemistry
from the University of Wisconsin-Madison. The board believes Dr. Jacob&rsquo;s broad management expertise in the pharmaceutical
and biotechnology industries provides relevant experience in a variety of strategic and operational areas and qualifies him to
serve as a director of our company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Dr. Jerry Kanellos,
Ph.D.</I>&nbsp;</B>has been our Chief Operating Officer since July 2015, and served as our Interim CEO from August 2017 until November
2018 and our Chief Scientific Officer from July 2015 to November 2018. In addition, since April 2018, Dr. Kanellos has served as
a director of IMC Canada Limited. Dr. Kanellos has over twenty-five years&rsquo; experience in the pharmaceutical and biotechnology
industry, and has held leadership roles in executive management, business development, project management, intellectual property
portfolio management research and development. From 2008 until 2012, Dr. Kanellos was the Chief Operating Officer of TransBio Limited
where he was responsible for the strategic identification, development and maintenance of commercial partnerships globally, along
with development, management and maintenance responsibility for the intellectual property portfolio, research and development and
technology transfer. Prior to this, Dr. Kanellos worked for five years as a consultant to the biotechnology industry and provided
development and commercialization strategies for various bodies including academic institutes, private and publicly listed companies
and government departments both national and international. He has also been involved in the establishment and management of several
startup biotechnology companies. During his ten year tenure in research and development at CSL Limited, a global specialty biotherapeutics
company that develops and delivers innovative biotherapies, Dr. Kanellos gained considerable experience in the international drug
development process, formulation development through to pharmaceutical scale up and cGMP manufacture successfully leading the Chemistry
Manufacturing and Controls (CMC) programs for the approval, manufacture and launch of several products. Dr. Kanellos holds a PhD
degree in Medicine from the University of Melbourne.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Phillip Hains&nbsp;</I></B>has
been our Chief Financial Officer and Secretary since April 2013. Mr. Hains is a Chartered Accountant and specialist in the public
company environment. He has served the needs of a number of public company boards of directors and related committees. He has over
20 years&rsquo; experience in providing accounting, administration, compliance and general management services. He holds a Masters
of Business Administration from RMIT and a Public Practice Certificate from the Institute of Chartered Accountants of Australia.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_011"></A>DESCRIPTION OF THE SECURITIES WE ARE
OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>American Depositary Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Bank of New York
Mellon, as depositary, will register and deliver ADSs. Each ADS will represent 40 shares (or a right to receive 40 shares) deposited
with HSBC Bank Australia, as custodian for the depositary. Each ADS will also represent any other securities, cash or other property
which may be held by the depositary. The depositary&rsquo;s office at which the ADSs will be administered and its principal executive
office are located at 240 Greenwich Street, New York, New York 10286.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may hold ADSs either
(A) directly (i) by having an American Depositary Receipt, or ADR, which is a certificate evidencing a specific number of ADSs,
registered in your name, or (ii) by having ADSs registered in your name in the Direct Registration System, or DRS, or (B) indirectly
by holding a security entitlement in ADSs through your broker or other financial institution. If you hold ADSs directly, you are
a registered ADS holder, also referred to as an ADS holder. This description assumes you are an ADS holder. If you hold the ADSs
indirectly, you must rely on the procedures of your broker or other financial institution to assert the rights of ADS holders described
in this section. You should consult with your broker or financial institution to find out what those procedures are.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The DRS is a system
administered by The Depository Trust Company, or DTC, under which the depositary may register the ownership of uncertificated ADSs,
which ownership is confirmed by statements sent by the depositary to the registered holders of uncertificated ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As an ADS holder, we
will not treat you as one of our shareholders and you will not have shareholder rights. Australian law governs shareholder rights.
The depositary will be the holder of the shares underlying your ADSs. As a registered holder of ADSs, you will have ADS holder
rights. A deposit agreement among us, the depositary, ADS holders and all other persons indirectly or beneficially holding ADSs
sets out ADS holder rights as well as the rights and obligations of the depositary. New York law governs the deposit agreement
and the ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a
summary of the material provisions of the deposit agreement. Because it is a summary, it does not contain all the information that
may be important to you. For more complete information, you should read the entire deposit agreement and the form of ADR which
summarizes certain terms of your ADSs. You may also obtain a copy of the deposit agreement at the SEC&rsquo;s Public Reference
Room which is located at 100 F Street, NE, Washington, DC 20549. You may obtain information on the operation of the Public Reference
Room by calling the SEC at 1-800-732-0330. You may also find the registration statement and the deposit agreement on the SEC&rsquo;s
website at http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dividends and Other Distributions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>How will you receive dividends and
other distributions on the shares?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary has
agreed to pay to ADS holders the cash dividends or other distributions it or the custodian receives on shares or other deposited
securities, after deducting its fees and expenses. You will receive these distributions in proportion to the number of shares your
ADSs represent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cash.&nbsp;</I></B>The
depositary will convert any cash dividend or other cash distribution we pay on the shares into U.S. dollars, if it can do so on
a reasonable basis and can transfer the U.S. dollars to the United States. If that is not possible or if any government approval
is needed and cannot be obtained, the deposit agreement allows the depositary to distribute the foreign currency only to those
ADS holders to whom it is possible to do so. It will hold the foreign currency it cannot convert for the account of the ADS holders
who have not been paid. It will not invest the foreign currency and it will not be liable for any interest.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Before making a distribution,
any withholding taxes, or other governmental charges that must be paid will be deducted. The depository will distribute only whole
U.S. dollars and cents and will round fractional cents to the nearest whole cent. If the exchange rates fluctuate during a time
when the depositary cannot convert the foreign currency, you may lose some or all of the value of the distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Shares.&nbsp;</I></B>The
depositary may distribute additional ADSs representing any shares we distribute as a dividend or free distribution. The depositary
will only distribute whole ADSs. It will sell shares which would require it to deliver a fraction of an ADS (or ADSs representing
those shares) and distribute the net proceeds in the same way as it does with cash. If the depositary does not distribute additional
ADSs, the outstanding ADSs will also represent the new shares. The depositary may sell a portion of the distributed shares sufficient
to pay its fees and expenses in connection with that distribution (or ADSs representing those shares).</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Rights
to purchase additional shares.&nbsp;</I></B>If we offer holders of our securities any rights to subscribe for additional shares
or any other rights, the depositary may make these rights available to ADS holders. If the depositary decides it is not legal
and practical to make the rights available but that it is practical to sell the rights, the depositary will use reasonable efforts
to sell the rights and distribute the proceeds in the same way as it does with cash. The depositary will allow rights that are
not distributed or sold to lapse. In that case, you will receive no value for them.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">If the depositary makes rights
available to ADS holders, it will exercise the rights and purchase the shares on your behalf. The depositary will then deposit
the shares and deliver ADSs to the persons entitled to them. It will only exercise rights if you pay it the exercise price and
any other charges the rights require you to pay together with the depositary&rsquo;s fees and expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">U.S. securities laws may restrict
transfers and cancellation of the ADSs represented by shares purchased upon exercise of rights. For example, you may not be able
to trade these ADSs freely in the United States. In this case, the depositary may deliver restricted depositary shares that have
the same terms as the ADSs described in this section except for changes needed to put the necessary restrictions in place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other Distributions.</I></B>&nbsp;The depositary will send to ADS holders anything else we distribute on deposited securities by any means it thinks is legal, fair and practical. If it cannot make the distribution in that way, the depositary (i) may decide to sell what we distributed and distribute the net proceeds, in the same way as it does with cash or (ii) it may decide to hold what we distributed, in which case ADSs will also represent the newly distributed property. However, the depositary is not required to distribute any securities (other than ADSs) to ADS holders unless it receives satisfactory evidence from us that it is legal to make that distribution. The depositary may sell a portion of the distributed securities or property sufficient to pay its fees and expenses in connection with that distribution.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary is not
responsible if it decides that it is unlawful or impractical to make a distribution available to any ADS holders. We have no obligation
to register ADSs, shares, rights or other securities under the Securities Act. We also have no obligation to take any other action
to permit the distribution of ADSs, shares, rights or anything else to ADS holders. This means that you may not receive the distributions
we make on our shares or any value for them if it is illegal or impractical for us to make them available to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Deposit, Withdrawal and Cancellation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>How are ADSs issued?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary will
deliver ADSs if you or your broker deposits shares or evidence of rights to receive shares with the custodian. Upon payment of
its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will register
the appropriate number of ADSs in the names you request and will deliver the ADSs to or upon the order of the person or persons
that made the deposit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>How can ADS holders withdraw the
deposited securities?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may surrender your
ADSs at the depositary&rsquo;s office. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or
stock transfer taxes or fees, the depositary will deliver the shares and any other deposited securities underlying the ADSs to
the ADS holder or a person the ADS holder designates at the office of the custodian. However, at the request, risk and expense
of the ADS holder, the depositary will deliver the deposited securities at its office, if feasible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>How do ADS holders interchange between
certificated ADSs and uncertificated ADSs?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may surrender your
ADR to the depositary for the purpose of exchanging your ADR for uncertificated ADSs. The depositary will cancel that ADR and will
send to the ADS holder a statement confirming that the ADS holder is the registered holder of uncertificated ADSs. Alternatively,
upon receipt by the depositary of a proper instruction from a registered holder of uncertificated ADSs requesting the exchange
of uncertificated ADSs for certificated ADSs, the depositary will execute and deliver to the ADS holder an ADR evidencing those
ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Voting Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>How do you vote?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary will
notify ADS holders of shareholders&rsquo; meetings and arrange to deliver our voting materials to them if we ask it to. Those materials
will describe the matters to be voted on and explain how ADS holders may instruct the depositary to vote. For instructions to be
valid, they much reach the depositary by a date set by the depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary will
try, as far as practical, subject to the laws of Australia and of our Constitution or similar documents, to vote or to have its
agents vote the shares or other deposited securities as instructed by ADS holders. The depositary will only vote or attempt to
vote as instructed. Accordingly, ADS holders must instruct the depositary how to vote the number of deposited shares their ADSs
represent; otherwise, such holders will not be able to exercise their right to vote unless they withdraw their shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot assure you
that you will receive the voting materials in time to ensure that you can instruct the depositary to vote your shares. In addition,
the depositary and its agents are not responsible for failing to carry out voting instructions or for the manner of carrying out
voting instructions. This means that you may not be able to exercise your right to vote and there may be nothing you can do if
your shares are not voted as you requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to give you
a reasonable opportunity to instruct the depositary as to the exercise of voting rights relating to deposited securities, if we
request the depositary to act, we agree to give the depositary notice of any such meeting and details concerning the matters to
be voted upon at least 30 days in advance of the meeting date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Fees and Expenses</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Persons depositing or withdrawing shares or ADS holders must pay</I>:</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>For</I>:</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$5.00 (or less) per 100 ADSs (or portion of 100 ADSs)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of ADSs, including issuances resulting from a distribution of shares or rights or other property and cancellation of ADSs for the purpose of withdrawal, including if the deposit agreement terminates</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.05 (or less) per ADS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any cash distribution to ADS holders</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A fee equivalent to the fee that would be payable if securities distributed to you had been shares and the shares had been deposited for issuance of ADSs</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distribution of securities distributed to holders of deposited securities which are distributed by the depositary to ADS holders</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.05 (or less) per ADS per calendar year</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depositary services</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration or transfer fees</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer and registration of shares on our share register to or from the name of the depositary or its agent when you deposit or withdraw shares</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses of the depositary</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cable, telex and facsimile transmissions (when expressly provided in the deposit agreement) &nbsp;and expenses of converting foreign currency to U.S. dollars</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes and other governmental charges the depositary or the custodian has to pay on any ADSs or shares underlying ADSs, such as&nbsp;&nbsp;stock transfer taxes, stamp duty or withholding taxes</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As necessary</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any charges incurred by the depositary or its agents for servicing the deposited securities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As necessary</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary collects
its fees for delivery and surrender of ADSs directly from investors depositing shares or surrendering ADSs for the purpose of withdrawal
or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting those fees
from the amounts distributed or by selling a portion of distributable property to pay the fees. The depositary may collect its
annual fee for depositary services by deduction from cash dividends or other cash distributions or by directly billing investors
or by charging the book-entry system accounts of participants acting for them. The depositary may collect any of its fees by deduction
from any cash distribution payable to ADS holders that are obligated to pay those fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time,
the depositary may make payments to us to reimburse us for costs and expenses generally arising out of establishment and maintenance
of the ADS program, waive fees and expenses for services provided to us by the depositary or share revenue from the fees collected
from ADS holders. In performing its duties under the deposit agreement, the depositary may use brokers, dealers, foreign currency
dealers or other service providers that are owned by or affiliated with the depositary and that may earn or share fees, spreads
or commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary may
convert currency itself or through any of its affiliates and, in those cases, acts as principal for its own account and not as
agent, advisor, broker or fiduciary on behalf of any other person and earns revenue, including, without limitation, transaction
spreads, that it will retain for its own account. The revenue is based on, among other things, the difference between the exchange
rate assigned to the currency conversion made under the deposit agreement and the rate that the depositary or its affiliate receives
when buying or selling foreign currency for its own account. The depositary makes no representation that the exchange rate used
or obtained in any currency conversion under the deposit agreement will be the most favorable rate that could be obtained at the
time or that the method by which that rate will be determined will be the most favorable to ADS holders, subject to the depositary&rsquo;s
obligations under the deposit agreement. The methodology used to determine exchange rates used in currency conversions is available
upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Payment of Taxes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You will be responsible
for any taxes or other governmental charges payable on your ADSs or on the deposited securities represented by any of your ADSs.
The depositary may refuse to register any transfer of your ADSs or allow you to withdraw the deposited securities represented by
your ADSs until such taxes or other charges are paid. It may apply payments owed to you or sell deposited securities represented
by your ADSs to pay any taxes owed and you will remain liable for any deficiency. If the depositary sells deposited securities,
it will, if appropriate, reduce the number of ADSs to reflect the sale and pay to ADS holders any proceeds, or send to ADS holders
any property, remaining after it has paid the taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Reclassifications, Recapitalizations
and Mergers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon any change in
nominal value, change in par value, split-up, consolidation, or any other reclassification of deposited securities, or upon any
recapitalization, reorganization, merger or consolidation, or sale of assets affecting us or to which we are a party, or upon the
redemption or cancellation by us of the deposited securities, any securities, cash or property which shall be received by the depositary
or a custodian in exchange for, in conversion of, in lieu of or in respect of deposited securities shall be treated as new deposited
securities under the deposit agreement, and ADSs shall thenceforth represent, in addition to the existing deposited securities,
the right to receive the new deposited securities so received, unless additional ADRs are delivered. In any such case the depositary
may execute and deliver additional ADRs as in the case of a dividend in ordinary shares, or call for the surrender of outstanding
ADRs to be exchanged for new ADRs specifically describing such new deposited securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Amendment and Termination</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>How may the deposit agreement be amended?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may agree with the
depositary to amend the deposit agreement and the ADRs without your consent for any reason. If an amendment adds or increases fees
or charges, except for taxes and other governmental charges or expenses of the depositary for registration fees, facsimile costs,
delivery charges or similar items, or prejudices a substantial right of ADS holders, it will not become effective for outstanding
ADSs until 30 days after the depositary notifies ADS holders of the amendment. <I>At the time an amendment becomes effective, you
are considered, by continuing to hold your ADSs, to agree to the amendment and to be bound by the ADRs and the deposit agreement
as amended.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>How may the deposit agreement be terminated?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary will
terminate the deposit agreement at our direction by mailing notice of termination to the ADS holders then outstanding at least
30 days prior to the date fixed in such notice for such termination. The depositary may also terminate the deposit agreement by
mailing notice of termination to us and the ADS holders if 30 days have passed since the depositary told us it wants to resign
but a successor depositary has not been appointed and accepted its appointment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After termination,
the depositary and its agents will do the following under the deposit agreement but nothing else: collect distributions on the
deposited securities, sell rights and other property, and deliver shares and other deposited securities upon cancellation of ADSs.
Four months after termination, the depositary may sell any remaining deposited securities by public or private sale. After that,
the depositary will hold the money it received on the sale, as well as any other cash it is holding under the deposit agreement
for the <U>pro rata</U> benefit of the ADS holders that have not surrendered their ADSs.<B>&nbsp;</B>It will not invest the money
and has no liability for interest. The depositary&rsquo;s only obligations will be to account for the money and other cash. After
termination our only obligations will be to indemnify the depositary and to pay fees and expenses of the depositary that we agreed
to pay.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Limitations on Obligations and Liability</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Limits on Our Obligations and the
Obligations of the Depositary; Limits on Liability to Holders of ADSs</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The deposit agreement
expressly limits our obligations and the obligations of the depositary. It also limits our liability and the liability of the depositary.
We and the depositary, among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">are only obligated to take the actions specifically set forth in the deposit agreement without negligence or bad faith;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">are not liable if we are or it is prevented or delayed by law or circumstances beyond our or its control from performing our or its obligations under the deposit agreement;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">are not liable if we or it exercises discretion permitted under the deposit agreement;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">are not liable for the inability of any holder of ADSs to benefit from any distribution on deposited securities that is not made available to holders of ADSs under the terms of the deposit agreement, or for any special, consequential or punitive damages for any breach of the terms of the deposit agreement;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">have no obligation to become involved in a lawsuit or other proceeding related to the ADSs or the deposit agreement on your behalf or on behalf of any other person;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">are not liable for the acts or omissions of any securities depository, clearing agency or settlement system; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may rely upon any documents we believe or it believes in good faith to be genuine and to have been signed or presented by the proper person.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the deposit agreement, we and the depositary
agree to indemnify each other under certain circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Requirements for Depositary Actions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Before the depositary
will deliver or register a transfer of ADSs, make a distribution on ADSs, or permit withdrawal of shares, the depositary may require,
among other things:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">payment of stock transfer or other taxes or other governmental charges and transfer or registration fees charged by third parties for the transfer of any shares or other deposited securities;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">satisfactory proof of the identity and genuineness of any signature or other information it deems necessary; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance with regulations it may establish, from time to time, consistent with the deposit agreement, including presentation of transfer documents.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary may
refuse to deliver ADSs or register transfers of ADSs when the transfer books of the depositary or our transfer books are closed
or at any time if the depositary or we think it advisable to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Your Right to Receive the Shares Underlying
Your ADSs</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ADS holders have the right to cancel their
ADSs and withdraw the underlying shares at any time except:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">when temporary delays arise because: (i) the depositary, we or the foreign registrar has closed its transfer books; (ii) the transfer of shares is blocked to permit voting at a shareholders&rsquo; meeting; or (iii) we are paying a dividend on our shares;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">when you owe money to pay fees, taxes and similar charges; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">when it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to ADSs or to the withdrawal of shares or other deposited securities.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This right of withdrawal may not be limited
by any other provision of the deposit agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Direct Registration System</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All parties to the
deposit agreement acknowledge that the DRS and Profile Modification System, or Profile, will apply to uncertificated ADSs upon
acceptance thereof to DRS by DTC. DRS is the system administered by DTC under which the depositary may register the ownership of
uncertificated ADSs, which ownership will be confirmed by statements sent by the depositary to the registered holders of uncertificated
ADSs. Profile is a required feature of DRS that allows a DTC participant, claiming to act on behalf of a registered holder of ADSs,
to direct the depositary to register a transfer of those ADSs to DTC or its nominee and to deliver those ADSs to the DTC account
of that DTC participant without receipt by the depositary of prior authorization from the ADS holder to register that transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
and in accordance with the arrangements and procedures relating to DRS/Profile, the parties to the deposit agreement understand
that the depositary will not determine whether the DTC participant that is claiming to be acting on behalf of an ADS holder in
requesting registration of transfer and delivery described in the paragraph above has the actual authority to act on behalf of
the ADS holder (notwithstanding any requirements under the Uniform Commercial Code). In the deposit agreement, the parties agree
that the depositary&rsquo;s reliance on and compliance with instructions received by the depositary through the DRS/Profile System
and in accordance with the deposit agreement will not constitute negligence or bad faith on the part of the depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Shareholder Communications; Inspection of Register of Holders
of ADSs</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary will
make available for your inspection at its office all reports and communications that it receives from us as a holder of deposited
securities that we make generally available to holders of deposited securities. The depositary will send you copies of those communications
that we ask it to send. You have a right to inspect the register of holders of ADSs, but not for the purpose of contacting those
holders about a matter unrelated to our business, the deposit agreement or the ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B><A NAME="ps_012"></A>TAXATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white; text-align: justify"><I>The following
is a summary of certain material U.S. federal and Australian income tax considerations to U.S. Holders, as defined below, of the
acquisition, ownership and disposition of ordinary shares and ADSs. This discussion is based on the laws in force as of the date
of this prospectus supplement, and is subject to changes in the relevant income tax law, including changes that could have retroactive
effect. The following summary does not take into account or discuss the tax laws of any country or other taxing jurisdiction other
than the United States and Australia. Holders are advised to consult their tax advisors concerning the overall tax consequences
of the acquisition, ownership and disposition of ordinary shares or ADSs in their particular circumstances. This discussion is
not intended, and should not be construed, as legal or professional tax advice.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify"><I>This summary does not address the effects
of U.S. federal estate and gift tax laws, the alternative minimum tax, or any state and local tax considerations within the United
States, and is not a comprehensive description of all U.S. federal or Australian income tax considerations that may be relevant
to a decision to acquire or dispose of ordinary shares or ADSs. Furthermore, this summary does not address U.S. federal or Australian
income tax considerations relevant to holders subject to taxing jurisdictions other than, or in addition to, the United States
and Australia, and does not address all possible categories of holders, some of which may be subject to special tax rules.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>AUSTRALIAN TAX CONSEQUENCES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">In this section we discuss the material
Australian tax considerations that apply to non-Australian tax residents who do not carry on business in Australia (&ldquo;foreign
residents&rdquo;), with respect to the acquisition, ownership and disposal of the absolute beneficial ownership of ADSs. This discussion
is based upon existing Australian tax law as of the date of this prospectus supplement, which is subject to change, possibly retrospectively.
This discussion does not address all aspects of Australian income tax law which may be important to particular investors in light
of their individual investment circumstances, such as ADSs or shares held by investors subject to special tax rules (for example,
financial institutions, insurance companies or tax exempt organizations). In addition, this summary does not discuss any foreign
or state tax considerations, other than Australian stamp duty. Prospective investors are urged to consult their tax advisors regarding
the Australian and foreign income and other tax considerations of the purchase, ownership and disposition of the ADSs or shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Nature of ADSs for Australian Taxation Purposes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Foreign resident holders of ADSs should
obtain specialist Australian tax advice regarding their rights and obligations under the deposit agreement with the depositary,
including whether the deposit arrangement constitutes a &lsquo;bare trust&rsquo; for Australian taxation purposes. Outside certain
limited aspects of the Australian tax legislation (for example, for Australian capital gains tax and dividend withholding tax purposes,
which are discussed below), there is no express legislative basis for disregarding &lsquo;bare trusts&rsquo; for Australian tax
purposes generally. There is stated to be some industry practice to disregard &lsquo;bare trusts&rsquo; for Australian tax purposes
generally. Industry consultation has been conducted in relation to a proposal to enact such legislation for Australian income tax
purposes. No legislation has yet been enacted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Holders of ADSs can be treated as the owners
of the underlying ordinary shares for Australian capital gains tax purposes under the presently enacted &lsquo;absolute entitlement&rsquo;
capital gains tax rules. Dividends paid on the underlying ordinary shares can be treated for Australian dividend withholding tax
purposes as if they were derived directly by the owners of ADSs under the presently enacted &lsquo;present entitlement&rsquo; dividend
withholding tax rules. In the following analysis we discuss the application of those Australian dividend withholding tax and capital
gains tax rules to foreign resident holders of ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Taxation of Dividends</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Australia operates a dividend imputation
system under which eligible dividends may be declared to be &lsquo;franked&rsquo; to the extent of tax paid on company profits.
Fully franked dividends are not subject to dividend withholding tax. Dividends that are not franked or are partly franked and are
paid to a foreign resident may be subject to dividend withholding tax, but only to the extent the dividends are not franked.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Unfranked dividends paid to a foreign resident
who is treated as deriving the dividend directly under the &lsquo;present entitlement&rsquo; dividend withholding tax rules are
subject to withholding tax at 30%, unless the foreign resident is a resident of a country with which Australia has a double taxation
agreement. In accordance with the provisions of the Double Taxation Convention between Australia and the U.S., the maximum rate
of Australian dividend withholding tax on unfranked dividends to which a resident of the U.S. is beneficially entitled is reduced
to 15%, 5% or nil, depending on the circumstances of the U.S. resident These reduced rates only apply to U.S. residents who are
&lsquo;qualified persons&rsquo; under the Convention. The Double Taxation Convention between Australia and the U.S. does not apply
to limit the dividend withholding tax rate on dividends where the ADSs are effectively connected to a permanent establishment of
the U.S. resident in Australia or a fixed base of the U.S. resident in Australia from which the U.S. resident provides independent
personal services. If no dividend withholding tax is paid by reason of a nil rate applying under the Convention, Australian ABN/TFN
withholding tax may instead be applicable and specialist tax advice should be sought.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Tax on Sales or other Dispositions of Shares - Capital Gains
Tax</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Capital gains derived by foreign residents
in respect of the disposal of capital assets that are not taxable Australian property may be disregarded. Foreign residents who
are treated as the direct owner of the underlying shares under the &lsquo;absolute entitlement&rsquo; capital gains tax rules will
not be subject to Australian capital gains tax on the capital gain made on a disposal of our shares, unless they, together with
associates, hold 10% or more of our issued capital, tested either at the time of disposal or over any continuous 12 month period
in the 24 months prior to disposal, and the value of our shares at the time of disposal are wholly or principally attributable
to Australian real property assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Australian capital gains tax applies to
net capital gains at a taxpayer&rsquo;s marginal tax rate. Foreign residents are not entitled to any discount on capital gains
where they acquired the relevant capital asset after May 8, 2012 and were foreign residents during their entire holding period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Net capital gains are calculated after
reduction for capital losses, which may only be offset against capital gains.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Tax on Sales or other Dispositions of ADS - Revenue Account</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Some foreign residents may hold their ADS
on revenue rather than on capital account. These foreign residents may have the gains made on the sale or other disposal of the
ADS included in their Australian assessable income under the ordinary income provisions of the income tax law, if the gains are
sourced in Australia. The ordinary income provisions of the Australian income tax law do not presently contain express provisions
to disregard &lsquo;bare trusts&rsquo; so as to treat ADS holders as holding our shares directly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Foreign residents assessable under these
ordinary income provisions in respect of gains made on ADS held on revenue account may be assessed for such gains at the Australian
tax rates for foreign residents, which start at a marginal rate of 32.5% for foreign resident individuals. Some relief from the
Australian income tax may be available to such foreign residents under the Double Taxation Convention between the U.S. and Australia.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">A situation may arise where a foreign resident
holds their ADS on revenue account but the depositary holds our shares on capital account. The tax implications of such a situation
are complex and foreign residents should seek specialist Australian tax advice for their circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">To the extent an amount would be included
in a foreign resident&rsquo;s assessable income under both the capital gains tax provisions and the ordinary income provisions,
the capital gain amount may be reduced, so that the foreign resident may not be subject to double tax on the gain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dual Residency</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">If an ADS holder were a resident of both
Australia and the U.S. under those countries&rsquo; domestic taxation laws, that holder may be subject to tax as an Australian
resident. If, however, the holder is determined to be a U.S. resident for the purposes of the Double Taxation Convention between
the U.S. and Australia, the Australian tax applicable may be limited by the Double Taxation Convention. Holders should obtain specialist
taxation advice in these circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Stamp Duty</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">A transfer of shares of a company listed
on the ASX is not subject to Australian stamp duty except in some circumstances where a person, either alone or when aggregated
with any associated persons or transactions, acquires 90% or more of the shares. The Australian stamp duty treatment of &lsquo;bare
trusts&rsquo; in respect of such shares for foreign residents is complex and specialist advice should be sought.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Australian Death Duty</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Australia does not have estate or death
duties. No capital gains tax liability is realized upon the inheritance of a deceased person&rsquo;s shares (assuming the shares
are treated as being held directly by the ADS holder under the &lsquo;absolute entitlement&rsquo; capital gains tax rules). The
disposal of inherited shares by beneficiaries (again, assuming the shares are treated as being held directly by the beneficiaries
under the &lsquo;absolute entitlement&rsquo; capital gains tax rules), may, however, give rise to a capital gains tax liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Goods and Services Tax</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">The issue or transfer of shares will not
incur Australian goods and services tax. The Australian goods and services tax treatment of &lsquo;bare trusts&rsquo; in respect
of such shares for foreign residents is complex and specialist advice should be sought.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>UNITED STATES FEDERAL INCOME TAX CONSEQUENCES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">The following is a summary of certain material
U.S. federal income tax consequences that generally apply to U.S. Holders (as defined below) who hold ADSs or ordinary shares as
capital assets. This summary is based on the U.S. Internal Revenue Code of 1986, as amended, (the &ldquo;Code&rdquo;), Treasury
regulations promulgated thereunder, judicial and administrative interpretations thereof, and the bilateral taxation convention
between Australia and the U.S. (the &ldquo;Tax Treaty&rdquo;), all as in effect on the date hereof and all of which are subject
to change either prospectively or retroactively. This summary does not discuss all the tax consequences that may be relevant to
an investment in ADSs or ordinary shares by a U.S. Holder in light of such holder&rsquo;s particular circumstances or to U.S. Holders
subject to special rules, including broker-dealers, banks or other financial institutions, traders in securities who elect to use
a mark-to-market method of accounting for securities holdings, insurance companies, investors liable for alternative minimum tax,
tax-exempt organizations, regulated investment companies, or real estate investment trusts, non-resident aliens of the U.S. or
taxpayers whose functional currency is not the U.S. dollar, partnerships or other pass-through entities for U.S. federal income
tax purposes or persons holding ADSs or ordinary shares through any such entities, persons who acquired their ADSs or ordinary
shares through the exercise or cancellation of any employee stock options or otherwise as compensation for their services, investors
that actually or constructively own 10% or more of our shares by vote or value, and investors holding ADSs or ordinary shares as
part of a straddle or appreciated financial position or as part of a hedging or conversion transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">If a partnership or an entity treated as
a partnership for U.S. federal income tax purposes owns ADSs or ordinary shares, the U.S. federal income tax treatment of a partner
in such a partnership will generally depend upon the status of the partner and the activities of the partnership. A partnership
that owns ADSs or ordinary shares and each partner in such partnership should consult its own tax advisors about the U.S. federal
income tax consequences of holding and disposing of ADSs or ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">This summary does not address the effect
of any U.S. federal taxation other than U.S. federal income taxation. In addition, this summary does not include any discussion
of U.S. federal estate and gift tax, state, local or foreign taxation. You are urged to consult your tax advisors regarding the
particular U.S. federal income tax consequences to you relating to the purchase, ownership and disposition of ADSs or ordinary
shares, the consequences to you under any other taxing jurisdiction foreign, as well as the U.S. federal, state and local tax considerations
of an investment in ADSs or ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">For purposes of this summary, the term
&ldquo;U.S. Holder&rdquo; means (i) an individual who is a citizen or, for U.S. federal income tax purposes, a resident of the
U.S., (ii) a corporation or other entity taxable as a corporation created or organized in or under the laws of the U.S. or any
political subdivision thereof, (iii) an estate whose income is subject to U.S. federal income tax regardless of its source, or
(iv) a trust if (a) a court within the U.S. is able to exercise primary supervision over administration of the trust, and one or
more U.S. persons have the authority to control all substantial decisions of the trust or (b) it has a valid election in effect
under applicable U.S. Treasury regulations to be treated as a U.S. person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Taxation of Dividends</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">For U.S. federal income tax purposes, U.S.
Holders of ADSs will be treated as owning the underlying ordinary shares represented by the ADSs held by them. Subject to the passive
foreign investment company, or PFIC rules discussed below, the gross amount of any distributions received with respect to the underlying
ordinary shares represented by the ADSs, including the amount of any taxes withheld therefrom, will constitute dividends for U.S.
federal income tax purposes, to the extent of our current and accumulated earnings and profits, as determined under U.S. federal
income tax principles. You will be required to include this amount of dividends in gross income as ordinary income. Distributions
in excess of our earnings and profits will be treated as a non-taxable return of capital to the extent of your tax basis in the
ADSs, and any amount in excess of your tax basis will be treated as gain from the sale of ADSs. See <I>Disposition of ADSs</I>
below for the discussion on the taxation of capital gains. Dividends will not qualify for the dividends-received deduction generally
available to corporations under Section 243 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Dividends that we pay in Australian dollars,
including the amount of any Australian taxes withheld therefrom, will be included in your income in a U.S. dollar amount calculated
by reference to the exchange rate in effect on the day such dividends are received. A U.S. Holder who receives payment in Australian
dollars and converts Australian dollars into U.S. dollars at an exchange rate other than the rate in effect on such day will likely
have a foreign currency exchange gain or loss, which would be treated as U.S.-source ordinary income or loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Subject to complex limitations, any Australian
withholding tax imposed on our dividends will be a foreign income tax eligible for credit against a U.S. Holder&rsquo;s U.S. federal
income tax liability (or, alternatively, for deduction against income in determining such tax liability). The limitations set forth
in the Code include computational rules under which foreign tax credits allowable with respect to specific classes of income cannot
exceed the U.S. federal income taxes otherwise payable with respect to each such class of income. Dividends generally will be treated
as foreign-source passive category income or general category income for U.S. foreign tax credit purposes, depending upon the holder&rsquo;s
circumstances. The rules relating to the determination of the foreign tax credit are complex. You should consult with your own
tax advisors to determine whether and to what extent you would be entitled to this credit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Subject to certain limitations, &ldquo;qualified
dividend income&rdquo; received by a non-corporate U.S. Holder will be subject to tax at a reduced maximum tax rate of 20 percent.
Distributions taxable as dividends generally qualify for the 20 percent rate provided that either: (i) the issuer is entitled to
benefits under the Tax Treaty or (ii) the ADSs are readily tradable on an established securities market in the U.S. and certain
other requirements are met. We believe that we are entitled to benefits under the Tax Treaty and that the ADSs currently are readily
tradable on an established securities market in the U.S. However, no assurance can be given that the ADSs will remain readily tradable.
Furthermore, the reduced rate does not apply to dividends received from PFICs. The amount of foreign tax credit is limited in the
case of foreign qualified dividend income. U.S. Holders of ADSs should consult their own tax advisors regarding the effect of these
rules in their particular circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Disposition of ADSs</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">If you sell or otherwise dispose of ADSs,
you will recognize gain or loss for U.S. federal income tax purposes in an amount equal to the difference between the amount realized
on the sale or other disposition and your adjusted tax basis in the ADSs. Subject to the PFIC rules discussed below, such gain
or loss generally will be capital gain or loss and will be long-term capital gain or loss if you have held the ADSs for more than
one year at the time of the sale or other disposition. In general, any gain that you recognize on the sale or other disposition
of ADSs will be U.S.-source for purposes of the foreign tax credit limitation; losses will generally be allocated against U.S.-source
income. Deduction of capital losses is subject to certain limitations under the Code. U.S. Holders are urged to consult their tax
advisors regarding the tax consequences if a foreign withholding tax is imposed on a disposition of our ADSs, including the availability
of the foreign tax credit under their particular circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Additional Tax on Investment Income</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">U.S. Holders that are individuals, estates,
or trusts and whose income exceeds certain thresholds will be subject to a 3.8% Medicare contribution tax on net investment income,
which will include dividends and capital gains from the sale or other taxable disposition of ADSs, subject to certain limitations
and exceptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Passive Foreign Investment Companies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">The Code provides special, generally adverse,
rules regarding certain distributions received by U.S. Holders with respect to, and sales, exchanges and other dispositions, including
pledges, of, shares of stock of a PFIC. A foreign corporation will be a PFIC for any taxable year if at least 75% of its gross
income for the taxable year is passive income or at least 50% of its gross assets during the taxable year, based on a quarterly
average and generally by value, produce or are held for the production of passive income. Passive income for this purpose generally
includes, among other things, dividends, interest, rents, royalties, gains from commodities and securities transactions and gains
from the disposition of assets that produce or are held for the production of passive income. In determining whether a foreign
corporation is a PFIC, a pro-rata portion of the income and assets of each corporation in which it owns, directly or indirectly,
at least a 25% interest (by value) is taken into account.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Based on our business results for the last
fiscal year and the composition of our assets, we believe that we were not a PFIC for U.S. federal income tax purposes for the
taxable year ended June 30, 2018. However, the determination of PFIC status is a factual determination that must be made annually
at the close of each taxable year and therefore, there can be no certainty as to our PFIC status for a taxable year until the close
of that taxable year. Our PFIC status could change depending, among other things, upon a decrease in the trading price of our ordinary
shares or ADSs and how quickly we make use of the proceeds from this offering, as well as changes in the composition and relative
values of our assets and the composition of our income. Moreover, the rules governing whether certain assets are active or passive
are complex and in some cases their application can be uncertain. If we were a PFIC in any year during a U.S. Holder&rsquo;s holding
period for the ordinary shares or ADSs, we generally would continue to be treated as a PFIC for each subsequent year during which
the U.S. Holder owned the ordinary shares or ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">If we are a PFIC for any taxable year during
which a U.S. Holder holds ordinary shares or ADSs, any &ldquo;excess distribution&rdquo; that the U.S. Holder receives and any
gain recognized from a sale or other disposition (including a pledge) of such ordinary shares or ADSs will be subject to certain
adverse tax rules, unless the U.S. Holder makes a mark-to-market election (provided the ADSs are &ldquo;marketable&rdquo;) or qualified
electing fund election, as discussed below. Any distribution in a taxable year that is greater than 125% of the average annual
distribution received by a U.S. Holder during the shorter of the three preceding taxable years or such holder&rsquo;s holding period
for the ordinary shares or ADSs will be treated as an excess distribution. Under these special tax rules:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; &nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the excess distribution or gain will be allocated ratably over the U.S. Holder&rsquo;s holding period for the ordinary shares or ADSs;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: justify; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; &nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the amount allocated to the current taxable year, and any taxable year prior to the first taxable year in which we were a PFIC in the U.S. Holder&rsquo;s holding period, will be treated as ordinary income arising in the current taxable year; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; &nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the amount allocated to each other year will be subject to income tax at the highest rate in effect for that year and applicable to the U.S. Holder and the interest charge generally applicable to underpayments of tax will be imposed on the resulting tax attributable to each such year.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">If we are a PFIC, the tax liability for
amounts allocated to years prior to the year of disposition or excess distribution cannot be offset by any net operating loss,
and gains (but not losses) recognized on the transfer of the ordinary shares or ADSs cannot be treated as capital gains, even if
the ordinary shares or ADSs are held as capital assets. In addition, non-corporate U.S. Holders will not be eligible for reduced
rates of taxation on any dividends that we pay if we are a PFIC for either the taxable year in which the dividend is paid or the
preceding year. Furthermore, unless otherwise provided by the U.S. Treasury Department, each U.S. Holder of a PFIC is required
to file an annual report containing such information as the U.S. Treasury Department may require.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">If we are a PFIC for any taxable year during
which any of our non-U.S. subsidiaries is also a PFIC, a U.S. Holder of ordinary shares or ADSs during such year would be treated
as owning a proportionate amount (by value) of the shares of the lower-tier PFIC for purposes of the application of these rules
to such subsidiary. You should consult your tax advisors regarding the tax consequences if the PFIC rules apply to any of our subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">In certain circumstances, in lieu of being
subject to the adverse tax rules discussed above, you may make an election to include gain on the stock of a PFIC as ordinary income
under a mark-to-market method, provided that such stock is regularly traded on a qualified exchange, or &ldquo;marketable.&rdquo;
Under current law, the mark-to-market election may be available to U.S. Holders of ADSs or ordinary shares if the ADSs or ordinary
shares are listed on NASDAQ, which constitutes a qualified exchange. As stated above, the ADSs will be listed on NASDAQ, although
there can be no assurance that the ADSs will be &ldquo;regularly traded&rdquo; for purposes of the mark-to-market election. It
should also be noted that it is intended that only the ADSs and not the ordinary shares will be listed on NASDAQ. While we would
expect the Australian Stock Exchange, on which the ordinary shares are listed, to be considered a qualified exchange, no assurance
can be given as to whether the Australian Stock Exchange is a qualified exchange, or that the ordinary shares would be traded in
sufficient frequency to be considered regularly traded for these purposes. Additionally, because a mark-to-market election cannot
be made for equity interests in any lower-tier PFIC that we may own, a U.S. Holder that makes a mark-to-mark election with respect
to its ADSs or ordinary shares may continue to be subject to the PFIC rules with respect to any indirect investments held by us
that are treated as an equity interest in a PFIC for U.S. federal income tax purposes. If you make an effective mark-to-market
election, you will include in each year that we are a PFIC as ordinary income the excess of the fair market value of your ordinary
shares or ADSs at the end of your taxable year over your adjusted tax basis in the ordinary shares or ADSs. You will be entitled
to deduct as an ordinary loss in each such year the excess of your adjusted tax basis in the ordinary shares or ADSs over their
fair market value at the end of the year, but only to the extent of the net amount previously included in income as a result of
the mark-to-market election. If you make an effective mark-to-market election, any gain you recognize upon the sale or other disposition
of your ordinary shares or ADSs in a year that we are a PFIC will be treated as ordinary income and any loss will be treated as
ordinary loss, but only to the extent of the net amount previously included in income as a result of the mark-to-market election.
Any gain or loss you recognize upon the sale or other disposition of your ordinary shares or ADSs in a year when we are not a PFIC
will be a capital gain or loss. See&nbsp;<I>Disposition of ADSs above&nbsp;</I>for the treatment of capital gains and losses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Your adjusted tax basis in the ordinary
shares or ADSs will be increased by the amount of any income inclusion and decreased by the amount of any loss under the mark-to-market
rules. If you make a mark-to-market election, it will be effective for the taxable year for which the election is made and all
subsequent taxable years unless the ordinary shares or ADSs are no longer regularly traded on a qualified exchange or the IRS consents
to the revocation of the election. You are urged to consult your tax advisors about the availability of the mark-to-market election,
and whether making the election would be advisable in your particular circumstances. In the case of a valid mark-to-market election,
any distributions we make would generally be subject to the rules discussed above under &ldquo;&mdash;<I>Taxation of Dividends</I>,&rdquo;
except the reduced rates of taxation on any dividends received from us would not apply if we are a PFIC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Alternatively, you can sometimes avoid
the PFIC rules described above by electing to treat us as a &ldquo;qualified electing fund&rdquo; under Section 1295 of the Code.
However, this option will not be available to you because we do not intend to comply with the requirements necessary to permit
you to make this election.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">U.S. Holders are urged to contact their
own tax advisors regarding the determination of whether we are a PFIC and the tax consequences of such status.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Backup Withholding and Information Reporting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.5in; text-align: justify">Payments in respect of ordinary shares
or ADSs may be subject to information reporting to the IRS and to U.S. backup withholding tax at a rate equal to the fourth lowest
income tax rate applicable to individuals (which, under current law, is 24%). Backup withholding will not apply, however, if you
(i) are a corporation or come within certain exempt categories and demonstrate the fact when so required or (ii) furnish a correct
taxpayer identification number and make any other required certification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.5in; text-align: justify">Backup withholding is not an additional
tax. Amounts withheld under the backup withholding rules may be credited against a U.S. Holder&rsquo;s U.S. tax liability. A U.S.
Holder may obtain a refund of any excess amounts withheld under the backup withholding rules by timely filing the appropriate claim
for refund with the IRS, which is generally an annual income tax return.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.5in; text-align: justify">U.S. Holders who are individuals generally
will be required to report our name, address and such information relating to an interest in the ADSs or ordinary shares as is
necessary to identify the class or issue of which the ADSs or ordinary shares are a part. These requirements are subject to exceptions,
including an exception for ADSs or ordinary shares held in accounts maintained by certain financial institutions and an exception
applicable if the aggregate value of all &ldquo;specified foreign financial assets&rdquo; (as defined in the Code) does not exceed
$50,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.5in; text-align: justify">U.S. Holders should consult their tax advisors
regarding the application of these information reporting rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="ps_013"></A>UNDERWRITING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">ThinkEquity, a
division of Fordham Financial Management, Inc. (&ldquo;ThinkEquity&rdquo;) is acting as representative of the underwriters of
the offering. We have entered into an underwriting agreement dated July 16, 2019 with the representative. Subject to the terms
and conditions of the underwriting agreement, we have agreed to sell to each underwriter named below, and each underwriter
named below has severally agreed to purchase, at the public offering price less the underwriting discounts set forth on the
cover page of this prospectus, the number of ADSs listed next to its name in the following table:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">Underwriter</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Number of ADSs</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left; padding-bottom: 1.5pt">ThinkEquity, a division of Fordham Financial Management, Inc.</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">339,130</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">339,130</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">The underwriters are committed to purchase
all the ADSs offered by us, other than those covered by the over-allotment option to purchase additional ADSs described below,
if they purchase any ADSs. The obligations of the underwriters may be terminated upon the occurrence of certain events specified
in the underwriting agreement. Furthermore, pursuant to the underwriting agreement, the underwriters&rsquo; obligations are subject
to customary conditions, representations and warranties contained in the underwriting agreement, such as receipt by the underwriters
of officers&rsquo; certificates and legal opinions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">We have agreed to indemnify the underwriters
against specified liabilities, including liabilities under the Securities Act, and to contribute to payments the underwriters may
be required to make in respect thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">The underwriters are offering the ADSs subject
to prior sale, when, as and if issued to and accepted by them, subject to approval of legal matters by their counsel and other
conditions specified in the underwriting agreement. The underwriters reserve the right to withdraw, cancel or modify offers to
the public and to reject orders in whole or in part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">We have granted the underwriters an over-allotment
option. This option, which is exercisable for up to 45 days after the date of this prospectus supplement, permits the underwriters
to purchase up to an aggregate of 50,869 additional ADSs at the public offering price per ADS less the underwriting discount, solely
to cover over-allotments, if any. If this option is exercised in full, the total price to the public will be $1,559,996 and the total
net proceeds, before expenses, to us will be $1,435,196.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Discounts, Commissions and Reimbursement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">The following table shows the public offering
price, underwriting discount and proceeds, before expenses, to us. The information assumes either no exercise or full exercise
by the underwriters of their over-allotment option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per ADS</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total with no<BR>
Over-Allotment</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total with<BR>
Over-Allotment</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public offering price</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right">4.00</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right">1,356,520</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right">1,559,996</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting discount (7.0%)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right">0.28</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right">94,956</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right">109,200</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accountable expense allowance (1%)<SUP>(1)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right">0.04</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>$</TD>
    <TD STYLE="text-align: right">13,565</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>$</TD>
    <TD STYLE="text-align: right">15,600</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds, before expenses, to us</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right">3.68</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right">1,247,998</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right">1,435,196</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) We have agreed to pay a non-accountable expense allowance
to the representative equal to 1.0% of the gross proceeds received in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">The underwriters propose to offer the ADSs
to the public at the public offering price set forth on the cover of this prospectus. In addition, the underwriters may offer some
of the ADSs to other securities dealers at such price less a concession not in excess of $0.16 per ADS. After the initial offering,
the public offering price and concession to dealers may be changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">We have also
agreed to pay certain expenses of the representative relating to the offering, including: (a)&nbsp;all filing fees and
communication expenses associated with the review of this offering by the Financial Industry Regulatory Authority, Inc.
(&ldquo;FINRA&rdquo;); (b)  fees, expenses and disbursements relating to the registration, qualification or exemption of
securities offered under the securities laws of such states and foreign jurisdictions designated by the representative;
(c)&nbsp; fees and expenses of the representative&rsquo;s legal counsel, up to $50,000; (d) the costs associated with bound
volumes of the public offering materials; (e)&nbsp;$15,000 for fees and expenses for the underwriters&rsquo; use of
book-building, prospectus tracking and compliance software for this offering; and  (f) fees and expenses for data services
and communications expenses, in the amount of $5,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">We estimate that the total expenses of the
offering payable by us, excluding the total underwriting discount, will be approximately $208,565.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Underwriter Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have also agreed
to issue to the representative or its designees, at the closing of this offering, warrants (the &ldquo;Underwriter&rsquo;s Warrants&rdquo;)
to purchase 13,565 ADSs. The Underwriter&rsquo;s Warrants will be exercisable at any time and from time to time, in whole or in
part, during a four and one-half year period commencing six months from the effective date of this offering. The Underwriter&rsquo;s
Warrants will be exercisable at a price equal to $5.00 per ADS. The Underwriter&rsquo;s Warrants and the ADSs underlying the Underwriter&rsquo;s
Warrants have been deemed compensation by FINRA and are, therefore, subject to a 180-day lock-up pursuant to Rule 5110(g)(1) of
FINRA. The underwriter or its permitted assignees under this Rule 5110(g)(1) shall not sell, transfer, assign, pledge or hypothecate
the Underwriter&rsquo;s Warrants or the ADSs underlying the Underwriter&rsquo;s Warrants, nor engage in any hedging, short sale,
derivative, put or call transaction that would result in the effective economic disposition of the Underwriter&rsquo;s Warrants
or the ADSs underlying the Underwriter&rsquo;s Warrants, for a period of 180 days from the effective date of the offering, except
that they may be assigned, in whole or in part, as specifically set forth in the underwriting agreement. The Underwriter&rsquo;s
Warrants will provide for cashless exercise and customary anti-dilution provisions (for share dividends, splits and recapitalizations
and the like) consistent with FINRA Rule 5110, and the number of ADSs underlying the Underwriter&rsquo;s Warrants shall be reduced,
or the exercise price increased, if necessary, to comply with FINRA rules or regulations. Further, the Underwriter&rsquo;s Warrants
will provide for a one-time demand registration right and unlimited piggyback rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Right of First Refusal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">We have granted the representative a right
of first refusal, for a period of 12 months from the consummation of this offering, to act as sole investment banker, book-runner,
financial advisor, underwriter and/or placement agent, at the representative&rsquo;s sole discretion, for each and every future
public and private equity offering, including all equity linked financings (each, a &ldquo;Subject Transaction&rdquo;), during
such 12 month period, of the Company, or any successor to or subsidiary of the Company, on terms and conditions customary to the
representative for such Subject Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Discretionary Accounts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">The underwriters do not intend to confirm
sales of the securities offered hereby to any accounts over which they have discretionary authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Electronic Offer, Sale and Distribution of Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">A prospectus in electronic format may be
made available on the websites maintained by one or more of the underwriters or selling group members. The representative may agree
to allocate a number of securities to underwriters and selling group members for sale to its online brokerage account holders.
Internet distributions will be allocated by the underwriters and selling group members that will make internet distributions on
the same basis as other allocations. Other than the prospectus in electronic format, the information on these websites is not part
of, nor incorporated by reference into, this prospectus or the registration statement of which this prospectus forms a part, has
not been approved or endorsed by us, and should not be relied upon by investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Listing</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">The ADSs and ADS Warrants are listed on
The Nasdaq Capital Market under the symbols &ldquo;IMRN&rdquo; and &ldquo;IMRNW,&rdquo; respectively. Our ordinary shares are currently
listed on the Australian Securities Exchange under the symbol &ldquo;IMC&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Stabilization</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">In connection with this offering, the underwriters
may engage in stabilizing transactions, over-allotment transactions, syndicate-covering transactions, penalty bids and purchases
to cover positions created by short sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Stabilizing transactions permit bids to
purchase ADSs so long as the stabilizing bids do not exceed a specified maximum, and are engaged in for the purpose of preventing
or retarding a decline in the market price of the ADSs while the offering is in progress.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Over-allotment transactions involve sales
by the underwriters of ADSs in excess of the number of ADSs the underwriters are obligated to purchase. This creates a syndicate
short position which may be either a covered short position or a naked short position. In a covered short position, the number
of ADSs over-allotted by the underwriters is not greater than the number of ADSs that they may purchase in the over-allotment option.
In a naked short position, the number of ADSs involved is greater than the number of ADSs in the over-allotment option. The underwriters
may close out any short position by exercising their over-allotment option and/or purchasing ADSs in the open market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Syndicate covering transactions involve
purchases of ADSs in the open market after the distribution has been completed in order to cover syndicate short positions. In
determining the source of ADSs to close out the short position, the underwriters will consider, among other things, the price of
shares available for purchase in the open market as compared with the price at which they may purchase shares through exercise
of the over-allotment option. If the underwriters sell more ADSs than could be covered by exercise of the over-allotment option
and, therefore, have a naked short position, the position can be closed out only by buying ADSs in the open market. A naked short
position is more likely to be created if the underwriters are concerned that after pricing there could be downward pressure on
the price of the ADSs in the open market that could adversely affect investors who purchase in the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Penalty bids permit the representative to
reclaim a selling concession from a syndicate member when the ADSs originally sold by that syndicate member are purchased in stabilizing
or syndicate covering transactions to cover syndicate short positions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">These stabilizing transactions, syndicate
covering transactions and penalty bids may have the effect of raising or maintaining the market price of our ADSs or preventing
or retarding a decline in the market price of our ADSs. As a result, the price of our ADSs in the open market may be higher than
it would otherwise be in the absence of these transactions. Neither we nor the underwriters make any representation or prediction
as to the effect that the transactions described above may have on the price of our ADSs. These transactions may be effected on
the Nasdaq Capital Market or otherwise and, if commenced, may be discontinued at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Passive market making</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">In connection with this offering, underwriters
and selling group members may engage in passive market making transactions in our ADSs on the Nasdaq Capital Market in accordance
with Rule 103 of Regulation M under the Exchange Act, during a period before the commencement of offers or sales of the ADSs and
extending through the completion of the distribution. A passive market maker must display its bid at a price not in excess of the
highest independent bid of that security. However, if all independent bids are lowered below the passive market maker&rsquo;s bid,
then that bid must then be lowered when specified purchase limits are exceeded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Other Relationships</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Certain of the underwriters and their affiliates
have in the past and may in the future provide various investment banking, commercial banking and other financial services for
us and our affiliates for which they received or may in the future receive customary fees. Without limiting the generality of the
foregoing, ThinkEquity acted as the underwriter for our public offering that we completed in May 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Offer restrictions outside the United States</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Other than in the United States, no action
has been taken by us or the underwriters that would permit a public offering of the securities offered by this prospectus in any
jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be offered or sold, directly
or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of
any such securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance
with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised
to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This
prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus
in any jurisdiction in which such an offer or a solicitation is unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="ps_014"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">Certain
legal matters with respect to Australian law with respect to the validity of the offered securities will be passed upon for us
by Francis Abourizk Lightowlers, Melbourne, Victoria, Australia. Sheppard Mullin Richter &amp; Hampton, LLP, New York, New York,
will be passing upon matters of United States law for us with respect to securities offered by this prospectus supplement. Sichenzia
Ross Ference LLP, New York, New York, is counsel to the underwriter in connection with this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_015"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements as of and for the year ended June 30, 2018 incorporated by reference in this prospectus supplement have been so incorporated&nbsp;by
reference in reliance upon the report of Grant Thornton Audit Pty Ltd., independent registered public accounting firm, upon the
authority of said firm as experts in accounting and auditing. The consolidated financial statements as of June 30, 2017 and for
the years ended June 30, 2017 and 2016 incorporated by reference in this prospectus supplement have been so included in reliance
upon the report of Marcum LLP, independent registered public accounting firm, upon the authority of said firm as experts in accounting
and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_016"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus supplement
and the accompanying prospectus are part of the registration statement on Form&nbsp;F-3 we filed with the SEC under the Securities
Act, and do not contain all the information set forth in the registration statement and the exhibits and schedules to the registration
statement. For further information, we refer you to the registration statement and the exhibits and schedules filed as part of
the registration statement. If a document has been filed as an exhibit to the registration statement, we refer you to the copy
of the document that has been filed. Each statement in this prospectus supplement and the accompanying prospectus relating to a
document filed as an exhibit is qualified in all respects by the filed exhibit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to the
informational requirements of the Exchange Act. Our annual report on <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577418011717/s113211_20f.htm">Form&nbsp;20-F</A> for the year ending June 30, 2018 has been
filed with the SEC. The Company has also filed periodic reports with the SEC on Form&nbsp;6-K. Such reports and other information
filed with the SEC are available to the public over the Internet at the SEC&rsquo;s website at http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">As
a foreign private issuer, we are exempt under the Exchange Act from, among other things, the rules prescribing the furnishing and
content of proxy statements, and our executive officers, directors and principal shareholders are exempt from the reporting and
short-swing profit recovery provisions contained in Section&nbsp;16 of the Exchange Act. In addition, we are be required under
the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies
whose securities are registered under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="ps_017"></A>INCORPORATION BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
SEC allows us to &ldquo;incorporate by reference&rdquo; information into this prospectus, which means that we can disclose important
information to you by referring you to other documents which we have filed or will file with the SEC. The information incorporated
by reference is considered a part of this prospectus and should be read carefully. Certain information in this prospectus supersedes
information incorporated by reference that we filed with the SEC prior to the date of this prospectus. Certain information that
we file later with the SEC will automatically update and supersede the information in this prospectus. Any statement so modified
or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
incorporate by reference into this prospectus the following documents, including any amendments to such filings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our annual report on <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577418011717/s113211_20f.htm">Form&nbsp;20-F</A> for the fiscal year ended&nbsp;June 30, 2018;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Reports on
    Form&nbsp;6-K&nbsp;furnished to the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577418012345/s113908_6k.htm">November
    9, 2018</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577418012976/s114118_6k.htm">November 19, 2018</A>
    (2), <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577419000148/s115184_6k.htm">January 3, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577419001183/s115587_6k.htm">January
    29, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577419003249/s116253_6k.htm">February 28,
    2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577419004182/s116784_6k.htm">March 19, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577419008071/s118410_6k.htm">May
    17, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577419008398/s118534_6k.htm">May 24, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577419008682/s118650_6k.htm">May
    30, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000121390019010544/f6k061219_immuronlimited.htm">June
    12, 2019;</A>  <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000121390019012790/f6k071619_immuron.htm">July 16,
    2019</A>; and <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000121390019012935/f6k071719_immuronlimited.htm">July 17, 2019</A>;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577419005432/s117296_6ka.htm">Form 6-K/A</A> furnished to the SEC on April 8, 2019; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the description of ADSs representing our ordinary shares and warrants to purchase ADSs contained in our Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577417002693/s106293_8a12b.htm">Form&nbsp;8-A</A> (File No. 001-38104)&nbsp;filed with the SEC on May 25, 2017, including any amendments or reports filed for the purpose of updating such description.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
are also incorporating by reference all subsequent Annual Reports on Form&nbsp;20-F&nbsp;that we file with the SEC and certain
reports on Form&nbsp;6-K&nbsp;that we furnish to the SEC after the date of this prospectus (if they state that they are incorporated
by reference into this prospectus) prior to the termination of this offering. In all cases, you should rely on the later information
over different information included in this prospectus or any accompanying prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Unless
expressly incorporated by reference, nothing in this prospectus shall be deemed to incorporate by reference information furnished
to, but not filed with, the SEC. Copies of all documents incorporated by reference in this prospectus, other than exhibits to those
documents unless such exhibits are specifically incorporated by reference in this prospectus, will be provided at no cost to each
person, including any beneficial owner, who receives a copy of this prospectus on the written or oral request of that person made
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Immuron Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Level 3, 62 Lygon
Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Carlton South,
Victoria, 3053, Australia 3053<BR>
Tel: +61 (0) 398 245 254</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">You
may also access these documents on our website,&nbsp;&nbsp;<I>www.immuron.com.au</I>. The information contained on, or that can
be accessed through, our website is not a part of this prospectus. We have included our website address in this prospectus solely
as an inactive textual reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">You
should rely only on information contained in, or incorporated by reference into, this prospectus. We have not authorized anyone
to provide you with information different from that contained in this prospectus or incorporated by reference in this prospectus.
We are not making offers to sell the securities in any jurisdiction in which such an offer or solicitation is not authorized or
in which the person making such offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make such
offer or solicitation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"></P>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>$100,000,000</B><BR>
<B>American Depositary Shares Representing Ordinary Shares</B><BR>
<B>Preference Shares</B><BR>
<B>Warrants</B><BR>
<B>Units</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">We
may offer, issue and sell from time to time up to $100,000,000, or its equivalent in any other currency, currency units, or
composite currency or currencies, of our ordinary shares, in the form of American Depositary Shares, or ADSs, preference
shares, warrants to purchase ordinary shares, in the form of ADSs and a combination of such securities, separately or as
units, in one or more offerings. Each ADS represents 40 ordinary shares. This prospectus provides a general description of
offerings of these securities that we may undertake.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">We
refer to our ADSs, ordinary shares, preference shares, warrants, and units collectively as &quot;securities&quot; in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">Each
time we sell our securities pursuant to this prospectus, we will provide the specific terms of such offering in a supplement to
this prospectus. The prospectus supplement may also add, update, or change information contained in this prospectus. You should
read this prospectus, the accompanying prospectus supplement, together with the additional information described under the heading
&quot;Where You Can More Find Information,&quot; before you make your investment decision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">We
may, from time to time, offer to sell the securities, through public or private transactions, directly or through underwriters,
agents or dealers, on or off The Nasdaq Capital Market, at prevailing market prices or at privately negotiated prices. If any underwriters,
agents or dealers are involved in the sale of any of these securities, the applicable prospectus supplement will set forth the
names of the underwriter, agent or dealer and any applicable fees, commissions or discounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">Our
ADSs and warrants issued in connection with our June 2017 initial public offering in the United States, or ADS Warrants, are listed
on The Nasdaq Capital Market under the symbols &quot;IMRN&quot; and &quot;IMRNW,&quot; respectively. On April 5, 2019, the last
reported price of our ADSs and ADS Warrants on The Nasdaq Capital Market was $5.49&nbsp;per
ADS and $1.40&nbsp;per ADS Warrant, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">Our
ordinary shares are currently listed on the Australian Securities Exchange, or ASX, under the symbol &ldquo;IMC. On April 5, 2019,
the last reported price of our ordinary shares on the ASX was AUD$0.19 per ordinary share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">We
are an &quot;emerging growth company,&quot; as defined by the Jumpstart Our Business Startups Act of 2012, and as such, have elected
to comply with certain reduced public company reporting requirements for this prospectus and future filings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><B>Investing
in these securities involves a high degree of risk. Please carefully consider the risks discussed in this prospectus under &quot;Risk
Factors&quot; in this prospectus, in any accompanying prospectus supplement and in the documents incorporated by reference in this
prospectus for a discussion of the factors you should carefully consider before deciding to purchase these securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><B>Neither
the U.S. Securities and Exchange Commission, any U.S. state securities commission, nor any other foreign securities commission
has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to
the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">The
date of this prospectus is April
17,
2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Table of Contents&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT THIS PROSPECTUS</FONT></A></TD>
    <TD STYLE="width: 10%; text-align: right">1</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUMMARY</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAPITALIZATION AND INDEBTEDNESS</FONT></A></TD>
    <TD STYLE="text-align: right">5</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</FONT></A></TD>
    <TD STYLE="text-align: right">5</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF SHARE CAPITAL AND CONSTITUTION</FONT></A></TD>
    <TD STYLE="text-align: right">5</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF AMERICAN DEPOSITARY SHARES</FONT></A></TD>
    <TD STYLE="text-align: right">11</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF PREFERENCE SHARES</FONT></A></TD>
    <TD STYLE="text-align: right">18</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF WARRANTS</FONT></A></TD>
    <TD STYLE="text-align: right">19</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF UNITS</FONT></A></TD>
    <TD STYLE="text-align: right">20</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="text-align: right">20</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TAXATION</FONT></A></TD>
    <TD STYLE="text-align: right">24</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPENSES</FONT></A></TD>
    <TD STYLE="text-align: right">24</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_015"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_016"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXPERTS</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_017"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ENFORCEMENT OF CIVIL LIABILITIES</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_018"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_019"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><A NAME="a_001"></A><B>ABOUT THIS PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">This
prospectus is part of a registration statement that we filed with the Securities and Exchange Commission, or SEC, using a &quot;shelf&quot;
registration process. Under this shelf registration process, we may sell our securities described in this prospectus in one or
more offerings up to a total dollar amount of $100,000,000. Each time we offer our securities, we will provide you with a supplement
to this prospectus that will describe the specific amounts, prices and terms of the securities we offer. The prospectus supplement
may also add, update or change information contained in this prospectus. This prospectus, together with applicable prospectus supplements
and the documents incorporated by reference in this prospectus and any prospectus supplements, includes all material information
relating to this offering. Please read carefully both this prospectus and any prospectus supplement together with additional information
described below under &quot;Where You Can Find More Information&quot; and &quot;Incorporation of Certain Information by Reference.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">You
should rely only on the information contained in or incorporated by reference in this prospectus and any applicable prospectus
supplement. We have not authorized anyone to provide you with different or additional information. If anyone provides you with
different or inconsistent information, you should not rely on it. The information contained in this prospectus is accurate only
as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sale of securities described in
this prospectus. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities
in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus
or any prospectus supplement, as well as information we have previously filed with the SEC and incorporated by reference, is accurate
as of the date on the front of those documents only. Our business, financial condition, results of operations and prospects may
have changed since those dates. This prospectus may not be used to consummate a sale of our securities unless it is accompanied
by a prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">Throughout
this prospectus, unless otherwise designated, the terms &quot;we&quot;, &quot;us&quot;, &quot;our&quot;, &quot;Immuron&quot;, &quot;the
Company&quot; and &quot;our Company&quot; refer to Immuron Limited and its wholly-owned subsidiaries. References to &quot;ordinary
shares&quot;, &quot;ADSs&quot;, &quot;preference shares&quot;, &quot;warrants&quot; and &quot;share capital&quot; refer to the
ordinary shares, ADSs, preference shares, warrants and share capital, respectively, of Immuron.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">Certain
figures included in this prospectus have been subject to rounding adjustments. Accordingly, figures shown as totals in certain
tables may not be an arithmetic aggregation of the figures that precede them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">We
have not authorized anyone to provide you with information that is different from that contained in this prospectus, any amendment
or supplement to this prospectus, or in any free writing prospectus we may authorize to be delivered or made available to you.
We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give
you. This prospectus is not an offer to sell securities, and it is not soliciting an offer to buy securities, in any jurisdiction
where the offer or sale is not permitted. The information contained in this prospectus is accurate only as of the date on the front
of this prospectus, regardless of the time of delivery of this prospectus or any sale of the securities. For investors outside
of the United States: We have not taken any action to permit this offering or possession or distribution of this prospectus in
any jurisdiction where action for that purpose is required, other than in the United States. You are required to inform yourselves
about and to observe any restrictions relating to this offering and the distribution of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="background-color: white">The
industry in which we operate is subject to a high degree of uncertainty and risk due to a variety of factors, including those described
in the section titled &quot;Risk Factors.&quot; These and other factors could cause results to differ materially from those expressed
in the estimates made by the independent parties and by us. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">We
qualify as an &quot;emerging growth company,&quot; as defined in the JOBS Act. An emerging growth company may take advantage of
specified reduced reporting and regulatory requirements in contrast to those otherwise applicable generally to public companies.
These provisions include, but are not limited to, an exemption from the auditor attestation requirement in the assessment of our
internal control over financial reporting pursuant to Section&nbsp;404 the Sarbanes-Oxley Act of 2002.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 36; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">We
may take advantage of these reduced reporting and other regulatory requirements for up to five years or such earlier time that
we are no longer an emerging growth company. We would cease to be an emerging growth company if we have more than $1.07&nbsp;billion
in annual revenue, become a &ldquo;large accelerated filer&rdquo; as defined in Rule 12b-2 of the Exchange Act, or issue more than
$1.0&nbsp;billion of non-convertible debt over a three-year period. In addition, the JOBS Act provides that an emerging growth
company may delay adopting new or revised accounting standards until those standards apply to private companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">We
are a &quot;foreign private issuer&quot; as defined in Rule&nbsp;3b-4 under the Securities Exchange Act of 1934, as amended, or
the Exchange Act. As a result, our proxy solicitations are not subject to the disclosure and procedural requirements of Regulation&nbsp;14A
under the Exchange Act and transactions in our equity securities by our officers and directors are exempt from Section&nbsp;16
of the Exchange Act. In addition, we are not required under the Exchange Act to file periodic reports and financial statements
as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white"><B><A NAME="a_002"></A>CAUTIONARY
STATEMENT REGARDING FORWARD-LOOKING STATEMENTS&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="background-color: white">This
prospectus contains forward-looking statements that involve substantial risks and uncertainties. The forward-looking statements
are contained principally in the sections of this prospectus titled &quot;About this Prospectus,&quot; &quot;Risk Factors,&quot;
and &quot;Business.&quot; All statements, other than statements of historical facts, contained in this prospectus, including statements
regarding our future results of operations and financial position, business strategy, prospective products, product approvals,
research and development costs, timing and likelihood of success, plans and objectives of management for future operations, and
future results of current and anticipated products, are forward-looking statements. These statements relate to future events or
to our future financial performance and involve known and unknown risks, uncertainties and other factors which may cause our actual
results, performance or achievements to be materially different from any future results, performance or achievements expressed
or implied by the forward-looking statements. The words &quot;anticipate,&quot; &quot;assume,&quot; &quot;believe,&quot; &quot;contemplate,&quot;
&quot;continue,&quot; &quot;could,&quot; &quot;estimate,&quot; &quot;expect,&quot; &quot;goal,&quot; &quot;intend,&quot; &quot;may,&quot;
&quot;might,&quot; &quot;objective,&quot; &quot;plan,&quot; &quot;potential,&quot; &quot;predict,&quot; &quot;project,&quot; &quot;positioned,&quot;
&quot;seek,&quot; &quot;should,&quot; &quot;target,&quot; &quot;will,&quot; &quot;would,&quot; or the negative of these terms or
other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain
these identifying words. These forward-looking statements are based on current expectations, estimates, forecasts and projections
about our business and the industry in which we operate and management's beliefs and assumptions, are not guarantees of future
performance or development and involve known and unknown risks, uncertainties and other factors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">Actual
results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements
we make. As a result, any or all of our forward-looking statements in this prospectus may turn out to be inaccurate. We have included
important factors in the cautionary statements included in this prospectus, particularly in the section of this prospectus titled
&quot;Risk Factors,&quot; that we believe could cause actual results or events to differ materially from the forward-looking statements
that we make. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and
you should not place undue reliance on our forward-looking statements. Moreover, we operate in a highly competitive and rapidly
changing environment in which new risks often emerge. It is not possible for our management to predict all risks, nor can we assess
the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results
to differ materially from those contained in any forward-looking statements we may make. Our forward-looking statements do not
reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">You
should read this prospectus and the documents that we reference in this prospectus and have filed as exhibits to the registration
statement of which this prospectus is a part completely and with the understanding that our actual future results may be materially
different from what we expect. The forward-looking statements contained in this prospectus are made as of the date of this prospectus,
and we do not assume any obligation to update any forward-looking statements except as required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B><A NAME="a_003"></A>PROSPECTUS SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>You should read
the following summary together with the more detailed information about us, the securities that may be sold from time to time,
and our financial statements and the notes thereto, all of which appear elsewhere in this prospectus or in the documents incorporated
by reference in this prospectus.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a
commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on the further
development and commercialization of a novel class of immunomodulator and anti-infectious disease polyclonal antibodies that
we believe can address significant unmet medical needs. Our oral polyclonal antibodies offer targeted delivery within the
gastrointestinal (GI) track but essentially do not cross into the bloodstream, potentially leading to much improved safety
and tolerability, without sacrificing efficacy. We believe that our two lead drug candidates, IMM-124E and IMM-529 currently
in clinical development, have the potential to transform the existing treatment paradigms for alcoholic steatohepatitis (ASH)
and for <I>C. difficile</I> infections, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently market
an over-the-counter product, Travelan, in Australia for prevention of travelers' diarrhea. We also market Travelan in the U.S.
and Canada as a dietary supplement for digestive tract protection. We plan to further develop Travelan as an approved drug to treat
travelers&rsquo; diarrhea in the U.S. Travelan is essentially the same active pharmaceutical ingredient (API) as our product candidate
IMM-124E, and targets 13 strains of <I>E.coli</I>. Global sales for fiscal year 2018 were gross A$2 million (net: A$1.8 million).
We recently began to market Protectyn, a health product targeting pathogenic bacteria and the toxins they produce in the gut to
prevent gut dysbiosis, in Australia. Sales of Protectyn have not been material to date.&nbsp; We also plan to expand the clinical
program for IMM-529 to treat patients with recurrent <I>C. difficile </I>infections by moving to file an IND with FDA for treatment
of patients with <I>C. difficile</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.6pt; text-align: justify; text-indent: 16.15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ADSs and ADS
Warrants are listed on The Nasdaq Capital Market under the symbols &ldquo;IMRN&rdquo; and &ldquo;IMRNW,&rdquo; respectively. Each
ADS represents 40 ordinary shares. Each ADS Warrant has a per ADS exercise price of US$10.00 and expires five years from the date
of issuance. Our ordinary shares are also listed on the Australian Securities Exchange under the symbol &ldquo;IMC.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Immuron Limited
was incorporated under the laws of Australia in 1994 and has been listed on the ASX since April 30, 1999. Our principal executive
office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, Australia 3053 and our telephone number is +61 (0)3 9824
5254. Our website address is www.immuron.com. Information on our website and the websites linked to it do not constitute a part
of this prospectus or the registration statement to which this prospectus forms a part. Our agent for service of process in the
United States is Puglisi &amp; Associates, 850 Library Avenue, Suite 204, Newark, DE 19711.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B><A NAME="a_004"></A>RISK FACTORS&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="background-color: white">Investing
in our securities involves significant risk. The prospectus supplement applicable to each offering of our securities will contain
a discussion of the risks applicable to an investment in the Company. Prior to making a decision about investing in our securities,
you should carefully consider the specific factors discussed under the heading &ldquo;Risk Factors&rdquo; in the applicable prospectus
supplement, together with all of the other information contained or incorporated by reference in the prospectus supplement or appearing
or incorporated by reference in this prospectus. You should also consider the risks, uncertainties and assumptions discussed under
the heading &ldquo;Risk Factors&rdquo; included in our most recent Annual Report on Form&nbsp;20-F&nbsp;and any subsequent Annual
Reports on Form&nbsp;20-F&nbsp;we file after the date of this prospectus, and all other information contained in or incorporated
by reference into this prospectus or the registration statement of which this prospectus forms a part, as updated by our subsequent
filings under the Exchange Act and the risk factors and other information contained in any applicable prospectus supplement before
acquiring any of our securities. Additional risks and uncertainties not presently known to us or that we currently deem immaterial
may also affect our operations. The occurrence of any of these risks might cause you to lose all or part of your investment in
the offered securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_005"></A><FONT STYLE="background-color: white"><B>CAPITALIZATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">A
prospectus supplement or report on Form&nbsp;6-K incorporated by reference into the registration statement of which this prospectus
forms&nbsp;a part will include information on our consolidated capitalization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><A NAME="a_006"></A><FONT STYLE="background-color: white"><B>USE
OF PROCEEDS&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">Except
as otherwise provided in the applicable prospectus supplement, we intend to use the net proceeds from the sale of the securities
offered by this prospectus for general corporate purposes, which may include working capital, capital expenditures, research and
development expenditures, regulatory affairs expenditures, clinical trial expenditures, acquisitions of new technologies and investments,
and the repayment, refinancing, redemption or repurchase of indebtedness or capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">The
intended application of proceeds from the sale of any particular offering of securities using this prospectus will be described
in the accompanying prospectus supplement relating to such offering. The precise amount and timing of the application of these
proceeds will depend on our funding requirements and the availability and costs of other funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><A NAME="a_007"></A><FONT STYLE="background-color: white"><B>DESCRIPTION
OF SHARE CAPITAL AND CONSTITUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a public company
limited by shares registered under the Corporations Act by the Australian Securities and Investments Commission, or ASIC. Our corporate
affairs are principally governed by our Constitution, the Corporations Act 2001, or the Corporations Act, and the ASX Listing Rules.
Our ordinary shares trade on the ASX, and our ADSs and warrants trade on Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Constitution is
not significantly different than a U.S. company&rsquo;s charter documents except we do not have a limit on our authorized share
capital, the concept of par value is not recognized under Australian law and as further discussed under &ldquo;&mdash;Our Constitution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to restrictions
on the issue of securities in our Constitution, the Corporations Act and the ASX Listing Rules and any other applicable law, we
may at any time issue shares and grant options or warrants on any terms, with the rights and restrictions and for the consideration
that our board of directors determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The rights and restrictions
attaching to ordinary and preference shares are derived through a combination of our Constitution, the common law applicable to
Australia, the ASX Listing Rules, the Corporations Act and other applicable law. A general summary of some of the rights and restrictions
attaching to our ordinary and preference shares are summarized below. Each ordinary shareholder is entitled to receive notice of,
and to be present, vote and speak at, general meetings. Each preference shareholder is entitled to receive notice of, and to be
present at general meetings, but may only vote on certain resolutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Constitution</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Constitution is
similar in nature to the bylaws of a U.S. corporation. It does not provide for or prescribe any specific objectives or purposes
of Immuron. Our Constitution is subject to the terms of the ASX Listing Rules and the Corporations Act. It may be amended or repealed
and replaced by special resolution of shareholders, which is a resolution passed by at least 75% of the votes cast by shareholders
entitled to vote on the resolution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under Australian law,
a company has the legal capacity and powers of an individual both within and outside Australia. The material provisions of our
Constitution are summarized below. This summary is not intended to be complete nor to constitute a definitive statement of the
rights and liabilities of our shareholders. Our Constitution is filed as an exhibit to the registration statement, of which this
prospectus forms&nbsp;a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><B><I>Interested Directors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A director may not vote
in respect of any contract or arrangement in which the director has, directly or indirectly, any direct or indirect material or
lesser interest according to our Constitution. Such director must not be counted in a quorum, must not vote on the matter and must
not be present at the meeting while the matter is being considered. However, that director may execute or otherwise act in respect
of that contract or arrangement notwithstanding any personal interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless a relevant exception
applies, the Corporations Act requires our directors to provide disclosure of certain interests or conflicts of interests and prohibits
directors from voting on matters in which they have a material personal interest and from being present at the meeting while the
matter is being considered. In addition, the Corporations Act and the ASX Listing Rules require shareholder approval of any provision
of related party benefits to our directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>Borrowing Powers Exercisable
by Directors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to our Constitution,
the management and control of our business affairs are vested in our board of directors. Our board of directors has the power to
raise or borrow money and grant security over any of our property or business or any uncalled capital, and may issue debentures
or give any other security for any of our debts, liabilities or obligations or of any other person, in each case, in the manner
and on terms it deems fit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B><I>Retirement of Directors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to our Constitution
and the ASX Listing Rules, there must be an election of directors at each annual general meeting. The directors, other than the
managing director, who are to stand for election at each annual general meeting are: (i) any director required to retire after
a period of three years in office, (ii) any director appointed by the other directors in the year preceding the annual general
meeting, (iii) any new directors, or (iv) if no person is standing for election for the aforementioned reasons then the director
longest in office since last being elected. A director, other than the director who is the managing director, must retire from
office at the conclusion of the third annual general meeting after which the director was elected. Retired directors are eligible
for a re-election to the board of directors unless disqualified from acting as a director under the Corporations Act or otherwise
ineligible for appointment under our Constitution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>Rights and Restrictions
on Classes of Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The rights attaching
to our ordinary shares are detailed in our Constitution. Our Constitution provides that our directors may issue shares with preferred,
deferred or other special rights, whether in relation to dividends, voting, return of share capital, payment of calls or otherwise
as our board of directors may determine. Subject to any approval which is required from our shareholders under the Corporations
Act and the ASX Listing Rules (see &ldquo;&mdash;Exemptions from Certain NASDAQ Corporate Governance Rules&rdquo; and &ldquo;&mdash;Change
of Control&rdquo;), any rights and restrictions attached to a class of shares, we may issue further shares on such terms and conditions
as our board of directors resolve. Currently, our outstanding share capital consists of only one class of ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">Specifically, the board of directors
may issue preference shares on such terms that the directors determine including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">Preference shares will confer the right to receive a preferential dividend, in priority to the
payment of a dividend on any other class of shares, at the rate and on the basis determined by the board of directors at the time
of issue of the preference shares. The board of directors may determine that the preferential dividend will be cumulative.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">The board of directors may determine at the time of issue of the preference shares that the preference
shares may participate with the shares of capital of the Company in dividends.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">Preference shares will confer the right to payment in cash in priority to any other class of shares,
on a winding up or on redemption, as applicable, of (i) the amount paid or agreed to be considered as paid on the preference shares
and (ii) the amount equal to any dividend accrued but unpaid on the preference shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">The board of directors may determine at the time of issue of any preference shares that they will
confer the right to participate with shares of capital of the Company in the assets or profits of the Company, to the extent determined
by the board of directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">Preference share holders have the right to vote at general meetings (A) on a proposal (i) to wind
up the Company, (ii) to reduce the share capital of the Company, (iii) that affects the rights attached to preference shares; or
(iv) to dispose of all or substantially all of the Company's property, business and undertaking; (B) on a resolution to approve
the terms of any buy-back agreement; (C) while a dividend or part of a dividend in respect of the preference shares is unpaid or
(D) any question considered at a meeting held during the winding up of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">The board of directors may determine whether preference shares may be redeemable or are convertible
into other securities of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">The board of directors may issue further preference shares ranking pari passu in all respects with
(but not in priority to) other preference shares already issued and the rights of the issued preference shares are not to be taken
to have been varied by the further issue of preference shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>Dividend Rights</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the Corporations
Act, our board of directors may from time to time determine to pay dividends to shareholders. All dividends unclaimed for one year
after having been declared may be invested or otherwise made use of by our board of directors for our benefit until claimed or
otherwise disposed of in accordance with our Constitution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>Voting Rights</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under our Constitution,
and subject to any voting exclusions imposed under the ASX Listing Rules (which typically exclude parties from voting on resolutions
in which they have an interest) and the rights and restrictions attaching to a class of shares, each shareholder has one vote on
a show of hands at a meeting of the shareholders unless a poll is demanded under the Constitution or the Corporations Act. On a
poll vote, each shareholder shall have one vote for each fully paid share and a fractional vote for each share held by that shareholder
that is not fully paid, such fraction being equivalent to the proportion of the amount that has been paid to such date on that
share. Shareholders may vote in person or by proxy, attorney or representative. Under Australian law, shareholders of a public
company are not permitted to approve corporate matters by written consent. Our Constitution does not provide for cumulative voting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Note that ADS holders
may not directly vote at a meeting of the shareholders but may instruct the depositary to vote the number of deposited ordinary
shares their ADSs represent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>Right to Share in Our
Profits</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to our Constitution,
our shareholders are entitled to participate in our profits only by payment of dividends. Our board of directors may from time
to time determine to pay dividends to the shareholders; however, no dividend is payable except in accordance with the thresholds
set out in the Corporations Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>Rights to Share in the
Surplus in the Event of Liquidation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Constitution provides
for the right of shareholders to participate in a surplus in the event of our liquidation, subject to the rights attaching to a
class of shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>No Redemption Provision
for Ordinary Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no redemption
provisions in our Constitution in relation to ordinary shares. Under our Constitution, any preference shares may be issued on the
terms that they are, or may at our option be, liable to be redeemed.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><B><I>Variation or Cancellation of Share Rights</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the terms
of issue of shares of that class, the rights attached to shares in a class of shares may only be varied or cancelled by either:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">a special resolution passed at a separate general meeting of members holding shares in the class;
or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">the written consent of members with at least 75% of the shares in the class.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><B><I>Directors May Make Calls</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Constitution provides
that subject to the terms on which the shares have been issued directors may make calls on a shareholder for amounts unpaid on
shares held by that shareholder, other than monies payable at fixed times under the conditions of allotment. Securities issued
in this offering will be fully paid and will not be subject to calls by directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General Meetings of Shareholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">General meetings of
shareholders may be called by our board of directors. Except as permitted under the Corporations Act, shareholders may not convene
a meeting. The Corporations Act requires the directors to call and arrange to hold a general meeting on the request of shareholders
with at least 5% of the votes that may be cast at a general meeting or at least 100 shareholders who are entitled to vote at the
general meeting. Notice of the proposed meeting of our shareholders is required at least 28&nbsp;clear days prior to such meeting
under the Corporations Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Foreign Ownership Regulation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no limitations
on the rights to own securities imposed by our Constitution. However, acquisitions and proposed acquisitions of securities in Australian
companies may be subject to review and approval by the Australian Federal Treasurer under the Foreign Acquisitions and Takeovers
Act 1975, or the FATA, which generally applies to acquisitions or proposed acquisitions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">by a foreign person (as defined in the FATA) or associated foreign persons that would result in
such persons having an interest in 20% or more of the issued shares of, or control of 20% or more of the voting power in, an Australian
company; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">by non-associated foreign persons that would result in such foreign person having an interest in
40% or more of the issued shares of, or control of 40% or more of the voting power in, an Australian company, where the Australian
company is valued above the monetary threshold prescribed by FATA.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">However, no such review
or approval under the FATA is required if the foreign acquirer is a U.S. entity and the value of the target is less than AUD$1,154
million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Australian Federal
Treasurer may prevent a proposed acquisition in the above categories or impose conditions on such acquisition if the Treasurer
is satisfied that the acquisition would be contrary to the national interest. If a foreign person acquires shares or an interest
in shares in an Australian company in contravention of the FATA, the Australian Federal Treasurer may order the divestiture of
such person&rsquo;s shares or interest in shares in that Australian company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Ownership Threshold</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no provisions
in our Constitution that require a shareholder to disclose ownership above a certain threshold. The Corporations Act, however,
requires a shareholder to notify us and the ASX once it, together with its associates, acquires a 5% interest in our ordinary shares,
at which point the shareholder will be considered to be a &ldquo;substantial&rdquo; shareholder. Further, once a shareholder owns
a 5% interest in us, such shareholder must notify us and the ASX of any increase or decrease of 1% or more in its holding of our
ordinary shares, and must also notify us and the ASX on its ceasing to be a &ldquo;substantial&rdquo; shareholder. Upon becoming
a U.S. public company, our shareholders became subject to disclosure requirements under U.S. securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Issues of Shares and Change in Capital</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to our Constitution,
the Corporations Act, the ASX Listing Rules and any other applicable law, we may at any time issue shares and grant options or
warrants on any terms, with preferred, deferred or other special rights and restrictions and for the consideration and other terms
that the directors determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to the requirements
of our Constitution, the Corporations Act, the ASX Listing Rules and any other applicable law, including relevant shareholder approvals,
we may consolidate or divide our share capital into a larger or smaller number by resolution, reduce our share capital (provided
that the reduction is fair and reasonable to our shareholders as a whole and does not materially prejudice our ability to pay creditors)
or buy back our ordinary shares whether under an equal access buy-back or on a selective basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Change of Control</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Takeovers of listed
Australian public companies, such as our company are regulated by the Corporations Act, which prohibits the acquisition of a &ldquo;relevant
interest&rdquo; in issued voting shares in a listed company if the acquisition will lead to that person&rsquo;s or their associate
(as defined in the Corporations Act) voting power in our company increasing from 20% or below to more than 20% or increasing from
a starting point that is above 20% and below 90%, subject to a range of exceptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Generally, a person
will have a relevant interest in securities if the person:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">is the holder of the securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">has power to exercise, or control the exercise of, a right to vote attached to the securities;
or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">has the power to dispose of, or control the exercise of a power to dispose of, the securities,
including any indirect or direct power or control.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If, at a
particular time, a person has a relevant interest in issued securities and the person:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">has entered or enters into an agreement with another person with respect to the securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">has given or gives another person an enforceable right, or has been or is given an enforceable
right by another person, in relation to the securities (whether the right is enforceable presently or in the future and whether
or not on the fulfillment of a condition);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">has granted or grants an option to, or has been or is granted an option by, another person with
respect to the securities; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">the other person would have a relevant interest in the securities if the agreement were performed,
the right enforced or the option exercised;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">the other
person is taken to already have a relevant interest in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are a number
of exceptions to the above prohibition on acquiring a relevant interest in issued voting shares above 20%. In general terms, some
of the more significant exceptions include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">when the acquisition results from the acceptance of an offer under a formal takeover bid;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">when the acquisition is conducted on market by or on behalf of the bidder under a takeover bid,
the acquisition occurs during the bid period, the bid is for all the voting shares in a bid class and the bid is unconditional
or only conditioned on prescribed matters set out in the Corporations Act;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">when our shareholders approve the takeover by resolution passed at a general meeting;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">an acquisition by a person if, throughout the six months before the acquisition, that person or
any other person has had voting power in our company of at least 19% and, as a result of the acquisition, none of the relevant
persons would have voting power in our company more than three percentage points higher than they had six months before the acquisition;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">when the acquisition results from the issue of securities under a rights issue;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">when the acquisition results from the issue of securities under dividend reinvestment schemes;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">when the acquisition results from the issue of securities under underwriting arrangements;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">when the acquisition results from the issue of securities through operation of law;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">an acquisition that arises through the acquisition of a relevant interest in another listed company
which is listed on a prescribed financial market or a financial market approved by ASIC;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">an acquisition arising from an auction of forfeited shares conducted on-market; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">an acquisition arising through a compromise, arrangement, liquidation or buy-back.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Breaches of the takeovers
provisions of the Corporations Act are criminal offenses. ASIC and the Australian Takeover Panel have a wide range of powers relating
to breaches of takeover provisions, including the ability to make orders canceling contracts, freezing transfers of, and rights
attached to, securities, and forcing a party to dispose of securities. There are certain defenses to breaches of the takeover provisions
provided in the Corporations Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Access to and Inspection of Documents
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Inspection of our records
is governed by the Corporations Act. Any member of the public has the right to inspect or obtain copies of our registers on the
payment of a prescribed fee. Shareholders are not required to pay a fee for inspection of our registers or minute books of the
meetings of shareholders. Other corporate records, including minutes of directors&rsquo; meetings, financial records and other
documents, are not open for inspection by shareholders. Where a shareholder is acting in good faith and an inspection is deemed
to be made for a proper purpose, a shareholder may apply to the court to make an order for inspection of our books.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Exemptions from Certain Nasdaq Corporate
Governance Rules</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nasdaq listing
rules allow for a foreign private issuer, such as our company, to follow our home country practices in lieu of certain of the Nasdaq&rsquo;s
corporate governance standards. We rely on exemptions from certain corporate governance standards that are contrary to the laws,
rules, regulations or generally accepted business practices in Australia. These exemptions being sought are described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">We rely on an exemption from the independence requirements for a majority of our board of directors
as prescribed by Nasdaq Listing Rules. The ASX Listing Rules do not require us to have a majority of independent directors although
ASX Corporate Governance Principles and Recommendations do recommend a majority of independent directors. During fiscal 2018, we
did not have a majority of directors who were &ldquo;independent&rdquo; as defined in the ASX Corporate Governance Principles and
Recommendations, which definition differs from NASDAQ&rsquo;s definition. Accordingly, because Australian law and generally accepted
business practices in Australia regarding director independence differ to the independence requirements under Nasdaq Listing Rules,
we seek to claim this exemption.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">We rely on an exemption from the requirement that our independent directors meet regularly in executive
sessions under Nasdaq Listing Rules. The ASX Listing Rules and the Corporations Act do not require the independent directors of
an Australian company to have such executive sessions and, accordingly, we seek to claim this exemption.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">We rely on an exemption from the requirement prescribed by Nasdaq Listing Rules that issuers obtain
shareholder approval prior to the issuance of securities in connection with certain acquisitions, private placements of securities,
or the establishment or amendment of certain stock option, purchase or other compensation plans. Applicable Australian law and
the ASX Listing Rules differ from Nasdaq requirements, with the ASX Listing Rules providing generally for prior shareholder approval
in numerous circumstances, including (i)&nbsp;issuance of equity securities exceeding 15% of our issued share capital in any 12-month
period (but, in determining the 15% limit, securities issued under an exception to the rule or with shareholder approval are not
counted), (ii)&nbsp;issuance of equity securities to related parties (as defined in the ASX Listing Rules) and (iii)&nbsp;issuances
of securities to directors or their associates under an employee incentive plan. Due to differences between Australian law and
rules and the Nasdaq shareholder approval requirements, we seek to claim this exemption.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">We rely on an exemption from the requirement that issuers must maintain charters for each of the
following committees in compliance with Nasdaq Listing Rules: audit committee, nomination committee and compensation committee.
In addition, we rely on an exemption from the requirement that issuers must maintain a code of conduct in compliance with Nasdaq
Listing Rules. Applicable Australian law does not require us to maintain any charters for their committees nor does such law require
us to maintain a code of conduct.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Ordinary Shares Eligible For Future Sale</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Future sales of substantial
amounts of our ordinary shares or ADSs in the public market in the United States or in Australia, including ordinary shares issued
upon exercise of outstanding warrants or options, or the possibility of such sales, could negatively affect the market price in
the United States of the ADSs and our ability to raise equity capital in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_008"></A>DESCRIPTION OF AMERICAN DEPOSITARY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>American Depositary Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Bank of New York
Mellon, as depositary, will register and deliver ADSs. Each ADS will represent 40 shares (or a right to receive 40 shares) deposited
with the principal Melbourne, Victoria, Australia offices of Australia and New Zealand Banking Group Ltd, Hongkong Bank of Australia
and National Australia Bank Limited as custodian for the depositary. Each ADS will also represent any other securities, cash or
other property which may be held by the depositary. The depositary&rsquo;s office at which the ADSs will be administered is located
at 101 Barclay Street, New York, New York 10286. The Bank of New York Mellon&rsquo;s principal executive office is located at 225
Liberty Street, New York, New York 10286.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may hold ADSs either
(A) directly (i) by having an American Depositary Receipt, or ADR, which is a certificate evidencing a specific number of ADSs,
registered in your name, or (ii) by having ADSs registered in your name in the Direct Registration System, or (B) indirectly by
holding a security entitlement in ADSs through your broker or other financial institution. If you hold ADSs directly, you are a
registered ADS holder, also referred to as an ADS holder. This description assumes you are an ADS holder. If you hold the ADSs
indirectly, you must rely on the procedures of your broker or other financial institution to assert the rights of ADS holders described
in this section. You should consult with your broker or financial institution to find out what those procedures are.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Direct Registration
System, or DRS, is a system administered by The Depository Trust Company, or DTC, under which the depositary may register the ownership
of uncertificated ADSs, which ownership is confirmed by statements sent by the depositary to the registered holders of uncertificated
ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As an ADS holder, we
will not treat you as one of our shareholders and you will not have shareholder rights. Australian law governs shareholder rights.
The depositary will be the holder of the shares underlying your ADSs. As a registered holder of ADSs, you will have ADS holder
rights. A deposit agreement among us, the depositary, ADS holders and all other persons indirectly or beneficially holding ADSs
sets out ADS holder rights as well as the rights and obligations of the depositary. New York law governs the deposit agreement
and the ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a summary
of the material provisions of the deposit agreement. Because it is a summary, it does not contain all the information that may
be important to you. For more complete information, you should read the entire deposit agreement and the form of ADR which summarizes
certain terms of your ADSs. A copy of the deposit agreement is filed as an exhibit to the registration statement of which this
prospectus forms a part. You may also obtain a copy of the deposit agreement at the SEC&rsquo;s Public Reference Room which is
located at 100 F Street, NE, Washington, DC 20549. You may obtain information on the operation of the Public Reference Room by
calling the SEC at 1-800-732-0330. You may also find the registration statement and the deposit agreement on the SEC&rsquo;s website
at http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dividends and Other Distributions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><B><I>How will you receive dividends and other distributions
on the shares?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary has agreed
to pay to ADS holders the cash dividends or other distributions it or the custodian receives on shares or other deposited securities,
after deducting its fees and expenses. You will receive these distributions in proportion to the number of shares your ADSs represent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><B><I>Cash.&nbsp;</I></B>The depositary will convert any cash dividend or other cash distribution
we pay on the shares into U.S. dollars, if it can do so on a reasonable basis and can transfer the U.S. dollars to the United States.
If that is not possible or if any government approval is needed and cannot be obtained, the deposit agreement allows the depositary
to distribute the foreign currency only to those ADS holders to whom it is possible to do so. It will hold the foreign currency
it cannot convert for the account of the ADS holders who have not been paid. It will not invest the foreign currency and it will
not be liable for any interest.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">Before making a distribution,
any withholding taxes, or other governmental charges that must be paid will be deducted. The depository will distribute only whole
U.S. dollars and cents and will round fractional cents to the nearest whole cent. If the exchange rates fluctuate during a time
when the depositary cannot convert the foreign currency, you may lose some or all of the value of the distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><B><I>Shares.&nbsp;</I></B>The depositary may distribute additional ADSs representing any shares
we distribute as a dividend or free distribution. The depositary will only distribute whole ADSs. It will sell shares which would
require it to deliver a fraction of an ADS (or ADSs representing those shares) and distribute the net proceeds in the same way
as it does with cash. If the depositary does not distribute additional ADSs, the outstanding ADSs will also represent the new shares.
The depositary may sell a portion of the distributed shares sufficient to pay its fees and expenses in connection with that distribution
(or ADSs representing those shares).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><B><I>Rights to purchase additional shares.&nbsp;</I></B>If we offer holders of our securities
any rights to subscribe for additional shares or any other rights, the depositary may make these rights available to ADS holders.
If the depositary decides it is not legal and practical to make the rights available but that it is practical to sell the rights,
the depositary will use reasonable efforts to sell the rights and distribute the proceeds in the same way as it does with cash.
The depositary will allow rights that are not distributed or sold to lapse. In that case, you will receive no value for them.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">If the depositary makes rights
available to ADS holders, it will exercise the rights and purchase the shares on your behalf. The depositary will then deposit
the shares and deliver ADSs to the persons entitled to them. It will only exercise rights if you pay it the exercise price and
any other charges the rights require you to pay together with the depository&rsquo;s fees and expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">U.S. securities laws may restrict
transfers and cancellation of the ADSs represented by shares purchased upon exercise of rights. For example, you may not be able
to trade these ADSs freely in the United States. In this case, the depositary may deliver restricted depositary shares that have
the same terms as the ADSs described in this section except for changes needed to put the necessary restrictions in place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><B><I>Other Distributions.</I></B>&nbsp;The depositary will send to ADS holders anything else we
distribute on deposited securities by any means it thinks is legal, fair and practical. If it cannot make the distribution in that
way, the depositary (i) may decide to sell what we distributed and distribute the net proceeds, in the same way as it does with
cash or (ii) it may decide to hold what we distributed, in which case ADSs will also represent the newly distributed property.
However, the depositary is not required to distribute any securities (other than ADSs) to ADS holders unless it receives satisfactory
evidence from us that it is legal to make that distribution. The depositary may sell a portion of the distributed securities or
property sufficient to pay its fees and expenses in connection with that distribution.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary is not
responsible if it decides that it is unlawful or impractical to make a distribution available to any ADS holders. We have no obligation
to register ADSs, shares, rights or other securities under the Securities Act. We also have no obligation to take any other action
to permit the distribution of ADSs, shares, rights or anything else to ADS holders. This means that you may not receive the distributions
we make on our shares or any value for them if it is illegal or impractical for us to make them available to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Deposit, Withdrawal and Cancellation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>How are ADSs issued?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary will
deliver ADSs if you or your broker deposits shares or evidence of rights to receive shares with the custodian. Upon payment of
its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will register
the appropriate number of ADSs in the names you request and will deliver the ADSs to or upon the order of the person or persons
that made the deposit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>How can ADS holders
withdraw the deposited securities?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may surrender your
ADSs at the depositary&rsquo;s office. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or
stock transfer taxes or fees, the depositary will deliver the shares and any other deposited securities underlying the ADSs to
the ADS holder or a person the ADS holder designates at the office of the custodian. However, at the request, risk and expense
of the ADS holder, the depositary will deliver the deposited securities at its office, if feasible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>How do ADS holders
interchange between certificated ADSs and uncertificated ADSs?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may surrender your
ADR to the depositary for the purpose of exchanging your ADR for uncertificated ADSs. The depositary will cancel that ADR and will
send to the ADS holder a statement confirming that the ADS holder is the registered holder of uncertificated ADSs. Alternatively,
upon receipt by the depositary of a proper instruction from a registered holder of uncertificated ADSs requesting the exchange
of uncertificated ADSs for certificated ADSs, the depositary will execute and deliver to the ADS holder an ADR evidencing those
ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Voting Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>How do you vote?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary will
notify ADS holders of shareholders&rsquo; meetings and arrange to deliver our voting materials to them if we ask it to. Those materials
will describe the matters to be voted on and explain how ADS holders may instruct the depositary to vote. For instructions to be
valid, they much reach the depositary by a date set by the depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary will
try, as far as practical, subject to the laws of Australia and of our Constitution or similar documents, to vote or to have its
agents vote the shares or other deposited securities as instructed by ADS holders. The depositary will only vote or attempt to
vote as instructed. Accordingly, ADS holders must instruct the depositary how to vote the number of deposited shares their ADSs
represent otherwise, such holders will not be able to exercise their right to vote unless their withdraw their shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot assure you
that you will receive the voting materials in time to ensure that you can instruct the depositary to vote your shares. In addition,
the depositary and its agents are not responsible for failing to carry out voting instructions or for the manner of carrying out
voting instructions. This means that you may not be able to exercise your right to vote and there may be nothing you can do if
your shares are not voted as you requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to give you
a reasonable opportunity to instruct the depositary as to the exercise of voting rights relating to deposited securities, if we
request the depositary to act, we agree to give the depositary notice of any such meeting and details concerning the matters to
be voted upon at least 30 days in advance of the meeting date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Fees and Expenses</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%"><FONT STYLE="font-size: 10pt"><B><I>Persons depositing or withdrawing shares or ADS holders must pay</I>:</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 46%; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>For</I>:</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">$5.00 (or less) per 100 ADSs (or portion of 100 ADSs)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Issuance of ADSs, including issuances resulting
        from a distribution of shares or rights or other property and</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">cancellation of ADSs for the purpose of
        withdrawal, including if the deposit agreement terminates</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">$0.05 (or less) per ADS</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Any cash distribution to ADS holders</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">A fee equivalent to the fee that would be payable if securities distributed to you had been shares and the shares had been deposited for issuance of ADSs</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Distribution of securities distributed to holders of deposited securities which are distributed by the depositary to ADS holders</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">$0.05 (or less) per ADS per calendar year</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Depositary services</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Registration or transfer fees</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Transfer and registration of shares on our share register to or from the name of the depositary or its agent when you deposit or withdraw shares</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Expenses of the depositary</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Cable, telex and facsimile transmissions (when expressly provided in the deposit agreement) converting foreign currency to U.S. dollars</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Taxes and other governmental charges the depositary or the custodian has to pay on any ADSs or shares underlying ADSs, such as&nbsp;&nbsp;stock transfer taxes, stamp duty or withholding taxes</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">As necessary</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Any charges incurred by the depositary or its agents for servicing the deposited securities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">As necessary</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary collects
its fees for delivery and surrender of ADSs directly from investors depositing shares or surrendering ADSs for the purpose of withdrawal
or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting those fees
from the amounts distributed or by selling a portion of distributable property to pay the fees. The depositary may collect its
annual fee for depositary services by deduction from cash dividends or other cash distributions or by directly billing investors
or by charging the book-entry system accounts of participants acting for them. The depositary may collect any of its fees by deduction
from any cash distribution payable to ADS holders that are obligated to pay those fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, the
depositary may make payments to us to reimburse us for costs and expenses generally arising out of establishment and maintenance
of the ADS program, waive fees and expenses for services provided to us by the depositary or share revenue from the fees collected
from ADS holders. In performing its duties under the deposit agreement, the depositary may use brokers, dealers, foreign currency
dealers or other service providers that are owned by or affiliated with the depositary and that may earn or share fees, spreads
or commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary may convert
currency itself or through any of its affiliates and, in those cases, acts as principal for its own account and not as agent, advisor,
broker or fiduciary on behalf of any other person and earns revenue, including, without limitation, transaction spreads, that it
will retain for its own account. The revenue is based on, among other things, the difference between the exchange rate assigned
to the currency conversion made under the deposit agreement and the rate that the depositary or its affiliate receives when buying
or selling foreign currency for its own account. The depositary makes no representation that the exchange rate used or obtained
in any currency conversion under the deposit agreement will be the most favorable rate that could be obtained at the time or that
the method by which that rate will be determined will be the most favorable to ADS holders, subject to the depositary&rsquo;s obligations
under the deposit agreement. The methodology used to determine exchange rates used in currency conversions is available upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Payment of Taxes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You will be responsible
for any taxes or other governmental charges payable on your ADSs or on the deposited securities represented by any of your ADSs.
The depositary may refuse to register any transfer of your ADSs or allow you to withdraw the deposited securities represented by
your ADSs until such taxes or other charges are paid. It may apply payments owed to you or sell deposited securities represented
by your American Depositary Shares to pay any taxes owed and you will remain liable for any deficiency. If the depositary sells
deposited securities, it will, if appropriate, reduce the number of ADSs to reflect the sale and pay to ADS holders any proceeds,
or send to ADS holders any property, remaining after it has paid the taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Reclassifications, Recapitalizations
and Mergers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon any change in
nominal value, change in par value, split-up, consolidation, or any other reclassification of deposited securities, or upon any
recapitalization, reorganization, merger or consolidation, or sale of assets affecting us or to which we are a party, or upon the
redemption or cancellation by us of the deposited securities, any securities, cash or property which shall be received by the depositary
or a custodian in exchange for, in conversion of, in lieu of or in respect of deposited securities shall be treated as new deposited
securities under the deposit agreement, and ADSs shall thenceforth represent, in addition to the existing deposited securities,
the right to receive the new deposited securities so received, unless additional ADRs are delivered. In any such case the depositary
may execute and deliver additional ADRs as in the case of a dividend in ordinary shares, or call for the surrender of outstanding
ADRs to be exchanged for new ADRs specifically describing such new deposited securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Limitations on Obligations and Liability</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B><I>Limits on Our
Obligations and the Obligations of the Depositary; Limits on Liability to Holders of ADSs</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The deposit agreement
expressly limits our obligations and the obligations of the depositary. It also limits our liability and the liability of the depositary.
We and the depositary, among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">are only obligated to take the actions specifically set forth in the deposit agreement without
negligence or bad faith;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">are not liable if we are or it is prevented or delayed by law or circumstances beyond our or its
control from performing our or its obligations under the deposit agreement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">are not liable if we or it exercises discretion permitted under the deposit agreement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">are not liable for the inability of any holder of ADSs to benefit from any distribution on deposited
securities that is not made available to holders of ADSs under the terms of the deposit agreement, or for any special, consequential
or punitive damages for any breach of the terms of the deposit agreement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">have no obligation to become involved in a lawsuit or other proceeding related to the ADSs or the
deposit agreement on your behalf or on behalf of any other person;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">are not liable for the acts or omissions of any securities depository, clearing agency or settlement
system; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">may rely upon any documents we believe or it believes in good faith to be genuine and to have been
signed or presented by the proper person.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the deposit agreement,
we and the depositary agree to indemnify each other under certain circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Requirements for Depositary Actions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Before the depositary
will deliver or register a transfer of ADSs, make a distribution on ADSs, or permit withdrawal of shares, the depositary may require,
among other things:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">payment of stock transfer or other taxes or other governmental charges and transfer or registration
fees charged by third parties for the transfer of any shares or other deposited securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">satisfactory proof of the identity and genuineness of any signature or other information it deems
necessary; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">compliance with regulations it may establish, from time to time, consistent with the deposit agreement,
including presentation of transfer documents.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary may
refuse to deliver ADSs or register transfers of ADSs when the transfer books of the depositary or our transfer books are closed
or at any time if the depositary or we think it advisable to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Your Right to Receive the Shares Underlying
Your ADSs</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ADS holders have the
right to cancel their ADSs and withdraw the underlying shares at any time except:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">when temporary delays arise because: (i) the depositary, we or the foreign registrar has closed
its transfer books; (ii) the transfer of shares is blocked to permit voting at a shareholders&rsquo; meeting; or (iii) we are paying
a dividend on our shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">when you owe money to pay fees, taxes and similar charges; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">when it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations
that apply to ADSs or to the withdrawal of shares or other deposited securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This right of withdrawal
may not be limited by any other provision of the deposit agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Direct Registration System</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All parties to the
deposit agreement acknowledge that the DRS and Profile Modification System, or Profile, will apply to uncertificated ADSs upon
acceptance thereof to DRS by DTC. DRS is the system administered by DTC under which the depositary may register the ownership of
uncertificated ADSs, which ownership will be confirmed by statements sent by the depositary to the registered holders of uncertificated
ADSs. Profile is a required feature of DRS that allows a DTC participant, claiming to act on behalf of a registered holder of ADSs,
to direct the depositary to register a transfer of those ADSs to DTC or its nominee and to deliver those ADSs to the DTC account
of that DTC participant without receipt by the depositary of prior authorization from the ADS holder to register that transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with
and in accordance with the arrangements and procedures relating to DRS/Profile, the parties to the deposit agreement understand
that the depositary will not determine whether the DTC participant that is claiming to be acting on behalf of an ADS holder in
requesting registration of transfer and delivery described in the paragraph above has the actual authority to act on behalf of
the ADS holder (notwithstanding any requirements under the Uniform Commercial Code). In the deposit agreement, the parties agree
that the depositary&rsquo;s reliance on and compliance with instructions received by the depositary through the DRS/Profile System
and in accordance with the deposit agreement will not constitute negligence or bad faith on the part of the depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Shareholder Communications; Inspection of Register of Holders
of ADSs</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The depositary will
make available for your inspection at its office all reports and communications that it receives from us as a holder of deposited
securities that we make generally available to holders of deposited securities. The depositary will send you copies of those communications
that we ask it to send. You have a right to inspect the register of holders of ADSs, but not for the purpose of contacting those
holders about a matter unrelated to our business, the deposit agreement or the ADSs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B><A NAME="a_009"></A>DESCRIPTION
OF PREFERENCE SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Subject to any
limitations under the Corporations Act, ASX Listing Rules or the Constitution, our board of directors may issue preference shares with any preferential rights,
privileges or conditions. The rights and restrictions attaching to any preference shares are set out in our Constitution
or in a special resolution of shareholders. Our Constitution does not limit the amount of preference shares that we may issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">We do not have
any preference shares outstanding as of the date of this prospectus. In the future we may issue preference shares that could be
converted into ordinary shares. A prospectus supplement will contain and describe the material terms of any preference shares that
we offer to the public in the United States, along with any material U.S. federal or Australian income tax considerations relating
to the offer of such preference shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Consistent with
the ASX Listing Rules and our Constitution, any preference shares issued by us must confer on the holders of those preference shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">the same rights as holders
of ordinary shares to receive notices of general meetings, other notices, reports and accounts and to attend general meetings;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">the right to vote in each of the following circumstances and in no
                                                                                                                           others: (i)&nbsp;in a period during which a dividend (or part of a dividend) in respect of the share is in
                                                                                                                           arrears; (ii)&nbsp;on a proposal to reduce our share capital; (iii)&nbsp;on a resolution to approve the terms of a buy-back
                                                                                                                           agreement; (iv)&nbsp;on a proposal that affects rights attached to the shares; (v)&nbsp;on a proposal to wind up our company;
                                                                                                                           (vi)&nbsp;on a proposal for the disposal of the whole of our property, business and undertaking; (vii)&nbsp;during the
                                                                                                                           winding up of our company; (viii)&nbsp;subject to the ASX Listing Rules and Nasdaq, in any additional circumstances
                                                                                                                           specified in the terms of issue of such preference shares by us relating to the shares upon issuance;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a dividend in preference
to holders of ordinary shares; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a return of capital
in preference to holders of ordinary shares if we were to be wound up.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">The ASX
Listing Rules  impose certain limitations on the issuance of preference shares by companies such as our company that are
listed on ASX, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any dividends on preference
shares must be at a commercial rate; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">any anti-dilution rights
must be limited to the right to adjust the number of ordinary shares into which preference shares convert in the event of a share
split or consolidation (<I>i.e.</I>, reverse stock split), a bonus or entitlement issue (e<I>.g.</I>, stock dividend), or other
capital reconstruction.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">Further, the
Corporations Act places certain limitations on payment of dividends, including preferred dividends. A right to receive dividends on a preference share may be expressed to be cumulative where it cannot be
paid due to legal limitations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_010"></A>DESCRIPTION OF WARRANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">We
may issue and offer warrants under the material terms and conditions described in this prospectus and any accompanying prospectus
supplement. The accompanying prospectus supplement may add, update or change the terms and conditions of the warrants as described
in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">We
may issue warrants to purchase our ordinary shares represented by ADSs. Warrants may be issued independently or together with any
securities and may be attached to or separate from those securities. The warrants may be issued under warrant or subscription agreements
to be entered into between us and a bank or trust company, as warrant agent, all of which will be described in the prospectus supplement
relating to the warrants we are offering. The warrant agent will act solely as our agent in connection with the warrants and will
not have any obligation or relationship of agency or trust for or with any holders or beneficial owners of warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">The
particular terms of the warrants, the warrant or subscription agreements relating to the warrants and the warrant certificates
representing the warrants will be described in the applicable prospectus supplement, including, as applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">the title of such warrants;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">the aggregate number of such warrants;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">the price or prices at which such warrants will be issued
and exercised;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">the currency or currencies in which the price of such warrants
will be payable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">the date on which the right to exercise such warrants shall
commence and the date on which such right shall expire;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">if applicable, the minimum or maximum amount of such warrants
which may be exercised at any one time;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">if applicable, the designation and terms of the securities
with which such warrants are issued and the number of such warrants issued with each such security;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">if applicable, the date on and after which such warrants
and the related securities will be separately transferable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">if applicable, any provisions for cashless exercise of the
warrants;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">if applicable; any exercise limitations with respect to the
ownership limitations by the holder exercising the warrant;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">information with respect to book-entry procedures, if any;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">any material Australian and United States federal income
tax consequences;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">the anti-dilution provisions of the warrants, if any; and&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">any other terms of such warrants, including terms, procedures
and limitations relating to the exchange and exercise of such warrants.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="background-color: white">Holders
of warrants will not be entitled, solely by virtue of being holders, to vote, to consent, to receive dividends, to receive notice
as shareholders with respect to any meeting of shareholders for the election of directors or any other matters, or to exercise
any rights whatsoever as a holder of the equity securities purchasable upon exercise of the warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="background-color: white">The
description in the applicable prospectus supplement of any warrants we offer will not necessarily be complete and will be qualified
in its entirety by reference to the applicable warrant agreement and warrant certificate, which will be filed with the SEC if we
offer warrants. For more information on how you can obtain copies of the applicable warrant agreement if we offer warrants, see
&quot;Where You Can Find More Information&quot; and &quot;Incorporation of Certain Information by Reference.&quot; We urge you
to read any applicable prospectus supplement and the applicable warrant agreement and form of warrant certificate in their entirety.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B></B></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><A NAME="a_011"></A><B>DESCRIPTION
OF UNITS&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-indent: 0.5in">We may issue units
comprised of one or more of the other securities described in this prospectus in any combination. Each unit will be issued so that
the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights
and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that the securities
included in the unit may not be held or transferred separately, at any time or at any time before a specified date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; text-indent: 0.5in">The applicable
prospectus supplement will describe:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">the designation and terms of the units and of the securities comprising the units, including
whether and under what circumstances those securities may be held or transferred separately;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">any unit agreement under which the units will be issued;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">any provisions for the issuance, payment, settlement, transfer or exchange of the units
or of the securities comprising the units; and&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="background-color: white">whether the units will be issued in fully registered or global form.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="background-color: white">The
applicable prospectus supplement will describe the terms of any units. The preceding description and any description of units in
the applicable prospectus supplement does not purport to be complete and is subject to and is qualified in its entirety by reference
to the unit agreement and, if applicable, collateral arrangements and depositary arrangements relating to such units. For more
information on how you can obtain copies of the applicable unit agreement if we offer units, see &quot;Where You Can Find More
Information&quot; and &quot;Incorporation of Certain Information by Reference.&quot; We urge you to read the applicable unit agreement
and any applicable prospectus supplement in their entirety.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><A NAME="a_012"></A><B>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">The
securities being offered by this prospectus may be sold:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">through agents;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">t<FONT STYLE="background-color: white">o or through one or more underwriters on a firm commitment
or agency basis;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">through put or call option transactions relating to the securities;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">to or through dealers, who may act as agents or principals,
including a block trade (which may involve crosses) in which a broker or dealer so engaged will attempt to sell as agent but may
position and resell a portion of the block as principal to facilitate the transaction;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">through privately negotiated transactions;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">purchases by a broker or dealer as principal and resale by
such broker or dealer for its own account pursuant to this prospectus;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">directly to purchasers, including our affiliates , through
a specific bidding or auction process, on a negotiated basis or otherwise; to or through one or more underwriters on a firm commitment
or best efforts basis;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">exchange distributions and/or secondary distributions;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">ordinary brokerage transactions and transactions in which
the broker solicits purchasers;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">in &quot;at-the-market&quot; offerings, within the meaning
of Rule&nbsp;415(a)(4) of the Securities Act to or through a market maker or into an existing trading market, on an exchange or
otherwise;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">transactions not involving market makers or established trading
markets, including direct sales or privately negotiated transactions;&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">transactions in options, swaps or other derivatives that
may or may not be listed on an exchange;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">through any other method permitted pursuant to applicable
law; or&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">through a combination of any such methods of sale.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">At
any time a particular offer of the securities covered by this prospectus is made, a revised prospectus or prospectus supplement,
if required, will be distributed which will set forth the aggregate amount of securities covered by this prospectus being offered
and the terms of the offering, including the name or names of any underwriters, dealers, brokers or agents, any discounts, commissions,
concessions and other items constituting compensation from us and any discounts, commissions or concessions allowed or re-allowed
or paid to dealers. Such prospectus supplement, and, if necessary, a post-effective amendment to the registration statement of
which this prospectus is a part, will be filed with the SEC to reflect the disclosure of additional information with respect to
the distribution of the securities covered by this prospectus. In order to comply with the securities laws of certain states, if
applicable, the securities sold under this prospectus may only be sold through registered or licensed broker-dealers. In addition,
in some states the securities may not be sold unless they have been registered or qualified for sale in the applicable state or
an exemption from registration or qualification requirements is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">The
distribution of securities may be effected from time to time in one or more transactions, including block transactions and transactions
on The Nasdaq Capital Market or any other organized market where the securities may be traded. The securities may be sold at a
fixed price or prices, which may be changed, or at market prices prevailing at the time of sale, at prices relating to the prevailing
market prices or at negotiated prices. The consideration may be cash or another form negotiated by the <FONT STYLE="background-color: white">parties.
Agents, underwriters or broker-dealers may be paid compensation for offering and selling the securities. That compensation may
be in the form of discounts, concessions or commissions to be received from us or from the purchasers of the securities. Any dealers
and agents participating in the distribution of the securities may be deemed to be underwriters, and compensation received by them
on resale of the securities may be deemed to be underwriting discounts. If any such dealers or agents were deemed to be underwriters,
they may be subject to statutory liabilities under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">Agents
may from time to time solicit offers to purchase the securities. If required, we will name in the applicable prospectus supplement
any agent involved in the offer or sale of the securities and set forth any compensation payable to the agent. Unless otherwise
indicated in the prospectus supplement, any agent will be acting on a best efforts basis for the period of its appointment. Any
agent selling the securities covered by this prospectus may be deemed to be an underwriter, as that term is defined in the Securities
Act, of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">To
the extent that we make sales to or through one or more underwriters or agents in at-the-market offerings, we will do so pursuant
to the terms of a distribution agreement between us and the underwriters or agents. If we engage in at-the-market sales pursuant
to a distribution agreement, we will sell any of our listed securities to or through one or more underwriters or agents, which
may act on an agency basis or on a principal basis. During the term of any such agreement, we may sell any of our listed securities
on a daily basis in exchange transactions or otherwise as we agree with the underwriters or agents. The distribution agreement
will provide that any of our listed securities which are sold will be sold at prices related to the then prevailing market prices
for our listed securities. Therefore, exact figures regarding proceeds that will be raised or commissions to be paid cannot be
determined at this time and will be described in a prospectus supplement. Pursuant to the terms of the distribution agreement,
we also may agree to sell, and the relevant underwriters or agents may agree to solicit offers to purchase, blocks of our listed
securities. The terms of each such distribution agreement will be set forth in more detail in a prospectus supplement to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">If
underwriters are used in a sale, securities will be acquired by the underwriters for their own account and may be resold from time
to time in one or more transactions, including negotiated transactions, at a fixed public offering price or at varying prices determined
at the time of sale, or under delayed delivery contracts or other contractual commitments. Securities may be offered to the public
either through underwriting syndicates represented by one or more managing underwriters or directly by one or more firms acting
as underwriters. If an underwriter or underwriters are used in the sale of securities, an underwriting agreement will be executed
with the underwriter or underwriters, as well as any other underwriter or underwriters, with respect to a particular underwritten
offering of securities, and will set forth the terms of the transactions, including compensation of the underwriters and dealers
and the public offering price, if applicable. The prospectus and prospectus supplement will be used by the underwriters to resell
the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">If
a dealer is used in the sale of the securities, we or an underwriter will sell the securities to the dealer, as principal. The
dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale. To
the extent required, we will set forth in the prospectus supplement the name of the dealer and the terms of the transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">We
may directly solicit offers to purchase the securities and may make sales of securities directly to institutional investors or
others. These persons may be deemed to be underwriters within the meaning of the Securities Act with respect to any resale of the
securities. To the extent required, the prospectus supplement will describe the terms of any such sales, including the terms of
any bidding or auction process, if used.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">Agents,
underwriters and dealers may be entitled under agreements which may be entered into with us to indemnification by us against specified
liabilities, including liabilities incurred under the Securities Act, or to contribution by us to payments they may be required
to make in respect of such <FONT STYLE="background-color: white">liabilities. If required, the prospectus supplement will describe
the terms and conditions of the indemnification or contribution. Some of the agents, underwriters or dealers, or their affiliates
may be customers of, engage in transactions with or perform services for us or our subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">Any
person participating in the distribution of securities registered under the registration statement that includes this prospectus
will be subject to applicable provisions of the Exchange Act and the applicable SEC rules and regulations, including, among others,
Regulation&nbsp;M, which may limit the timing of purchases and sales of any of our securities by that person. Furthermore, Regulation&nbsp;M
may restrict the ability of any person engaged in the distribution of our securities to engage in market-making activities with
respect to our securities. These restrictions may affect the marketability of our securities and the ability of any person or entity
to engage in market-making activities with respect to our securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">Certain
persons participating in an offering may engage in over-allotment, stabilizing transactions, short-covering transactions, penalty
bids and other transactions that stabilize, maintain or otherwise affect the price of the offered securities. These activities
may maintain the price of the offered securities at levels above those that might otherwise prevail in the open market, including
by entering stabilizing bids, effecting syndicate covering transactions or imposing penalty bids, each of which is described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">a stabilizing bid means the placing of any bid, or the effecting
of any purchase, for the purpose of pegging, fixing or maintaining the price of a security.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">a syndicate covering transaction means the placing of any
bid on behalf of the underwriting syndicate or the effecting of any purchase to reduce a short position created in connection with
the offering.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">a penalty bid means an arrangement that permits the managing
underwriter to reclaim a selling concession from a syndicate member in connection with the offering when offered securities originally
sold by the syndicate member are purchased in syndicate covering transactions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">These
transactions may be effected on an exchange or automated quotation system, if the securities are listed on that exchange or admitted
for trading on that automated quotation system, or in the over-the-counter market or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">If
so indicated in the applicable prospectus supplement, we will authorize agents, underwriters or dealers to solicit offers from
certain types of institutions to purchase offered securities from us at the public offering price set forth in such prospectus
supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. Such contracts
will be subject only to those conditions set forth in the prospectus supplement and the prospectus supplement will set forth the
commission payable for solicitation of such contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">In
addition, the securities may be issued upon conversion of or in exchange for debt securities or other securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">Any
underwriters to whom offered securities are sold for public offering and sale may make a market in such offered securities, but
such underwriters will not be obligated to do so and may discontinue any market making at any time without notice. The offered
securities may or may not be listed on a national securities exchange. No assurance can be given that there will be a market for
the offered securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">Any
securities that qualify for sale pursuant to Rule&nbsp;144 or Regulation&nbsp;S under the Securities Act, may be sold under Rule&nbsp;144
or Regulation&nbsp;S rather than pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">In
connection with offerings made through underwriters or agents, we may enter into agreements with such underwriters or agents pursuant
to which we receive our outstanding securities in <FONT STYLE="background-color: white">consideration for the securities being
offered to the public for cash. In connection with these arrangements, the underwriters or agents may also sell securities covered
by this prospectus to hedge their positions in these outstanding securities, including in short sale transactions. If so, the underwriters
or agents may use the securities received from us under these arrangements to close out any related open borrowings of securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">We
may enter into derivative transactions with third parties or sell securities not covered by this prospectus to third parties in
privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, such
third parties (or affiliates of such third parties) may sell securities covered by this prospectus and the applicable prospectus
supplement, including in short sale transactions. If so, such third parties (or affiliates of such third parties) may use securities
pledged by us or borrowed from us or others to settle those sales or to close out any related open borrowings of shares, and may
use securities received from us in settlement of those derivatives to close out any related open borrowings of shares. The third
parties (or affiliates of such third parties) in such sale transactions will be underwriters and will be identified in the applicable
prospectus supplement (or a post-effective amendment).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">We
may loan or pledge securities to a financial institution or other third party that in turn may sell the securities using this prospectus.
Such financial institution or third party may transfer its short position to investors in our securities or in connection with
a simultaneous offering of other securities offered by this prospectus or in connection with a simultaneous offering of other securities
offered by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">
<A NAME="a_013"></A><B>TAXATION&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">The
material Australian and U.S. federal income tax consequences relating to the purchase, ownership and disposition of any of the
securities offered by this prospectus will be set forth in the prospectus supplement offering those securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><A NAME="a_014"></A><FONT STYLE="background-color: white"><B>EXPENSES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="background-color: white">The
following is a statement of expenses in connection with the distribution of the securities registered. All amounts shown are estimates
except the SEC registration fee and FINRA fee.&nbsp; The estimates do not include expenses related to offerings of particular securities.
Each prospectus supplement describing an offering of securities will reflect the estimated expenses related to the offering of
securities under that prospectus supplement</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 87%; text-align: left; text-indent: -10pt; padding-left: 10pt">U.S. Securities and Exchange Commission registration fee</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">12,120</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">FINRA fee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Legal fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Accounting fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Printing expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Depositary fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt; padding-bottom: 1pt">Other miscellaneous fees and expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">3,380</TD><TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">118,000</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><A NAME="a_015"></A><B>LEGAL MATTERS&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">Certain
legal matters with respect to Australian law with respect to the validity of the offered securities will be passed upon for the
Company by Francis Abourizk Lightowlers, Melbourne, Victoria, Australia. Sheppard Mullin Richter &amp; Hampton, LLP, New York,
New York, will be passing upon matters of United States law for us with respect to securities offered by this prospectus and any
accompanying prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><A NAME="a_016"></A><FONT STYLE="background-color: white"><B>EXPERTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">The consolidated financial
statements as of and for the year ended June 30, 2018 incorporated by reference in this prospectus and elsewhere in the registration
statement, have been so incorporated&nbsp; by reference in reliance upon the report of Grant Thornton Audit Pty Ltd., independent
registered public accounting firm, upon the authority of said firm as experts in accounting and auditing. The consolidated financial
statements as of June 30, 2017 and for the years ended June 30, 2017 and 2016 incorporated by reference in this prospectus and
elsewhere in the registration statement, have been so included in reliance upon the report of Marcum LLP, independent registered
public accounting firm, upon the authority of said firm as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><A NAME="a_017"></A><B>ENFORCEMENT
OF CIVIL LIABILITIES&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain
of our directors and executive officers may be nonresidents of the United States. All or a substantial portion of the
assets of such nonresident persons are located outside the United States. As a result, it may be difficult for investors to
effect service of process within the United States upon such persons, or to enforce against such persons judgments obtained
in United States courts, including judgments predicated upon the civil liability provisions of the federal securities laws
of the United States or any State in the United States. We have been advised by Francis Abourizk Lightowlers that there may
be significant practical and legal difficulties in enforcing in Australia judgments that are obtained in U.S. courts, against
our Company and our executive officers and directors who are non-residents of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><A NAME="a_018"></A><B>INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">The
SEC allows us to &quot;incorporate by reference&quot; information into this prospectus, which means that we can disclose important
information to you by referring you to other documents which we have filed or will file with the SEC. The information incorporated
by reference is considered a part of this prospectus and should be read carefully. Certain information in this prospectus supersedes
information incorporated by reference that we filed with the SEC prior to the date of this prospectus. Certain information that
we file later with the SEC will automatically update and supersede the information in this prospectus. Any statement so modified
or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">We
incorporate by reference into this prospectus and the registration statement of which it is a part the following documents, including
any amendments to such filings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">our annual report on <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577418011717/s113211_20f.htm">Form&nbsp;20-F</A> for the fiscal year ended&nbsp;June
30, 2018;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0">our Reports on Form&nbsp;6-K&nbsp;furnished to the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577418012345/s113908_6k.htm">November 9, 2018</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577418012976/s114118_6k.htm">November 19, 2018</A> (2), <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577419000148/s115184_6k.htm">January 3, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577419001183/s115587_6k.htm">January 29, 2019</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577419003249/s116253_6k.htm">February 28, 2019</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577419004182/s116784_6k.htm">March 19, 2019</A>;</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD></TR>                                                                                  <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">our Report on <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577419005432/s117296_6ka.htm">Form 6-K/A</A> furnished to the SEC on April 8, 2019; and</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">the description of ADSs representing our ordinary shares and warrants to purchase ADSs contained
in our Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577417002693/s106293_8a12b.htm">Form&nbsp;8-A</A>&nbsp;filed with the SEC on May 25, 2017, including any amendments or reports filed
for the purpose of updating such description.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
are also incorporating by reference all subsequent Annual Reports on Form&nbsp;20-F&nbsp;that we file with the SEC and certain
reports on Form&nbsp;6-K&nbsp;that we furnish to the SEC after the date of this prospectus (if they state that they are incorporated
by reference into this prospectus) prior to the termination of this offering. In all cases, you should rely on the later information
over different information included in this prospectus or any accompanying prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18.35pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Unless
expressly incorporated by reference, nothing in this prospectus shall be deemed to incorporate by reference information furnished
to, but not filed with, the SEC. Copies of all documents incorporated by reference in this prospectus, other than exhibits to those
documents unless such exhibits are specifically incorporated by reference in this prospectus, will be provided at no cost to each
person, including any beneficial owner, who receives a copy of this prospectus on the written or oral request of that person made
to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Immuron Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Level 3, 62 Lygon
Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Carlton South,
Victoria, 3053, Australia 3053<BR>
Tel: +61 (0) 398 245 254<BR></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">You
may also access these documents on our website,&nbsp; <I>www.immuron.com.au</I>. The information contained on, or that can be accessed
through, our website is not a part of this prospectus. We have included our website address in this prospectus solely as an inactive
textual reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="background-color: white">You
should rely only on information contained in, or incorporated by reference into, this prospectus. We have not authorized anyone
to provide you with information different from that contained in this prospectus or incorporated by reference in this prospectus.
We are not making offers to sell the securities in any jurisdiction in which such an offer or solicitation is not authorized or
in which the person making such offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make such
offer or solicitation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><A NAME="a_019"></A><B>WHERE YOU CAN
FIND MORE INFORMATION&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">We
have filed with the SEC a registration statement (including amendments and exhibits to the registration statement) on Form&nbsp;F-3
under the Securities Act. This prospectus, which is part of the registration statement, does not contain all of the information
set forth in the registration statement and the exhibits and schedules to the registration statement. For further information,
we refer you to the registration statement and the exhibits and schedules filed as part of the registration statement. If a document
has been filed as an exhibit to the registration statement, we refer you to the copy of the document that has been filed. Each
statement in this prospectus relating to a document filed as an exhibit is qualified in all respects by the filed exhibit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">We
are subject to the informational requirements of the Exchange Act. Our annual report on <A HREF="http://www.sec.gov/Archives/edgar/data/1660046/000161577418011717/s113211_20f.htm">Form&nbsp;20-F</A> for the year ending June
30, 2018 has been filed with the SEC. The company has also filed periodic reports with the SEC on Form&nbsp;6-K. You may inspect
and copy reports and other information filed with the SEC at the Public Reference Room at 100&nbsp;F Street, N.E., Washington,
D.C.&nbsp;20549. Information on the operation of the Public Reference Room may be obtained by calling the SEC at 1-800-SEC-0330.
In addition, the SEC maintains an Internet website that contains reports and other information about issuers, like us, that file
electronically with the SEC. The address of that website is&nbsp;<I>www.sec.gov</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">As
a foreign private issuer, we are exempt under the Exchange Act from, among other things, the rules prescribing the furnishing and
content of proxy statements, and our executive officers, directors and principal shareholders are exempt from the reporting and
short-swing profit recovery provisions contained in Section&nbsp;16 of the Exchange Act. In addition, we will not be required under
the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies
whose securities are registered under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>339,130 American
Depositary Shares Representing 13,565,200 Ordinary Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><IMG SRC="image_004.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-top: Black 1pt solid; padding-bottom: 2.25pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>PROSPECTUS SUPPLEMENT</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 2.25pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ThinkEquity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>a division of Fordham Financial Management,
Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">July 16, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !' 00# 2(  A$! Q$!_\0
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M?W<D:X(KROP5=S:5XTMX=_#R&"4>M1R4ZL&X*S17/.E-<SNF>]9P.*XSQ/\
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MTZ/\&9-7^+$]LQ7DOQ=4"_TY@,$HPS7K=>3?%[_C\T__ '6_G6>%_BHUQ/\
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MX6LKBX?]]MV,?4CC-%/\*Z.VD^&K*TF $JIN?ZGFBBT17F=)1116)UA1110
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-N9CY4C5P****0'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" (4!$@# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&W%L98[&9@\KP=9\\::J5J<VG=J4HQ@HJVWQ=TF?F;X6_:\^+WAYU>;6=/\
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M8^)OL</AV^T*?5KBVET_7);MH;8:9<-;0)>O=S) +99%N'%N\RM_9>?V-O\
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MO"/[._[ /Q>_:]T[7=(FT?3?@UJGB?P'J#W,)LM8\4:UHNSP?8PR,6BECO\
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M /@H;_P4<^ 7_!-'X0:;\:OVAYO$@\(ZQXD@\-V \+:1)JUZ;^X5%CCDB17
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M>%HO"R_%?4O#EB5L%?5I+EM,CUW4+.5MA&7*QL[@D-NQL(!^_?PT_P"#L/\
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M7+OND4Y(8,<G^)K_ (-!&(_;I_X*"!8]N;'7L,$FD4D?$R1 #(I*( &*[RI
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MK6O@Z^U^^\4 :X/ -Y,NHW((N!YC>(Y9Y#,N4$!F$(R B!B6K]3/V:_VF?\
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MQ%=77Q'^(?QF@T_5=0N_ VL:-JW@[Q;X^UG5],N[2#_A)4FB:ZMWMYE>6,2
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MEVH8XV!W,I8;J_0X]#]#_GCG\J_GO_X-]?!G_!3#P5\!OBC8?\%+K?XA6_Q
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MCL?AO[+XBH9U"DYT,32E@YJFKU8UJE2+A.6T532TD[MKL]#XN\7>$])^)O\
MP6$\.CQ=##>Z?X ^$RZCI&E7T22VT]_;3K=VE]%$V/,:UN(DE!<.I*X<,N17
M[9WMUI^DVLMQ=2P65A9Q;YI78110Q1+G)(VA4B49XP%53@ "OP1_;^\4W/[,
M/[='[//[6;,T?@W7-!D\ ^)+V,L]A)IJR17&H7[[=\1G&FO((X]JG.TJ=QR?
MUM^+&KQ_$K]G[7_$7@.\74X?$'A1M2TF>S<L+B*XMRTJ0,A8&[\AWCCCEW)Y
MV R$@XG,,$\REPK2G4JT,MK4L-@95(MJG1K^WY<1*:NH)RG/F5]6H^\DHR1>
M'Q3P<L]<%2GB\.OK<5+>I!492M3T<G*ZL]$D]+N]S@M>_;8^%.D:G>:;$-5U
M#[)+-;/<PPJUM++&64QPG 63<1M#'/!&3@\^7^*OV\=,%K-#X4\*WD\\D,B0
M2W3I$B3&,K"T@7 V*Y5G_P!D'ZG\SV(MV>.:2"&2VDFCEM;EG%S#<+GS);J(
M8!16RTK*-RH#L8'IZM\,OA5XQ^*>K1:7X?TVYBM&DA%UKDEH!806[NJRSVYE
MC*RM%&6E5'#;R@# @XK^D%X0^&V0X2&<9G76(I4*-.M7J5L5#V=3]VIM0M4I
MN2=M4VE=\JB[Z_C$^/N,,\Q=3!8*-2G&O*I2I4J5*:J0<:CIIU%R67=.,G[N
MK/H3X VOB[XX_',^/?$\DUW#X:5;NYF4;+.QNPRRV=O:^0L,+*"B)*%4[@"7
MR<U^F7Q*U:ST/X>>/-3O[B*WM--\(:_<W,T[*L<4,.F71W%FXS+*H5%;.6PH
M'(%8?PD^%NA_";P?8^&M*A_?0IYU]=Q^8\UU>. 97FDD>224,^=L;,8T&!&B
MC 'Y:?\ !7#]K72OAG\*KOX%^%]4AG^(7Q&BAM-7BM6$DNB: LHF(<@.JRR.
M3(P?YV \MV,+M$/P'/\ ,J?&G&."PV2X65/*<JQ%+"Y;2IP484\'3K1JSJ3A
M!<L'.4$TM4H\B;4DT?K>38!<-</8G$YK4J3S',,/+ZU&34JDZ\HRC3Y.9IN,
M5/W[V=T]&C\[?^".NNW>N?MK>+=3M1-%INN^"O$^NW4.XF)6FU6Q2")E8E5=
M9+B6Y0C:V)-HQ&JJI7MG_!#CX575UXH^)_QAGM[BVTRPBM/"FDO)$RQWQOEM
MY)Y87("LD7V6*)PN0&!? <LQ*\_C^=.7$5:G'1T*%"C-1LTIQC=I^>O77N=W
M"M*M2RFFJB3YZE2I'63M&;;2VW5[-=T?TJD @@YP00<$J<$8X92&!]"""#R"
M#4?DQX&5R5! 8EF?!;<R^827*L1\REB&'RL"O%2T5\0?6C2JD$$9!&"O.TCI
MC;TQC@C&".M(8T)#$'<,@,&8-@G)7<"&*YYVD[>G' I]% $8BC!W $-@ MN;
M+ =-YSE\=MY;C(Z$TYD5L[AG(*GDC*GJ#@C(-.HH C$48.<$_-N +.RAL[@5
M1F*J0>1M VGD8-*(T50H4%1G .6QNSG!8D\Y/?VZ4^B@",Q(3DC/& "S% /9
M"=@/8$*"!QFG;5].V!@D8'M@C!]Q@^].HH C:&)R"\:.5;<I=0Y5LYRNX':0
M0""N,$ ]J/)BP%V+M 8;<<$,"&!'0Y!(.<U)10 PQ(1M*C "@ $KPIR%^4CY
M<\,O1ERK J2*1H8F8,R*S!@P9AD@CI@G) &,@#@'G%244 -*J0054@@@@@$$
M'@@@C!!'!!ZTP0Q@EMI+-D%BSLX#'<55RQ95R 0JD*,< "I:* (S#&3EE##@
MA6)9 5.0RQDE%8'G<JAL]ZB%G;+C9$(]L<<2^6SQ;8HI/-6,>6RX0OS(HPLJ
M_)*'3Y:LT4 1-!$P8%<;_O;69"?D,>,HRG&PD  @ _,!NYI3%&S!F1696W*6
M&XJWJI.<8QQC !Y&#4E% !41@B+;C&N=C1GKAHV.61ESM92>S XR<8R:EHH
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M1(IR <@R')9C_K7#R#DGAF ..@QA0!Q088V(+KOVOYBARSA7SD,H<D*5/*8
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M8#C&,"IJ* (VB1LAEW E6PQ9@&4Y4J"2$(/(*!2" >HI?+3>9 BAV #.!AF
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M ",H92K#(8%2/4$8(_$4WRTX^4<-O''\6,;CZMCC)R>GH*?10 4?Y]/Y444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCJ***H HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#_/<?G1S_?'Y#_/<?G0%UW'44WG^^/R'^>X_.CG^^/R'^>X_.@+KN.HIO/\
M?'Y#_/<?G1S_ 'Q^0_SW'YT!==QU%-Y_OC\A_GN/SHY_OC\A_GN/SH"Z[CJ*
M;S_?'Y#_ #W'YT<_WQ^0_P ]Q^= 77<=13>?[X_(?Y[C\Z.?[X_(?Y[C\Z N
MNXZBF\_WQ^0_SW'YT<_WQ^0_SW'YT!==QU%-Y_OC\A_GN/SHY_O?H/\ /<?Y
M(P!=?U?_ "'44T]#\W&#V'3\/J/\D8CPO][_ ,=-&XN:*WDEZW_R)J*APO\
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M"O\ Y(_TC/\ AZ[_ ,$_/^CH?AO_ .!S_P#Q-'_#UW_@GY_T=#\-_P#P.?\
M^)K_ #<_^$?T3_H%V?\ WY6C_A']$_Z!=G_WY6C_ (A+A/\ H-J?^!2_R#_B
M*.(_Z J?_@*_^2/](S_AZ[_P3\_Z.A^&_P#X'/\ _$T?\/7?^"?G_1T/PW_\
M#G_^)K_-S_X1_1/^@79_]^5H_P"$?T3_ *!=G_WY6C_B$N$_Z#:G_@4O\@_X
MBCB/^@*G_P" K_Y(_P!(S_AZ[_P3\_Z.A^&__@<__P 31_P]=_X)^?\ 1T/P
MW_\  Y__ (FO\W/_ (1_1/\ H%V?_?E:/^$?T3_H%V?_ 'Y6C_B$N$_Z#:G_
M (%+_(/^(HXC_H"I_P#@*_\ DC_2,_X>N_\ !/S_ *.A^&__ ('/_P#$T?\
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M / 5_P#)'^D9_P /7?\ @GY_T=#\-_\ P.?_ .)H_P"'KO\ P3\_Z.A^&_\
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MIJS\T^;5'^D;_P /7?\ @GY_T=#\-_\ P.?_ .)H_P"'KO\ P3\_Z.A^&_\
MX'/_ /$U_F[?\([H9*!M.L(XW3*M';->3LY^[$JPLD1D8\*&*@M@$@<U$="T
M($K]BTHL.BO;K!,OH9X9+UW*#JX@7S"N0@+$4?\ $)<+I_MM2[O9.;3:Z-)[
MI[IKH)>*5;[6"@K;M0NEZM-V/]([_AZ[_P $_/\ HZ'X;_\ @<__ ,31_P /
M7?\ @GY_T=#\-_\ P.?_ .)K_-U/A_0HU+S:79Q @[99?L\%LQQQY2R[9I,G
MHAE4MTW G-1KH>B,"Z:9ISQK\SNNFW$Z*HY9F>WO_E4 9+!&(&2%/ +?A)AT
MTGBZJYE=7F+_ (BI4E\.#IM+1WAU^\_TCO\ AZ[_ ,$_/^CH?AO_ .!S_P#Q
M-'_#UW_@GY_T=#\-_P#P.?\ ^)K_ #;ET;PZ0573[*60D%C"(;E8X^K,;6!5
MNH@J\YG9L?Q9P:5]$T&(!I-.TX*Q&PA8UE;T M782RL>@BC=))#\BLK,&%2\
M(L-!.3QL[)-W53MT]7NAKQ1Q,FE# 0FV[:0V\W>6Q_I(?\/7?^"?G_1T/PW_
M / Y_P#XFC_AZ[_P3\_Z.A^&_P#X'/\ _$U_FZMH&A1@+<:59H70O&R16T *
M@<;Q<WLA1CW&./0U')H6B*OFIIFG"WY >5(7/F#H))8;CRX8B<;YW0K&N7((
M4@Q'PFP34>;,94W*G*HHSJ-/EB[.Z2>K>P3\3\9#F_X3.91J1IWC333<ES)K
MWM4MGYG^D=_P]=_X)^?]'0_#?_P.?_XFC_AZ[_P3\_Z.A^&__@<__P 37^;C
M_8>@*OF/I]A&O4YC2Y60#DK:O 8U:5AQ$)7V%B-Q R:0Z+H*JOFZ;IT3.1Y2
MO!&C2*>@9VOC'$YZ992BD[F!4$4?\0FP;A"HL?-QFVDU4>EG:[O;3S1<?$_$
M.I.E+ P4X)-^YH[J]EJ_>\G8_P!(_P#X>N_\$_/^CH?AO_X'/_\ $T?\/7?^
M"?G_ $=#\-__  .?_P")K_-S70M =7\K3].9D5FDW0+.$4 DD/;7 4D=1\K9
MP/E89%$NB>'4$1;3+2%I,+BZ-M:(^X@;X!/M=GYRBR.$)P&(!)K*7A7@834)
MX^I%2DH*HYOV;;5[\W9=27XH8CEYH8",W>S@H7FG?M=>I_I&?\/7?^"?G_1T
M/PW_ / Y_P#XFC_AZ[_P3\_Z.A^&_P#X'/\ _$U_FYMH.B $G3+!5Q\C&S$
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M3_2)_P"'KO\ P3\_Z.A^&_\ X'/_ /$T?\/7?^"?G_1T/PW_ / Y_P#XFO\
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M^@*G_P" K_Y(_P!(S_AZ[_P3\_Z.A^&__@<__P 31_P]=_X)^?\ 1T/PW_\
M Y__ (FO\W/_ (1_1/\ H%V?_?E:/^$?T3_H%V?_ 'Y6C_B$N$_Z#:G_ (%+
M_(/^(HXC_H"I_P#@*_\ DC_2,_X>N_\ !/S_ *.A^&__ ('/_P#$T?\ #UW_
M ()^?]'0_#?_ ,#G_P#B:_S<_P#A']$_Z!=G_P!^5H_X1_1/^@79_P#?E:/^
M(2X3_H-J?^!2_P @_P"(HXC_ * J?_@*_P#DC_2,_P"'KO\ P3\_Z.A^&_\
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M .$?T3_H%V?_ 'Y6C_A']$_Z!=G_ -^5H_XA+A/^@VI_X%+_ "#_ (BCB/\
MH"I_^ K_ .2/](S_ (>N_P#!/S_HZ'X;_P#@<_\ \31_P]=_X)^?]'0_#?\
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M6TRU(8%2/+Z@C!'7N*%X28>32CCIK?>4NFO8;\49I7E@EO;2,?7K(_TA)O\
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M / 5_P#)'^D9_P /7?\ @GY_T=#\-_\ P.?_ .)H_P"'KO\ P3\_Z.A^&_\
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M $"[/_ORM'_"/Z)_T"[/_ORM'_$)<)_T&U/_  *7^0?\11Q'_0%3_P# 5_\
M)'^D9_P]=_X)^?\ 1T/PW_\  Y__ (FC_AZ[_P $_/\ HZ'X;_\ @<__ ,37
M^;G_ ,(_HG_0+L_^_*T?\(_HG_0+L_\ ORM'_$)<)_T&U/\ P*7^0?\ $4<1
M_P! 5/\ \!7_ ,D?Z1G_  ]=_P""?G_1T/PW_P# Y_\ XFC_ (>N_P#!/S_H
MZ'X;_P#@<_\ \37^;G_PC^B?] NS_P"_*T?\(_HG_0+L_P#ORM'_ !"7"?\
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MP]H]K+=Q6-GJMIYD%]<I:.()KJY'FSRQ1M^^(+*_W=_P2+_:;^'GQGU'Q?\
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MF7R?$WVV.0P,EC"S,[_:WFN[6&(O8-!,%:OIK_@I_P##_P#X)U_LQMK?[/\
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M_L,I?^F9'XSXG_[S@O\ L%K?^GD34445^PU-UZ?J?D-/9^OZ!11169H%%%%
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M/[_^ 'LY_P K'44W>/[]O_W]7_XY1O']^W_[^K_\<HYZ7_/ZG]__   ]G/\
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M)-_Y7,I1J3;DXOF>[[L=13=X_OV__?U?_CE&\?W[?_OZO_QRIYZ7_/ZG]_\
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M_#_@;35\!21Z=--/,UN=:MK*2]@AF::628W$DK[?M4DL2EL!%BR@^[OVF?\
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M#^+#U?Y,/LS_ ,/ZG[$?\$"O^4I_@+_LA_Q@_P#0?#]?Z %?Y_\ _P $"O\
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M.O>*5"@DO]MDPP'7&9".?;_Z]1_\*CT5<,WB'Q85)X'VMOZ/G^7-?LS^S/\
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MHF?^1A\5GV^VMS[<-GGVYIQ^$FA?]#%XK4]@;QN3CIS(?Y5ZB00"59D(!(8
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M];:V:=]&^PJ??7_>7^8KQOX2?\??Q6_[*-/_ .DE>R)]]?\ >7^8KQOX2?\
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M2KK^ D=Y>0I=Q07EY;PWZLE];V]U<6]M>HTRSF.[MH9([>YC\U%8)-&ZC!4
M*S*8UFG26&>.YNHIK;S?LTL5S/%);^<FR0P/'(C0DKT,14H<,A5@#7R=;A3"
M8BKG-6M)MYA3A##M:RI-*TG*_P -UVYK[-6NG]-1XDQ5"GE$*48I8"I.=:^T
MTTU'D[O76]EN?UM_LJ_\%'/%WQ._;'_:T^$_Q TG]GSPG\.?#W@_XNKX?\9>
M&O"-GX>\5ZO]B@O5M1JGB2(PO?\ VE57S#Y\WF%L[')&?ESX8>,/V./V2_\
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M(P1U<C(5E8CU"D$C\<4J_P"J'T'\Z97I0:Y8>4()_P#@'_!/.E%IR6FLY_\
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M5/\ $OR9P2^&'H_S"BBBK("BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M .0Z/^'%OP\_Z.G^._\ WUH?_P AT_[<P_\ SXQ7_@$/_DP_L#$_]!&%_P#
MY_\ R!^%_EC^\?\ OX?_ )"H\L?WC_W\/_R%7[H?\.+?AY_T=/\ '?\ [ZT/
M_P"0Z/\ AQ;\//\ HZ?X[_\ ?6A__(=']N8?_GQBO_ (?_)A_8&)_P"@C"_^
M!S_^0/PO\L?WC_W\/_R%1Y8_O'_OX?\ Y"K]T/\ AQ;\//\ HZ?X[_\ ?6A_
M_(='_#BWX>?]'3_'?_OK0_\ Y#H_MS#_ //C%?\ @$/_ ),/[ Q/_01A?_ Y
M_P#R!^%_EC^\?^_A_P#D*CRQ_>/_ '\/_P A5^Z'_#BWX>?]'3_'?_OK0_\
MY#H_X<6_#S_HZ?X[_P#?6A__ "'1_;F'_P"?&*_\ A_\F']@8G_H(PO_ ('/
M_P"0/PO\L?WC_P!_#_\ (5'EC^\?^_A_^0J_=#_AQ;\//^CI_CO_ -]:'_\
M(='_  XM^'G_ $=/\=_^^M#_ /D.C^W,/_SXQ7_@$/\ Y,/[ Q/_ $$87_P.
M?_R!^%_EC^\?^_A_^0J/+']X_P#?P_\ R%7[H?\ #BWX>?\ 1T_QW_[ZT/\
M^0Z/^'%OP\_Z.G^._P#WUH?_ ,AT?VYA_P#GQBO_  "'_P F']@8G_H(PO\
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MNCRZ+?\ [4/QR>V>\M9Y8R=#C#M:3"6!M\5I'(I1E# *X!(!8'@5KP?\$*/
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M_P#R%1Y8_O'_ +^'_P"0J_=#_AQ;\//^CI_CO_WUH?\ \AT?\.+?AY_T=/\
M'?\ [ZT/_P"0Z:SS#M)_5\4KWT<(75G;7W^O0E9#B)1C..(PO+*]KSG?1V?_
M "[/PO\ +']X_P#?P_\ R%0(\'.X\<_ZP_\ R%7[H?\ #BWX>?\ 1T_QW_[Z
MT/\ ^0Z/^'%OP\_Z.G^._P#WUH?_ ,AT?V[17PT,3YWA#_Y,%D.(ZXC#?*<_
M_E9^&1#$$;NO'WA_\@TSRQ_>/_?P_P#R%7[H?\.+?AY_T=/\=_\ OK0__D.C
M_AQ;\//^CI_CO_WUH?\ \ATI9Y2:YG1Q&G]R%_\ TL3R*OS1BJ^&U[SGI_Y3
M/PQ1 '0[L893EI&"C!')/V+@>I]*\7^*K#^V/A !Y4@7QU'M*W$F1G2'_P"G
M, GTSGGL17]&P_X(5_#UCM'[4_QVR>!EM#QSQSFSQCUSQZUA:Q_P0,^&>LW&
MBR7'[3OQR8^']134[%R^B*T,Z1B%Y%*6JEV:WW18DWJ,[E4/\P\W&YU2Q-*-
M&-#$J<:T*EY0@H\L;)ZJ;U[:'?@LEK82LZM3$864:E&<$J<YR:;O:Z<(Z7MU
M\[.Q^(\9)10=_) YD/?I_P N(^O7\*E\L?WC_P!_#_\ (5?N>/\ @A9\/  !
M^U/\=P!T^?1/_D.E_P"'%OP\_P"CI_CO_P!]:'_\AUZ,<[PZC']QB?ABM(0^
MRDG]ON<-3),0I?Q\-JY->]/9RO\ R>9^%_EC^\?^_A_^0J/+']X_]_#_ /(5
M?NA_PXM^'G_1T_QW_P"^M#_^0Z/^'%OP\_Z.G^.__?6A_P#R'5K.\._^7.)7
MK"'_ ,F*.0XB2TQ&%5N\ZG_RL_"_RQ_>/_?P_P#R%1Y8_O'_ +^'_P"0J_=#
M_AQ;\//^CI_CO_WUH?\ \AT?\.+?AY_T=/\ '?\ [ZT/_P"0ZB>?8:$E%T,4
MVU=6A3[V_P"?@WD->.^(PSOM:<_UIGX7B/!SN/'/^L/_ ,A4\AB"-W7C[P_^
M0:_<W_AQ;\//^CI_CO\ ]]:'_P#(='_#BWX>?]'3_'?_ +ZT/_Y#JXYWAY-I
M4,3I!S=X0V73X]_P\P_L*LHJ7UC#6<U!>_._,U=?\NS\+_+']X_]_#_\A4>6
M/[Q_[^'_ .0J_=#_ (<6_#S_ *.G^.__ 'UH?_R'1_PXM^'G_1T_QW_[ZT/_
M .0ZC^WL-RQG]7Q5IWM[D+Z.VOO]RY</UXSE!XC#-QM>TYV]Y75OW9^%_EC^
M\?\ OX?_ )"H\L?WC_W\/_R%7[H?\.+?AY_T=/\ '?\ [ZT/_P"0Z/\ AQ;\
M//\ HZ?X[_\ ?6A__(=-9[AI;4,5_P" 0_\ DR7D&(Z8C#?.<_\ Y6?A?Y8_
MO'_OX?\ Y"I5C 9?FSR.#(P!Y[D660/4CD#I7[G_ /#BWX>?]'3_ !W_ .^M
M#_\ D.E7_@A;\/ RD_M3?'<@$$@MH9!P<X(-E@@^AK*IGV&BY7P^*]^C."M"
M&\M%?W]M1QR'$J5-_6,+[E6,W[\]4K7M[FY_.;X'_P"1]^) _<@'5H1Q/(2,
MPKT!L\$^F?Q%>P^6/[Q_[^'_ .0J_;'3/^"!'PSTK5=6U>']J#XY)-K$GG7;
MA]%9I)<;4?#6K+'M& !$J+@<CM6__P .+?AY_P!'3_'?_OK0_P#Y#KFP6=4*
M-)PE0Q+?,W[L(-:^LT=.-R>MB*WM*=?#J/+%>]*:=TDGHH/\S\+_ "Q_>/\
MW\/_ ,A4>6/[Q_[^'_Y"K]T/^'%OP\_Z.G^._P#WUH?_ ,AT?\.+?AY_T=/\
M=_\ OK0__D.NY9[AI;4,5_X!#_Y,Y5D&(ZXC#?*<_P#Y6?A?Y8_O'_OX?_D*
MCRQ_>/\ W\/_ ,A5^Z'_  XM^'G_ $=/\=_^^M#_ /D.C_AQ;\//^CI_CO\
M]]:'_P#(=/\ MS#_ //C%?\ @$/_ ),'D&(Z8C#?.<__ )6?A?Y8_O'_ +^'
M_P"0J!'@YW'CG_6'_P"0J_=#_AQ;\//^CI_CO_WUH?\ \AT?\.+?AY_T=/\
M'?\ [ZT/_P"0Z/[<P_\ SXQ7_@$/_DP608CKB,-\IS_^5GX9$,01NZ\?>'_R
M#3!'@YW'CG_6'_Y"K]T/^'%OP\_Z.G^._P#WUH?_ ,AT?\.+?AY_T=/\=_\
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M\.+?AY_T=/\ '?\ [ZT/_P"0Z/[<P_\ SXQ7_@$/_DP_L#$_]!&%_P# Y_\
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M .0/PO\ +']X_P#?P_\ R%1Y8_O'_OX?_D*OW0_X<6_#S_HZ?X[_ /?6A_\
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M_P"'%OP\_P"CI_CO_P!]:'_\AT?VYA_^?&*_\ A_\F']@8G_ *",+_X'/_Y
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MR/\ []Q__$T?+_<C_P"_<?\ \3111[:I_=_KY![*'\T_O_X(?+_<C_[]Q_\
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MYI_?_P $/E_N1_\ ?N/_ .)H^7^Y'_W[C_\ B:**/;5/[O\ 7R#V4/YI_?\
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M\2W7AS3K[3]4\5Q00K$MG->QQO;S:@'MK*.-YD2-4<'K_P#@J7\3_@K^T?\
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M\+:I<:=XAL?&%O::?XATIXK>6\5[JQMXVA$+6\$K12%XDE7#"900X\9^!/\
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M/_OW'_\ $T44>VJ?W?Z^0>RA_-/[_P#@A\O]R/\ []Q__$T?+_<C_P"_<?\
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M*/+/]U_TK*_X=Q?\%#O^CSO@S_X8*Y_^:FC_ (=Q?\%#O^CSO@S_ .&"N?\
MYJ:?^N&4_P#3_P#\!I__ "8O]4LU[4?_  *?_P @:OEG^Z_Z4>6?[K_I65_P
M[B_X*'?]'G?!G_PP5S_\U-'_  [B_P""AW_1YWP9_P##!7/_ ,U-'^N&4_\
M3_\ \!I__)A_JEFO:C_X%/\ ^0-7RS_=?]*/+/\ =?\ 2LK_ (=Q?\%#O^CS
MO@S_ .&"N?\ YJ:/^'<7_!0[_H\[X,_^&"N?_FIH_P!<,I_Z?_\ @-/_ .3#
M_5+->U'_ ,"G_P#(&KY9_NO^E'EG^Z_Z5E?\.XO^"AW_ $>=\&?_  P5S_\
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MO:C_ .!3_P#D#5\L_P!U_P!*/+/]U_TK*_X=Q?\ !0[_ */.^#/_ (8*Y_\
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M_P %#O\ H\[X,_\ A@KG_P":FC_AW%_P4._Z/.^#/_A@KG_YJ:/]<,I_Z?\
M_@-/_P"3#_5+->U'_P "G_\ (&KY9_NO^E'EG^Z_Z5E?\.XO^"AW_1YWP9_\
M,%<__-31_P .XO\ @H=_T>=\&?\ PP5S_P#-31_KAE/_ $__ / :?_R8?ZI9
MKVH_^!3_ /D#5\L_W7_2CRS_ '7_ $K*_P"'<7_!0[_H\[X,_P#A@KG_ .:F
MC_AW%_P4._Z/.^#/_A@KG_YJ:/\ 7#*?^G__ (#3_P#DP_U2S7M1_P# I_\
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M_"0:27WFSU*&&XBMY(PW)E6%+A0"!*!7O0_X)R_\%$P"H_;4^$(4@AD'P*U
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MN?\ YJ:T_P!<,I_Z?_\ @-/_ .3,_P#5+->U'_P*?_R!J^6?[K_I1Y9_NO\
MI65_P[B_X*'?]'G?!G_PP5S_ /-31_P[B_X*'?\ 1YWP9_\ #!7/_P U-'^N
M&4_]/_\ P&G_ /)A_JEFO:C_ .!3_P#D#5\L_P!U_P!*/+/]U_TK*_X=Q?\
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M#*?^G_\ X#3_ /DP_P!4LU[4?_ I_P#R!J^6?[K_ *4>6?[K_I65_P .XO\
M@H=_T>=\&?\ PP5S_P#-31_P[B_X*'?]'G?!G_PP5S_\U-'^N&4_]/\ _P !
MI_\ R8?ZI9KVH_\ @4__ ) U?+/]U_TH\L_W7_2LK_AW%_P4._Z/.^#/_A@K
MG_YJ:/\ AW%_P4._Z/.^#/\ X8*Y_P#FIH_UPRG_ *?_ /@-/_Y,/]4LU[4?
M_ I__(&KY9_NO^E'EG^Z_P"E97_#N+_@H=_T>=\&?_#!7/\ \U-'_#N+_@H=
M_P!'G?!G_P ,%<__ #4T?ZX93_T__P# :?\ \F'^J6:]J/\ X%/_ .0-7RS_
M '7_ $H\L_W7_2LK_AW%_P %#O\ H\[X,_\ A@KG_P":FC_AW%_P4._Z/.^#
M/_A@KG_YJ:/]<,I_Z?\ _@-/_P"3#_5+->U'_P "G_\ (&KY9_NO^E'EG^Z_
MZ5E?\.XO^"AW_1YWP9_\,%<__-31_P .XO\ @H=_T>=\&?\ PP5S_P#-31_K
MAE/_ $__ / :?_R8?ZI9KVH_^!3_ /D#5\L_W7_2CRS_ '7_ $K*_P"'<7_!
M0[_H\[X,_P#A@KG_ .:FC_AW%_P4._Z/.^#/_A@KG_YJ:/\ 7#*?^G__ (#3
M_P#DP_U2S7M1_P# I_\ R!J^6?[K_I1Y9_NO^E97_#N+_@H=_P!'G?!G_P ,
M%<__ #4T?\.XO^"AW_1YWP9_\,%<_P#S4T?ZX93_ -/_ /P&G_\ )A_JEFO:
MC_X%/_Y U?+/]U_TH\L_W7_2LK_AW%_P4._Z/.^#/_A@KG_YJ:/^'<7_  4.
M_P"CSO@S_P"&"N?_ )J:/]<,I_Z?_P#@-/\ ^3#_ %2S7M1_\"G_ /(&KY9_
MNO\ I1Y9_NO^E97_  [B_P""AW_1YWP9_P##!7/_ ,U-'_#N+_@H=_T>=\&?
M_#!7/_S4T?ZX93_T_P#_  &G_P#)A_JEFO:C_P"!3_\ D#5\L_W7_2CRS_=?
M]*RO^'<7_!0[_H\[X,_^&"N?_FIH_P"'<7_!0[_H\[X,_P#A@KG_ .:FC_7#
M*?\ I_\ ^ T__DP_U2S7M1_\"G_\@:OEG^Z_Z4>6?[K_ *5E?\.XO^"AW_1Y
MWP9_\,%<_P#S4T?\.XO^"AW_ $>=\&?_  P5S_\ -31_KAE/_3__ ,!I_P#R
M8?ZI9KVH_P#@4_\ Y U?+/\ =?\ 2CRS_=?]*RO^'<7_  4._P"CSO@S_P"&
M"N?_ )J:/^'<7_!0[_H\[X,_^&"N?_FIH_UPRG_I_P#^ T__ ),/]4LU[4?_
M  *?_P @:OEG^Z_Z4>6?[K_I65_P[B_X*'?]'G?!G_PP5S_\U-'_  [B_P""
MAW_1YWP9_P##!7/_ ,U-'^N&4_\ 3_\ \!I__)A_JEFO:C_X%/\ ^0-7RS_=
M?]*/+/\ =?\ 2LK_ (=Q?\%#O^CSO@S_ .&"N?\ YJ:/^'<7_!0[_H\[X,_^
M&"N?_FIH_P!<,I_Z?_\ @-/_ .3#_5+->U'_ ,"G_P#(&KY9_NO^E'EG^Z_Z
M5E?\.XO^"AW_ $>=\&?_  P5S_\ -31_P[B_X*'?]'G?!G_PP5S_ /-31_KA
ME/\ T_\ _ :?_P F'^J6:]J/_@4__D#5\L_W7_2CRS_=?]*RO^'<7_!0[_H\
M[X,_^&"N?_FIH_X=Q?\ !0[_ */.^#/_ (8*Y_\ FIH_UPRG_I__ . T_P#Y
M,/\ 5+->U'_P*?\ \@:OEG^Z_P"E*(\$':_!'I63_P .XO\ @H=_T>=\&?\
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M]_\ R0:=Y?U_V\)S_<'YC_"CG^X/S'^%+L7T_4_XT;%]/U/^-'LX?S3^]_\
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M[T_W'_/[_P G_P""+_6WAW_H;8?_ ,#_ ."?:_/]P?F/\*.?[@_,?X5\4?\
M#>_[/_\ T$?$7_A-:K[?],_K^GO1_P -[_L__P#01\1?^$UJOM_TS^OZ>]'[
MC_G]_P"3_P#!#_6WAW_H;8?_ ,#_ ."?:_/]P?F/\*.?[@_,?X5\4?\ #>_[
M/_\ T$?$7_A-:K[?],_K^GO1_P -[_L__P#01\1?^$UJOM_TS^OZ>]'[C_G]
M_P"3_P#!#_6WAW_H;8?_ ,#_ ."?:_/]P?F/\*.?[@_,?X5\4?\ #>_[/_\
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M_@B?%G#J_P"9OAO_  /_ ()]L<_W!^8_PHY_N#\Q_A7Q/_PWO\ /^@CXA_\
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M_<'YC_"CG^X/S'^%?%'_  WO^S__ -!'Q%_X36J^W_3/Z_I[T?\ #>_[/_\
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M[,/B$?"RT;PK\.].^+?B+Q'';VRB#PC?VUS?P6,6^T\@:G<6D02,LI"3[0Q
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M_?(_PIU%/V4?YZG]?,.1]Y?^#)#=B?W5_P"^1_A1L3^ZO_?(_P *=11[*/\
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M@Z%XLM[KQ#JOC#7]?L/#VC>-["YN+:*WL]/,U_'=-8I<V=L0-DJHI)6U:_\
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M[V:&VM;2WV&/?<7,P\J"%9L2//*0J+DLP0$5^&'B;_@HQ^U3?>!OB_\ M9>
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M?6%K)HT.G36UG:D^2]IM+* ?U5-T."0<'E0"PXZ@$$$CJ 01GJ".*@,CF-F
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MAJFZV$V]K@QR1D":[F6>X,DBJX_3@7:#/S(=S[VW"-M[>8LN7W7AWX91@/N
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M_P#($M%1?:(O5/\ R'_\FT?:(O5/_(?_ ,FT7E_S[G]R_P PYEVG_P""ZO\
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M7%U-&6#_ *C&*-L;E#88L Q) )&W@$D 8XVXVCL*7RURI^8E69AF1R,L"IW
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M_$"QBM-;T;77TS3K1[J%YH(9O+G,NPH4A*1O()/NLPQDLQ7YFQE@6## P-K
M@KT_A(YYZ\T&&(@@HI4@#:1E.#D$(?E!SSD '/>@#\G/A/\ \$L/#WPS\=?#
MGQUK'[3/[1'Q-N_@_IGC+0_A7I?BW7/#AL? ^D>,;&33?[.L(H-(A1UT6U:&
M'29+L7$S_9XS+(Q9V;3\+?\ !+?X?1:1\>+#XL?&;XL?'75/COX,3X=:WXI\
M<R:'INOZ)X6C9_L5MIEQX;L-'AO9[%#;Q6FK:G#>:B'MHI9+J23,B_J@8HV&
M&7<.X8E@V#D;@20Q4@%2V2I *D$4OEH<<<#/&3C!&"N,XVX_AQM'89H ^ /
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_H.:Q_X,[W_X_1]8?:'W?_:!_P 1'RC_ *)7+?\ P33_ /D#]V_^&>OV7/\
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M\H_Z)7+?_!-/_P"0/W;_ .&>OV7/^A \ ?\ ?R+_ .2J/^&>OV7/^A \ ?\
M?R+_ .2J_"3_ (2'7_\ H.:Q_P"#.]_^/T?\)#K_ /T'-8_\&=[_ /'Z/K#[
M0^[_ .T#_B(^4?\ 1*Y;_P"":?\ \@?NW_PSU^RY_P!"!X _[^1?_)5'_#/?
M[+?_ $('@#_ON/\ ^2O?^?H:_"3_ (2'7_\ H.:Q_P"#.]_^/T'Q%KP&3KNL
M #DG^T[WH.O_ "W]*/K#[0^[_P"T$_$?*>G"N6_^"J7_ ,@S]V_^&>_V6_\
MH0/ '_?R/_Y*_P _@:/^&>OV7/\ H0/ '_?R+_Y*K\(6U_Q"2&'B+651L?\
M,0O#@'ODRGU]Z!XA\0$X/B#60%Z$ZA> /[9\W'/3BHGC'!I<B=_Y4OUB@7B/
ME23<N%,NC;9NC2]Y=U:&Q^[W_#/7[+G_ $('@#_OY%_\E4?\,]_LM_\ 0@>
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M_P!.W_X"O_D0_P"(CY3+6'"N7-=;4:>_SIG[M?\ #/?[+?\ T('@#_OY$/\
MVZ_S^!I?^&>_V6_^B?\ @$?2:('\_M/%?A$?$&OX8-K^M(R@D[=0O&Z#/.9N
M/R_&D&OZ^HW?\)'KDO0E1?W>5'<G;(#QR>_]*/KW_3M_^ K_ .1#_B(N6=.$
M,MGYNC3T\OX9^\!_9]_9=(Q_P@/@/_O_ !_K_I/(]1WIG_#/?[+?_0@> /\
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M?_C]7]8?:'W?_:#_ .(CY1_T2N6_^":?_P @?NW_ ,,]?LN?]"!X _[^1?\
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MFWMX9IMT.+=&$<\";GH _I*HK\6_V:O^"L'C#QM^U;H7[&'[5O[*GQ*_9/\
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MU"#5-/B'SJ+:&UFG0;5E1V#CYB_X*-?MC?&[]E36_@?:_!?P[X>\60^,'O\
M5O&7A[5[)Y=5U'0;=@EUI^D74BNEKJ%G;B6:UN$9!Y_EF[$T&Y*^?/V'/V)O
MVA?A+^U'X;^,OQ.\+/X?TO3_ (/KX+UW4=2\<^(/&>N^+/%IU=I[S6M-;6M8
MU271-'FMR3_9-O\ 9+2"!L16D?('W#^TU\ O&GQ;_:%_99\>Z-!::CX(^&FH
M>)_^$Z6^PXDT[68Q"Y%D^;:<6\)E:.!XVAE8!9(V#-E.%/\ X:S_ $.#V648
M/'4?9U88BA.$G4Y/>49<W*E*[CT=U9]/D_"?B5^WMXYT7XI?$#3/AXG@[7O
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M4!L&OL"OS?\ ^"3G@W5O"?[%OA'4=?M9+>_^(WB'QGX]AM+A'^T64=_XPNS
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M,%(5B&8952 ?F89&0.I&1D#J.M.IDF=C[?O;&V_+NYP<?*64-S_"67/3<,Y
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MK4%TV+[7-^V?I)-RUD89#IT&B^(8[.UAOKT(TJ+-9P2*@N!;QW"><2CEW/\
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MJVECU>YUOP[XPN?&'A#Q3&UPB7D6HZW>:?;W3WT4BW#+*T7F-"?*/]<?CO\
M9#_9=^*'CS2OB?\ $;X!?"GQO\0=%??I_BWQ/X,T76=94C:(Q=7-]:S?VBD.
MU?L\>HK=QVVT&W6,@5Z=X'^%OPY^&FEW.A_#WP3X:\%:+>7DNH7.C^&=)M-&
MTN:[GA:"69K"QCAM?GB9D,:Q"+DL$#<T ?QK?\$N/C-XG_X*R?MH?L:3^/\
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MV7_@4?\ ,_+NBOU$_P"'<W_506_\ 8O\*/\ AW-_U4%O_ &+_"CV']V7X?\
MR0?\0ZXL_P"A;+_P*/\ F?EW17ZB?\.YO^J@M_X Q?X4?\.YO^J@M_X Q?X4
M>P_NR_#_ .2#_B'7%G_0ME_X%'_,_+NBOU$_X=S?]5!;_P  8O\ "C_AW-_U
M4%O_  !B_P */8?W9?A_\D'_ !#KBS_H6R_\"C_F?EW17ZB?\.YO^J@M_P"
M,7^%'_#N;_JH+?\ @#%_A1[#^[+\/_DAKP\XMBFEEKL][RC?Y:L_+TL22V%7
M<H5E1$C1@!@%HT58V;'\94L>[4A.4\O"B(*J"%5580J-N \E0(^3]\[<R E9
M"RD@_J'_ ,.YO^J@M_X Q?X4?\.YO^J@M_X Q?X4>P_NR_#_ .2,Y>&_%<W>
M6 K*VUJBM_Z4?ET %D\[ :7S)96E<>9+(9HS$Z32/N>: 1DK';2E[>'K%$C
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MI)4YRP) (;CA0&<; X0B1P4W@@E6#!E<9RK@AT.&1E8 C]1?^'<W_506_P#
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M[Y7_  HX_NK_ -\K_A1]8Q'>/WO_ "#_ %ZXN_Z'%?\ KY'Z!_\ #Q#XE?\
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M^29]^?\ #Q#XE?\ 0JZ1_P!_E_PH_P"'B'Q*_P"A5TC_ +_+_A7Y];9/1?\
MOA?_ (BC:_<+CO\ (O3_ +YJ7BZ\=U^?^1G_ *_<5?\ 0ZKOO9/3_P E/T%_
MX>(?$K_H5=(_[_+_ (4?\/$/B5_T*ND?]_E_PK\_./[J_P#?*_X4<?W5_P"^
M5_PI?7:_;\REQWQ;)-K.:[MTU3_%(_0/_AXA\2O^A5TC_O\ +_A1_P /$/B5
M_P!"KI'_ '^7_"OS\QZ!<]OE7K^5-VR>B_\ ?"__ !%'UVOV_,?^O?%B^+.J
MT;]'>_X(_07_ (>(?$K_ *%72/\ O\O^%'_#Q#XE?]"KI'_?Y?\ "OS["MD;
MBBKD;F,>0HSRQ"J"0!R0""0, YK,EUW0H-8M?#L^N:#!XAU'3VO].\,7-_!:
M^*;NUL;E;74=2@TN8[IM/C9Q)(8XRX0$1E6/-+%XA[+;U_R$^/.*TKK.JSMO
M9/\ ^1/T7_X>(?$K_H5=(_[_ "_X4?\ #Q#XE?\ 0JZ1_P!_E_PK\_S$P!^5
M>A_@'_Q-1;9/1?\ OA?_ (BD\77CNOS_ ,C./B!Q2[WSJO&W\R:OZ:'Z"_\
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M_P"%'_#Q#XE?]"KI'_?Y?\*_/SC^ZO\ WRO^%'']U?\ OE?\*KZQB.\?O?\
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M **** "BBB@ HHHH **** "BBB@ HHHH *B;[K?[Y_E4C$A6(ZA21]0*C/W
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M/O?^0<L_^?<OOC_\D%%%%'-#^>'WO_(.6?\ S[E]\?\ Y(****.:'\\/O?\
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M_ 'BP6MYHN@>(+;4M;@T"/PI*;O3DM;MGN+I+C[;:Q^>8H699E0D'[W\1?L
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M#:G_ ."[5?\ Y K^G?[%9?\ /A;_ /?H?X4?8K+_ )\+?_OT/\*/[,P_=_\
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M1]@U7_H#:G_X+M5_^0*_IW^Q67_/A;_]^A_A1]BLO^?"W_[]#_"C^S,/W?\
MX"P_X@[A?^AM6_\  :__ ,@?S$?8-5_Z VI_^"[5?_D"C[!JO_0&U/\ \%VJ
M_P#R!7]._P!BLO\ GPM_^_0_PH^Q67_/A;_]^A_A1_9F'[O_ ,!8?\0=PO\
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MIM,\7?&N]\/ZA\0[T7VHO#K%[X8TV31](N&M9[R6RMI(=/FDMU_LZWM!)O\
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M]O\ (?X4:?S+\?\ (.>G_,__  74_P#D"?RH\.-O#YW@$@-G@E@#@DCAB>2
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M/P _XBC?V0O^C<?VM/\ PW3>_P#T]^_^<"C_ (BC?V0O^C<?VM/_  W3>_\
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M$IQ)_P"'VE_\K#ZGQ/\ ]#ZG_P"$E/\ ^1/P _XBC?V0O^C<?VM/_#=-[_\
M3W[_ .<"C_B*-_9"_P"C<?VM/_#=-[_]/?O_ )P*_?\ _P"&5?V;/^B&?"W_
M ,(O0??_ *<O?_.!1_PRK^S9_P!$,^%O_A%Z#[_].7O_ )P*/[8\+?\ HE.)
M/_#[2_\ E8?4^)_^A]3_ /"2G_\ (GX ?\11O[(7_1N/[6G_ (;IO?\ Z>_?
M_.!1_P 11O[(7_1N/[6G_ANF]_\ I[]_\X%?O_\ \,J_LV?]$,^%O_A%Z#[_
M /3E[_YP*/\ AE7]FS_HAGPM_P#"+T'W_P"G+W_S@4?VQX6_]$IQ)_X?:7_R
ML/J?$_\ T/J?_A)3_P#D3\ /^(HW]D+_ *-Q_:T_\-TWO_T]^_\ G H_XBC?
MV0O^C<?VM/\ PW3>_P#T]^_^<"OW_P#^&5?V;/\ HAGPM_\ "+T'W_Z<O?\
MS@4?\,J_LV?]$,^%O_A%Z#[_ /3E[_YP*/[8\+?^B4XD_P##[2_^5A]3XG_Z
M'U/_ ,)*?_R)^ '_ !%&_LA?]&X_M:?^&Z;W_P"GOW_S@4?\11O[(7_1N/[6
MG_ANF]_^GOW_ ,X%?O\ _P##*O[-G_1#/A;_ .$7H/O_ -.7O_G H_X95_9L
M_P"B&?"W_P (O0??_IR]_P#.!1_;'A;_ -$IQ)_X?:7_ ,K#ZGQ/_P!#ZG_X
M24__ )$_ #_B*-_9"_Z-Q_:T_P##=-[_ /3W[_YP*/\ B*-_9"_Z-Q_:T_\
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MOW__ .&5?V;/^B&?"W_PB]!]_P#IR]_\X%'_  RK^S9_T0SX6_\ A%Z#[_\
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M#_HAGPS_ /"+T3_Y#H_X97_9P_Z(9\,__"+T3_Y#H_M[PG_Z)7B;_P /,?\
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MC^WO"?\ Z)7B;_P\Q_\ E ?4N*/^A]#_ ,):7^1^!/\ Q%&?L@_]&Z?M9_\
MAN']_P#I]]_\X%'_ !%&?L@_]&Z?M9_^&X?W_P"GWW_S@5^^W_#*_P"SA_T0
MSX9_^$7HG_R'1_PRO^SA_P!$,^&?_A%Z)_\ (=']O>$__1*\3?\ AYC_ /*
M^I<4?]#Z'_A+2_R/P)_XBC/V0?\ HW3]K/\ \-P_O_T^^_\ G H_XBC/V0?^
MC=/VL_\ PW#^_P#T^^_^<"OWV_X97_9P_P"B&?#/_P (O1/_ )#H_P"&5_V<
M/^B&?#/_ ,(O1/\ Y#H_M[PG_P"B5XF_\/,?_E ?4N*/^A]#_P ):7^1^!/_
M !%&?L@_]&Z?M9_^&X?W_P"GWW_S@4?\11G[(/\ T;I^UG_X;A_?_I]]_P#.
M!7[[?\,K_LX?]$,^&?\ X1>B?_(='_#*_P"SA_T0SX9_^$7HG_R'1_;WA/\
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M &</^B&?#/\ \(O1/_D.C_AE?]G#_HAGPS_\(O1/_D.D\^\*.G"O$OSSF/\
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MG_R'0L^\*.O"O$WRSF/_ ,H#ZEQ1_P!#Z'_A+2_R/P)_XBC/V0?^C=/VL_\
MPW#^_P#T^^_^<"C_ (BC/V0?^C=/VL__  W#C_V\XZ_A^ K]]O\ AE?]G#_H
MAGPS_P#"+T3_ .0Z/^&5_P!G#_HA?PS_ /"+T/\ ^0Z'GWA1TX5XE^><Q_\
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M_P"$7H/O_P!.7O\ YP*K^V/"W_HE.)%ZY[2_^5B^I\4?]#ZGYKZI3T_\E/P
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M/_#=-[_]/?O_ )P*/^(HW]D+_HW']K3_ ,-TWO\ ]/?O_G K]_O^&5/V;/\
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M/"W_ *)7B3_P^T__ )6'U/B?_H?4_P#PDI__ ")^ O\ Q%&_LA?]&X_M:?\
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M_I3#ZGQ/_P!#ZG_X24__ )$_ K_B*-_9"_Z-Q_:T_P##=-[_ /3W[_YP*/\
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M>%O_ $2O$?\ X?:?_P J#ZGQ/_T/J?\ X24__D3\!O\ B*-_9"_Z-Q_:T_\
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M77\'/^BI_#[_ ,+7P[_\L:_A=_X5UX$_Z%.R_P"_MY_\E4?\*Z\"?]"G9?\
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MX$_Z%.R_[^WG_P E4?\ $$,G_P"BJS+_ ,-N%_\ FD/];N,O^A/D?_A7B_\
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M#[_PM?#O_P L:/\ A=?P<_Z*G\/O_"U\._\ RQK^%W_A77@3_H4[+_O[>?\
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M_H3Y'_X5XO\ ^9C^Z+_A=?P<_P"BI_#[_P +7P[_ /+&C_A=?P<_Z*G\/O\
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M3?$6FZ?K.C7UOJ&E:I96VHV-_;21RPW-K=(LD$UNZ95XV1E=BPR%;CU&[E\
MJP8=R0!@=^WIZ?\ Z_PSEG1G*C7;6(4FI4IW4TXMQ:Y6DU9Q:=[----)Z'ZC
M3KTL13AB:$E5H5H0JTZU.49TZE.<4X3A*+:E&<9*46GJO,EHIGS#'S Y([ ?
MD>]/JD[^3ZI]/N-$[ZZ_/J%%%%,84444 %%%% !1110 4444 %%%% !1110
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M+- N]:.K>!;.;R?+\1R:?92V$,0MH+&76=QM+V>>VGF#@'&ZA_P41_:9\$?
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M6A:; &>SM(-)\ >*--*1/=//</%YZO)+YTTIDD)EE+/\U44?N9_P3G_X*@?
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M/E(VTYK]QM,OIM2T_3]0:"6Q-[9VU[]DN% FMQ=VR3"UO 5RES;M(%D5"HW
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M^-6IZOXRUN)+>ZU?Q=#X=U[Q-=ZLT,200Q3B[MT@M;B%(Y'2*-&.QWC;I?\
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M=IAHB5(S^,O[4%G\5X_^"-_[3=O\3]'^"8UB3X4?":#PII_PVU&UFT?4H_\
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M/BB#6_'?CWXBZ%</9>'/AI\4K&62&Z\.)XN\/:F^I6D<6HFWGGTX":*?=,'
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MSUN&\:1[>"&V66[8V[@M)YH\P2-'&R_H^B*5*\@9!^5F7USRI!&?4$$4\0Q
M8$:@$EBH&%+%P^\J/E+AP&#D;E/*D5^5QV7S_.1]%#2*79R_,_$']G7_ ((W
M_#GX"?\ !2_X\_\ !0/2O%JZSH_Q0TE)? WP=%I>1V'PZ\4WL.DP>(O$^EO<
MW+V\6I:M)8W7GW,.9)([B2$!8998CZ1\.?\ @FC?^ _$/_!1[5)?BG9Z@O[=
MUYK-W8+'I\\5QX*GU+1-3LIGU)\^3=11W6I2SR+"I?RU:.!D(B4?KH8(R9&(
M?,JHC_O9<;8V=DV+OVQD&1B6C",WRAB0B!9"BG.=QR5/WVQE""N!NPO(!.,;
MOXLTRC\*/BQ_P1OT[XN_\$F_"/\ P3BU[XFVNF^*? .FZ:_@_P"+]CITXF\+
MZYIOB6^U\ZG8(")H"8-0N;>=X@L\B,RC(6)TZ[XJ?\$FM)\5?\$V/@U^P!X,
M\<Z9X:/PTUKX8:_JWC>XTN::+Q=KO@=IK_Q#JCPDRSB]\2W4TS/-.2@,N"(T
M0*/VI**>NX_=_C;^ [E/WNN>IZMT8D<4A12 #NPNW!WN&^7IE@VXDY^8DDM_
M%F@#D?"^BKH?AGP]H<TMO?'P]H6CZ.UU'$4%Q%IFG6]H\^)-SH#/;_:$$6UU
MVJ%P3M/Y4?\ !4/]A3]KW]O'P-XQ^!7PT_:4\"?![X!_$7PA:^&_'/A_6_!&
MI^(O$^M727]KJ$]Q!J>GW%O#96_FV5K)&BA 3"L<D4EO)/')^PVQ3U![=SD;
M3D8.<C!YXQ[TWR8L%0BJ"Q;"#9\YZO\ +CY^X?[P/((/- 'Y-?#']C[]MCP]
M^Q7\2_V:O%_[67A*X^(>K>%8? _PI^+G@_P)=6S^ - AT*70UDETVX97O]4M
MXWCN(GG2Y19XUV,I.X?&7[(__!+C_@HO^Q=\._#?PI^$W[9GP3M?!.G:Y!XB
M\77EY\*=<?Q?XSU>^UP7^NZQK_B.ZN+[4K[7-3LY)[6YUC5+N]F\B403&2SC
M\D?T9>5'O$FQ3(%VAR,OM/4;CEB/J31Y,8)(7:2[.2K,I9F!4EBI&[@]#D#@
M@ @$ 'S5XF_94_9V\?:P/%GQ(^"WPR\8>,[N&-M5\1:OX1TG4;[4IUM(K6ZG
M^T20-=7%K/(7=EOGEE,<A7<%P%^"OV"?^"4G@[]BG]G7]H'X-6VM>'M:\3_'
M?7_C<=2^(>C^'7L;W3?#?Q1U+46T7PY/B>'5+^'08=8D%N$NDA01JH=4$>/V
M*$48Y"C.&&>2<,V]E))R5+<E2<'D8P2*3R(BH5D#@*4_>$R$H5*E&+EBRE6(
M*L2IR<C- '\\?[*G_!-K_@IK^R'\*/AA\!?AW^W-\)I/A)\-)5L].TO5/A9J
MRZO-H,TVIZE=:/+>^=<6HC@AO)((&DCN(4F'GO&S#YOZ!-*CU"'2].@U2XCN
M]1CTW3H;^ZMT6.VOKV&&-+R:U@9?-CM[J8.RM+CRHW&S:!N.R(HP,*H4<852
M0JXX!500J''=0#ZFD,$1R=IW%!&9-[B78&+!?-#>9C<22 W/?- '\_O[&'A?
M6OV5O^"PG[=GP<U+P]J[> ?VL?#_ ($_:&^%GBR*TD;2)]7TW2M0_P"%@Z;<
M7.PI'>-J4\MPT9<8;:D211*J+]S?%S]AN^^(W_!0']G_ /;63Q[#IMK\%/AY
MXH\"W7@L63&ZUJ3Q*MXD%U;7R!3;RQ/J$YC;S%568,RN(U _0V70]&GU6TUV
M;2M.EUK3[:>SL=7DL[=]2M+2ZQ]HMK>]:,W$-O-C]Y"DBQMDY7YCG1\M1MY?
MY,X'F2$'/!W@MA_;?NV_PXH _.OPG^Q->^'/^"B?Q2_;ED\<6UW8_$#X1^&/
MAK%X'@M)(+C39=!%O;-JLERQ\M<6EM%YJVQB^T!"TRO([EOE?XB_\$TOVBO#
M_P"VE\5OVKOV3?VB_"GPPM/VE/#>C>'?C?X;^(O@B?QKK^C2V,JVR>(?A#KN
M^YL/#^K6UF[7ED9+=;:VU!+>2Z@N(T97_;W:/?MU9CC'3&3Q^'4<'BHQ;PJ,
M+&J#G 3*!2V<L@4@1N<Y+H%<GG.>: /QA_9A_P""3NF?!O\ X)V_&+]@KXF?
M$Z;XNV?QCU[XO^(-7^(5S:3"_EO/B3K:>(+6:]M_W8EN-"O[:SN8)%"R$VWD
MAS%)+%+T?_!+7_@EU8?L#? /XF?"_P")7Q"B^/OC;XT>,?%.M_$GQWJMO<*^
MO^&M9M5TK3_#3Q7&T?8;'1X;>PGMK>*"QC1)'2(--,\GZ_&-"&&"-W4HS(?<
MAD*E2>Y4@^]-,,;-N926XP2S?+C (3YL1A@ )%3:)!Q(&!(H _!;X6?\$WOV
M]_V1[77O@]^QS^U_\-= _9BU7Q;KGBS0?"GQ>^'NI>+?B3\/H_$VK/JFM^'_
M  -XDM6>&WTB6:65;$:Q)?1Z?F/R8HX%:(_7GBG]ACQ/XK_;._8U_:\U?XIV
MM[=?LN?"#XJ_#CQ-ID^FWMG?>/M3^)&@K8W6NKJ%M<16UI:65Y!;R,K1&3[-
M$UL?,MI9[>3], JJ %& #G R.??'7WSUZ'BH_L\'EB+RU$0 41C(C #;Q\@.
MW.[DMC<Q^\30!_.U?_\ !'W]ICP-XA_; \"?LZ?M=^'?AE^SO^V'J7BGQ'XZ
MAU'P-=ZO\<O#'B3Q5HMYINJ6>@^-+;R4?PI>I>2QRVEU.X6V<[(%8LM>VZK_
M ,$DM3U']D?_ ()W_LR6WQ;BA'[#7QE^&/Q/O?$%QHKG_A/K;X:ZGJ%X^DI:
M"5HK-M8GG5XY98BEO/(MP%!4D_MWY:$Y*Y._S.22-^  V,X)  QQA2 1@\TU
M8(5966-0Z]' ^<_*5^=_O/D'G>6R<,<L : /SO\ VD/V)KKX[?MD?L7?M3)X
MVM=&@_95UCQMJ5SX6N;![H^(H/&VA2:%!' [!XK>>*:64K/M1XRX.XA$Q^AA
MM( "5@1BH;RT;)1"1AEC4DK"DG258PJR GS V34P11MQN^7./G?OV;YOF [!
ML[?X<4X@,"#G!!!P2#@C!P000?0@@CJ"#0!^2O\ P6I^)'B/P%_P3M^.6@>!
M] U7Q?XZ^-&FZ9\#_!^C:5;O-<27_P 4];T_PC=:A(L$;-'!IMCK%Y).X"JD
M!9V^9$=/L+]BWX(/^S9^RA^SQ\!)DA2]^$WPB\$>"=3\@LT4^K:'HUI9ZI>"
M1V=F-U?17%Q@.44OMC58U51]):IH&B:RMNNKZ1IVJI9W,=[:1ZC9P7L5M=PC
M]S<P17*21QSPD!XI44/'(JRH5D56%W8D<(5=X7J6WL[C&7+%Y"Y8Y)8;RP.<
M$$<&9M+V4WHJ=5REZ2@XJWS>OD1*+DYQ5KSI**7I/FU\M/O/Q:_X+9#/[/\
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MYLX_Z)W//_!-'_Y>?DQY1])/R3_"CRCZ2?DG^%?K/_PY:^.'_1;/#W_@I_\
MN>C_ (<M?'#_ *+9X>_\%/\ ]ST?ZY\#_P#1497_ .7'_P SAS9Q_P!$[GG_
M ()H_P#R\_)CRCZ2?DG^%'E'TD_)/\*_6?\ X<M?'#_HMGA[_P %/_W/1_PY
M:^.'_1;/#W_@I_\ N>C_ %SX'_Z*C*__ "X_^9PYLX_Z)W//_!-'_P"7GY,>
M4?23\D_PH\H^DGY)_A7ZS_\ #EKXX?\ 1;/#W_@I_P#N>C_ARU\</^BV>'O_
M  4__<]'^N? _P#T5&5_^7'_ ,SAS9Q_T3N>?^":/_R\_)CRCZ2?DG^%'E'T
MD_)/\*_6?_ARU\</^BV>'O\ P4__ '/1_P .6OCA_P!%L\/?^"G_ .YZ/]<^
M!_\ HJ,K_P#+C_YG#FSC_HG<\_\ !-'_ .7GY,>4?23\D_PH\H^DGY)_A7ZS
M_P##EKXX?]%L\/?^"G_[GH_X<M?'#_HMGA[_ ,%/_P!ST?ZY\#_]%1E?_EQ_
M\SAS9Q_T3N>?^":/_P O/R8\H^DGY)_A1Y1])/R3_"OUG_X<M?'#_HMGA[_P
M4_\ W/1_PY:^.'_1;/#W_@I_^YZ/]<^!_P#HJ,K_ /+C_P"9PYLX_P"B=SS_
M ,$T?_EY^3'E'TD_)/\ "CRCZ2?DG^%?K/\ \.6OCA_T6SP]_P""G_[GH_X<
MM?'#_HMGA[_P4_\ W/1_KGP/_P!%1E?_ )<?_,X<V<?]$[GG_@FC_P#+S\F/
M*/I)^2?X4>4?23\D_P *_6?_ (<M?'#_ *+9X>_\%/\ ]ST?\.6OCA_T6SP]
M_P""G_[GH_USX'_Z*C*__+C_ .9PYLX_Z)W//_!-'_Y>?DQY1])/R3_"CRCZ
M2?DG^%?K/_PY:^.'_1;/#W_@I_\ N>C_ (<M?'#_ *+9X>_\%/\ ]ST?ZY\#
M_P#1497_ .7'_P SAS9Q_P!$[GG_ ()H_P#R\_)CRCZ2?DG^%'E'TD_)/\*_
M6?\ X<M?'#_HMGA[_P %/_W/1_PY:^.'_1;/#W_@I_\ N>C_ %SX'_Z*C*__
M "X_^9PYLX_Z)W//_!-'_P"7GY,>4?23\D_PH\H^DGY)_A7ZS_\ #EKXX?\
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MK.S?N0<4DU;62>NBL?V8Q]_P_K4E?R-_\1/FN#)'["OQL'_<G^-CT]O['_\
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M._\ $3[KO_1BOQL_\(_QK_\ *>C_ (B?==_Z,5^-G_A'^-?_ )3T?\0<X_\
M^A5@_P#P]9/_ /-H?ZSY+_T%2_\ !%?_ .5']<5%?R._\1/NN_\ 1BOQL_\
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M-?R3_P#$3[K!_P";%/C9_P"$?XX]_P#J$>_Z#TH_XB>]:_Z,4^-W_A'^.?\
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M_E1_6U@>DG^<_P")_,T8'I)_G/\ B?S-?R2_\1/>M?\ 1BGQN_\ "/\ '/\
M\J*/^(GO6O\ HQ3XW?\ A'^.?_E11_Q!SC__ *$^7_\ AYR?_P";@_UIR?\
MZ&=7_P )*O\ \J/ZVL#TD_SG_$_F:,#TD_SG_$_F:_DE_P"(GO6O^C%/C=_X
M1_CG_P"5%'_$3WK7_1BGQN_\(_QS_P#*BC_B#G'_ /T)\O\ _#SD_P#\W#7$
M^4/;,ZO_ (25?_E1_6U@>DG^<_XG\S2<^C_F?\*_DF_XB>]:_P"C%/C=_P"$
M?XY_^5%'_$3WK7_1BGQN_P#"/\<__*BA^#?B ]LJP,?\.<9-K]^.'_K-E/\
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M_P""*_\ \J/ZXJ*_D=_XB?==_P"C%?C9_P"$?XU_^4]'_$3[KO\ T8K\;/\
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M_P""*_\ \J/ZXJ*_D=_XB?==_P"C%?C9_P"$?XU_^4]'_$3[KO\ T8K\;/\
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M_P""*_\ \J/ZXJ*_D=_XB?==_P"C%?C9_P"$?XU_^4]'_$3[KO\ T8K\;/\
MPC_&O_RGH_X@YQ__ -"K!_\ AZR?_P";0_UGR7_H*E_X(K__ "H_KBHK^1W_
M (B?==_Z,5^-G_A'^-?_ )3T?\1/NN_]&*_&S_PC_&O_ ,IZ/^(.<?\ _0JP
M?_AZR?\ ^;0_UGR7_H*E_P""*_\ \J/ZXJYCQOIEYK7@SQ=HVG1QS:AJWAC7
M],L899OL\4MY?Z5=VMK'+<?\L(WGE17F_P"62DO_  U_*)_Q$^Z[_P!&*_&S
M_P (_P :_P#RGH_XB?=</7]A7XV?^$=XU_\ E/1_Q!SC_P#Z%6#_ /#UD_\
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M_P '/.L@@C]A+XU A0@(\'>-1A%.57_D#_=4\J.@/(Q1_P 0<X__ .A5@_\
MP]9/_P#-H?ZSY+_T%2_\$5__ )4?URT5_([_ ,1/NN_]&*_&S_PC_&O_ ,IZ
M/^(GW7?^C%?C9_X1_C7_ .4]'_$'./\ _H58/_P]9/\ _-H?ZSY+_P!!4O\
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M^?U_S^'UR>UJ_P#/ZM_X48C_ .6A[%?].?\ PEI?Y&1_9NE_\^5E_P" -O\
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M^/?^A-\*_P#@;J'_ ,?H_P"&U?'O_0F^%?\ P-U#_P"/UM_9F9=ZO_A3B/\
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M[4R_O3_\),/_ )GZ+?V=IO\ SZVO_@)#_A1_9VF_\^MK_P" D/\ \37YT_\
M#:OCT<_\(9X6;'\(OK\%O8$SX!/0$\9ZU]E?";XN^'_BMH,6I:8X@U&';%JV
MD2,J7=K/\JN\*%PTEH&+$2XSL &2<;\<1A,=AJ;J5'6Y5_+7Q#?_ *<1M0QN
M"Q%14Z<J/,]KX6@D_N;/3/[/TS_GTMO_  $A_P#B/?\ GZ&C^SM-_P"?6U_\
M!(?\*U-HXP,CN<G^IS^'X4[8OO\ G]?\_A]<\$:U22NJM;LTZ]>Z?G^]/15%
M?].?EA:*_)&3_9VF_P#/K:_^ D/^%']G:;_SZVO_ ("0_P"%:VQ??\_K_G\/
MKDV+[_G]?\_A]<W[2K_S]K?^#Z__ ,M#V2_Z<_\ A-2_R,G^SM-_Y];7_P !
M(?\ XFD_LW3/^?2T_P# .'_XFM?8OO\ G]?\_A]<FQ??\_K_ )_#ZY/:5?\
MG[6_\'XC_P"6A[)?].?_  FI?Y&1_9NF?\^EI_X!P_\ Q-']FZ9_SZ6G_@'!
M_P#$UK[%]_S^O^?P^N38OO\ G]?\_A]<GM:O_/ZM_P"%&(_^6A[)?].?_":E
M_D9']FZ7_P ^5E_X V__ ,11_9NE_P#/E9?^ -O_ /$5K[%]_P _K_G\/KDV
M+[_G]?\ /X?7)[6K_P _JW_A1B/_ ):'L5_TY_\ "6E_D9']FZ7_ ,^5E_X
MV_\ \11_9NE_\^5E_P" -O\ _$5K[%]_S^O^?P^N38OO^?U_S^'UR>UJ_P#/
MZM_X48C_ .6A[%?].?\ PEI?Y&1_9NE_\^5E_P" -O\ _$4?V;I?_/E9?^ -
MO_\ $5K[%]_S^O\ G\/KDV+[_G]?\_A]<GM:O_/ZM_X48C_Y:'L5_P!.?_"6
ME_D9']FZ7_SY67_@#;__ !%']FZ7_P ^5E_X V__ ,16OL7W_/Z_Y_#ZY-B^
M_P"?U_S^'UR>UJ_\_JW_ (48C_Y:'L5_TY_\):7^1D?V;I?_ #Y67_@#;_\
MQ%']FZ7_ ,^5E_X V_\ \16OL7W_ #^O^?P^N38OO^?U_P _A]<GM:O_ #^K
M?^%&(_\ EH>Q7_3G_P ):7^1D?V;I?\ SY67_@#;_P#Q%']FZ7_SY67_ ( V
M_P#\16OL7W_/Z_Y_#ZY-B^_Y_7_/X?7)[6K_ ,_JW_A1B/\ Y:'L5_TY_P#"
M6E_D9']FZ7_SY67_ ( V_P#\11_9NE_\^5E_X V__P 16OL7W_/Z_P"?P^N3
M8OO^?U_S^'UR>UJ_\_JW_A1B/_EH>Q7_ $Y_\):7^1D?V;I?_/E9?^ -O_\
M$4?V;I?_ #Y67_@#;_\ Q%:^Q??\_K_G\/KDV+[_ )_7_/X?7)[6K_S^K?\
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M]?\ /X?7)[6K_P _JW_A1B/_ ):'L5_TY_\ "6E_D9']FZ7_ ,^5E_X V_\
M\11_9NE_\^5E_P" -O\ _$5K[%]_S^O^?P^N38OO^?U_S^'UR>UJ_P#/ZM_X
M48C_ .6A[%?].?\ PEI?Y&1_9NE_\^5E_P" -O\ _$4?V;I?_/E9?^ -O_\
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MZ3>^.G\)R>%8KN]U"2WTI8Y;ZV"SSK^\@YE4]K5_Y_5O_"C$?_+0]BO^G/\
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M/8K_ *<_^$M+_(_0;^S=+_Y\K+_P!M__ (BC^S=+_P"?*R_\ ;?_ .(KQ;X
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M6\-U\0;U+C0=4TBW\9V5SI]S.;$LUI>1PBYMG*2P2Q2QK(/MG]@']M#]GO\
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M3 ]!^0HP/0?D*6BCVD_Y8?<O_D0]G#^:?WO_ .2$P/0?D*,#T'Y"EHH]I/\
MEA]R_P#D0]G#^:?WO_Y(3 ]!^0HP/0?D*6BCVD_Y8?<O_D0]G#^:?WO_ .2$
MP/0?D*,#T'Y"EHH]I/\ EA]R_P#D0]G#^:?WO_Y(3 ]!^0HP/0?D*6BCVD_Y
M8?<O_D0]G#^:?WO_ .2$P/0?D*,#T'Y"EHH]I/\ EA]R_P#D0]G#^:?WO_Y(
M3 ]!^0HP/0?D*6BCVD_Y8?<O_D0]G#^:?WO_ .2$P/0?D*,#T'Y"EHH]I/\
MEA]R_P#D0]G#^:?WO_Y(3 ]!^0HP/0?D*6BCVD_Y8?<O_D0]G#^:?WO_ .2$
MP/0?D*,#T'Y"EHH]I/\ EA]R_P#D0]G#^:?WO_Y(3 ]!^0HP/0?D*6BCVD_Y
M8?<O_D0]G#^:?WO_ .2$P/0?D*,#T'Y"EHH]I/\ EA]R_P#D0]G#^:?WO_Y(
M  "#@<'/05UG@_QKXA^'VNVOB3P]<NMZDL!DMHQ'Y=[!'(DCV4R.CQB.Y53
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M117F'KA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %,DP(W)7> C90C(8;3E<'@[
MAQCOG%/HH _*_P#X*!-]F^-W_!/LHD49?]HS5)KFXDB$YQ!X9,5D)C*LL3";
M<;>!KM7BCD<2 "1 X\'_ &=?B5\-/A;_ ,%#/^"B-K\==<\-^"/B)KDGPIU[
M0M3\6*EE;^(_A;8>!KR>U&B:OJ*F#4[/PWI<=U::I:V3_:M0:0_:7N+KR9$_
M9WQ!X'\(^*KK0;[Q'H&G:U=^&+_^U- GU"$SR:7J'DF#[5;%FP)?*)7+AQG#
MXW@,///BE^S;\"?C5<6%Y\4OA?X6\8W^EB!;#4M1LY(=4MHK:=+B*V34[":S
MOVLQ(@#V4ER]I+$9+>6%X)9(G /S3_X)(Z=_:-]^W?\ $#PW:RK\$?B9^V7X
MT\2? 65HI(]#O/ 4&A:%9S7^BV%P +2UF\51Z\T0A1%=BK#Y5C"_$7@']G+]
MH;]KS7?VS_@#I^M>"O _[-7B[]H6UO\ Q]K5Q:PW7CF\32M8MM7N/#^B6I@/
M]F'59;8Q0:I;M;S6YD"?:%MV>)OZ6?#WA;PWX2T>S\/>%M"TKPYH.G0F"PT;
M0[*#2M,LXRYD;[/96*06\4C2$R/,D8E>1FD9R[%C1\/^!O"'A*?6[SPUX=TW
M1;KQ%J+ZOKMQIT'V>?5M2==K7-[*K;YY&7@*[&,$[@@;F@#^5?\ :DTC]HVR
M\:?\%$M+^&=WX-;]GC28_!W@S]H"SUNR@?Q<_P (=.TZRT_QUK&@WK6,\T5_
M%X7AU2YMGMI%B2Y2/S$9 RGWCPJOC9/VV+:V_9B_:P\&? OX6VG[+WP3_L=?
M'WPUTSXAZS\1?!=MIGA1-'NK34]>N1!ICW&BW!:YEM8H&CEU*22Z21K2 Q?T
M-2?"WX>2R^+)YO!^BS2>/K.?3_&8FLHI(_$=E=(T5Q!K,+@PWL4L;M'(LJ-O
MB+(<H2*\4\5_L0_LI>-KC1+WQ1\%/!VL7OAO3(M&T.\FCU&*\L-(@*&WTJ*Z
MM=0@G?3K<111V]E-)+;0111P11)#&B  _(#]O/XFWW[$/[5.M?%GPS>W=[J/
M[=WP+U/X0>$)])L+F70[#X[>!;:*?P)>06<-Q</%>^+[K4;324E>^D!;$F&=
M X\Z^)/P9\=_ 3QO_P $Z?A/\%_C)X/_ &:?&%E\+?%'B/Q%XT\;?#VT\?>'
M[OQ+XM47WB73+7PU?S16JZO>ZM->[99I5O)))1 ES$FW;_0QXE^"'PE\9Z7X
M,T3Q5\/?#FOZ7\/M9LO$'@JTU73HKN+PSK6GC%EJ6D&4L]I=6IVO!)&P,<B1
M2J!+#$Z8WQ<_9K^!GQXCTE/B[\.-!\=_V"TKZ*^LB]:73&F9WD^QRVMW;21*
M7=B(U?8O"JH55  /PO\ VZ?V?;S]J3]J+_@GM\,?&'CW2O%WQ0MOV?\ ]I'Q
M#X'^,_AO1;+PYIMA\;?"N@Z.WA[X@Z%X?CEO8M+DT_4UNYDMGN);&TDQ/;V:
M7%K;/#?_ ."2GQQ\0?'G]LK]JO5_B!I1\/?%GP=X%\'_  V^+?A6:"Y%YHOB
M_P ':BNG0S:E+.@BNO[;TNW35[><9;=-M#!<"OW3\*_ CX0>"#X.;PQX T72
MY?A_8:SI?@NXAMY9;GPYI_B&7SM;M-.NKB>:XBBU&3FX#ROE#Y2%8LI6UX>^
M%7PZ\)^*_%WCCPOX)T'0/%_C^XM[OQMXCTO3K>RU;Q1=6RJEO<:U>0*LM]+$
MBJJR3,S!0!G'4 _.7_@D@8KKX _%JX58GE_X:N_:#C$JVYM6*#Q?&C+(0D;I
M(!GR63: V"IS7E'_  5'7XOS_M0?\$Q5^!.I>&=.^)</Q7_: NM G\96QU#P
MZJ-\%YK%Y=0T]XY;1Q/#>3VL+>0MW&\WVC3YK;4(K>XB_8KPEX&\(>!+.^T[
MPAH.G>'K'4]:U3Q%?VFFQ>1;W.MZU<K=ZIJ,D08I]HO+E5ED*@*K#$:HORTS
M6O /@WQ'KWA7Q/K?A[3-5U_P1>7U_P"$]4O8C/=:#>:E8KIM]<:<[,1"]S9*
ML+_*RY E4+-^\H _D0O(O&%I^S!^SNEA\0-'^"_[23_\%=;9OB[XL\0^$(+[
MPSX!^(DNI^/K6&[?PA*\=I?Z3>Z;%8ZAH=K=01V=[-=P1AHWE$R_H7^UKK.M
M^&]=_P""=_CK]ISXO>$/C9\&_!?[0GC.3XW?%#0/#</A7P+I?B*\T?P^?A0F
MLZ%H\MU:6XL/$L\5X+NX$0M<,T\I@C4+^RGCG]E?]GGXD6WB*U\;_";PGXAA
M\5ZYI7B?Q"+RTG5M4\2:';K:Z5KUP]O<0/\ VM:0(J+?1LEQ-\S7$DKN[,OA
MC]F+X!^#?AYK7PGT+X6^&H?AQXBN);S6_"%]8MK>B:C=36T5I)<W-KK<NH[I
M3!!$@<,"FP,F&+$@'YC_ /!4;XD_##QC\!?#/BKP;XJ\/>*-'^#GQ>^&7B_X
M@7?AB:/5X?"?ANZN;*VAU'56LE<6]J;.0RJ;<1FV1-^(Y$#5?^(OQ+\ ?&;_
M (*:?\$]?^%3^*]-^(B^ _A]^TGXD\=_\(QMU"#PCH/C?X<V<'A35-9O;8+I
M6GWFNWSG3UMI%BN_WC9;>01^F?@;]FWX$?#GPCJ_@7PA\+O"VG^$_$*7,6O:
M-=Z<NM6NMQ74OG20ZTVNOJ,^JVT4A_T2WOYKF"PC'DV4=O"!'5SX5_L[_!/X
M(IJW_"JOAMX9\&R:[*9M7N]+M'?4+_Y@P@FU&]EN[YK)"JB+3EN5L(0H2*V1
M>* /Y0?V:+/XROX;_8:N/C%?^'7_ &/[?]NGXWR^'+WP_P"'A:>+?#'CNW^*
M7Q#/A7_A(]0N07M-$OM?LMUS()1936VH!98I8+>WBCDU/3OC+)I/QKC\8:GX
M<7]A^'_@L#XHA^(ITC3S%\0_#)M_$?A>*Q\13:C=6DVSP[<33*VH:G#)Y%O:
M^:S QJR-_6*WP'^#S^#$^'9^'GA__A"HM3.LP>'19LMA:ZNVHS:JVJ6@6036
MFH/J%Q-=/>6TL5P[RN'D*$I5Z;X+?"N?PSXI\&S>!]"F\+>-M6U37O%6A26I
M?3]:UG6989M2U*ZA9R!=W$EO"RRPF(VXC"VWDIE2 ?@S^S%=_%M?^"AG_!0"
M^\&_M4?#CX6?#*W_ &D/ #^)_A;JWP]T?Q!XC\9M=?"SPW<HVG^-+N2WO+33
M[W3YI)(+O3VDLM.N9R\5J5C6,^!^+O!^O_#']HK]JO\ X*"_#>T-UXO_ &=_
MBMK^A_&O1+**X%SXF^"/B6RU6?XB7PB8NFHZSHPL$N/#GEPFY:>.&&.98))(
MG_H&\0_L1_LM>*?&8^(6M_!WPW=>,S=:%>2>($?5K/4)[OPW!9VNB74\NGZE
M;+-=6-M86D$=U*K7#QPJLTD@+[O<8OAC\/H$\4QQ>$-#$7C9WE\7P&RC>#Q(
M[P3VS_VQ;R;H;\/#<S*RSHZ%G$A'F(CJ ?R8_L;>,_!.F_ S_@B9\6OB3<6U
MG^S_ *CXD_: UC0?$$UK<1>!_"GC_P 7ZY\1=5T2?Q-"WEI9)$UY+HVDW6H$
MQ0:Y<1W(*7-M;S1?HU_P5<^)6B?$3PA^R'_PHCXV> ?#'C'1OV^/V?X#\1%T
MO3O'6B>!-<U'3/$,NEZMXAT+R5TR\9YK=+.UAO9IH!+?1OF"=8)8/V%F_9Y^
M!L_POA^"LOPG\%R?"BUMKJUL? ,F@6,GAG3HKR[N[^<:;ILB-#ISO>WUU<"6
MR$$L;RGRW1515XJZ_8X_9EO?A\OPJN/@]X8G\!+KT/B8^')XKV2U?7[<2"UU
M2>Y>]-_-<60E<6!ENY$L5.+-(0JX +?[-=]X[?X=6\'Q'^-WA+X^^++/5)8-
M2\=>%O#-AX*TF0.,16:Z7I;W%A]JB)PBP+"[L0KR#-?%O[83B/\ ;>_8QE\O
MS"FD_$JX2158N7&D2AB+C&VUE0+F%=ZQ,YRR,,@?H9\)?@=\+/@5X?G\*?"K
MPC8^#/#]U=R7TVEZ9<ZE-;R7<HQ),3?WMY*&8$@*L@5<_(%KK]6\"^$-=US1
MO$NL>'].U+7?#PO%T74KN$RSZ>M_$8+Q8 S>5MGB8HZO&XY)4!N: /XQ/BGH
MUY^R5^R9^U-^V+X7M0WPJ^.?AKXZ_L^?M,:&MG>3066JW=I+IWPN\<Z;86>8
MYI]2UO618:[?Q0QL]G+)]LDFB0*O]6_[#42P_L:_LI6OF([6W[.GP61G@\Q(
M!Y7@'0(MB%BLJLS0 30N0N1M9,%@WK5[\#?A#J7@37?AAJ7P\\,:C\/?$S7S
MZ]X.O]/2\T#4Y-2:)[R2YT^Y,L)DD>&-TD0(\#KOMVB8DGT#1=#TCP[I.F:%
MH6GVVE:/HUG;V&EZ;8Q^19V-E:0+;6UK;PH0B0P0(D<:8(55&.0#0!JT444
M?E3\=O\ E*G^P3_V1O\ :A_],_A"OU6K\J?CM_RE3_8)_P"R-_M0_P#IG\(5
M^JU !1110!^:G_!3G_DBOP__ .RY_#G_ -+;ZOT6TS_CQTO_ +!UM_Z)LZ_.
MG_@IS_R17X?_ /9<_AS_ .EM]7Z+:9_QXZ7_ -@ZV_\ 1-G0!JT444 %%%%
M!1110 4444 (<X.,9P<9Z9QQG'.,]<=J_-__ (*Q?LZ?$O\ :X_X)[?M,_LZ
M?"%-,N/B/\4O".D:5X1@UJ9K33Y)[3QAX5UBY\^XBV&)%@T^Z8NYRJ$E3D)7
MZ0,H=61AE64JPR1D,"",@@C@]001V-1^3'NW[22"&&6<A2$,8"J6VJI0D%5
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M9@I*@L#DDA2!\W20=)5)20,I(*^4NW;E\;MW,LA.00<9+D[.,%,[",@J02*
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M>"SKT<QCABN-+O0J:NMM=W<+'S]L\B>6WE/QX_X*&_M,>%_V1_C#\2K;XX>
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M_P +O_#DVO\ \8H _2.BOS<_X6E_P4A_Z-O^%W_AR;7_ .,4?\+2_P""D/\
MT;?\+O\ PY-K_P#&* /TCHK\W/\ A:7_  4A_P"C;_A=_P"')M?_ (Q1_P +
M2_X*0_\ 1M_PN_\ #DVO_P 8H _2.BOS<_X6E_P4A_Z-O^%W_AR;7_XQ1_PM
M+_@I#_T;?\+O_#DVO_QB@#](Z*_-S_A:7_!2'_HV_P"%W_AR;7_XQ1_PM+_@
MI#_T;?\ "[_PY-K_ /&* /TCHK\W/^%I?\%(?^C;_A=_X<FU_P#C%'_"TO\
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M3:__ !BB\_YY_>')_A_\ C_D?HWY0_N+^2T>4/[B_DM?G)_PM+_@I#_T;?\
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M\/\ X!'_ "/T;\H?W%_):/*']Q?R6OSD_P"%I?\ !2'_ *-O^%W_ (<FU_\
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M?FY_PM+_ (*0_P#1M_PN_P##DVO_ ,8H_P"%I?\ !2'_ *-O^%W_ (<FU_\
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M_P#C% 'Z1U&(HP -IP%5<%F(PN[&02<GYVR3RV1N)PN/S@_X6E_P4A_Z-O\
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MRQ7*DE217YP_\+2_X*0_]&W_  N_\.3:_P#QBC_A:7_!2'_HV_X7?^')M?\
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MD889W"D"1B ,EPW(!Z@&OS@_X6E_P4A_Z-O^%W_AR;7_ .,4?\+2_P""D/\
MT;?\+O\ PY-K_P#&* /TCHK\W/\ A:7_  4A_P"C;_A=_P"')M?_ (Q1_P +
M2_X*0_\ 1M_PN_\ #DVO_P 8H _2.BOS<_X6E_P4A_Z-O^%W_AR;7_XQ1_PM
M+_@I#_T;?\+O_#DVO_QB@#](Z*_-S_A:7_!2'_HV_P"%W_AR;7_XQ2'XI_\
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M\K_A1Y<?_/-/^^5_PHHH /+C_P">:?\ ?*_X4>7'_P \T_[Y7_"BB@ \N/\
MYYI_WRO^%'EQ_P#/-/\ OE?\*** #RX_^>:?]\K_ (4>7'_SS3_OE?\ "BB@
M \N/_GFG_?*_X4>7'_SS3_OE?\*** #RX_\ GFG_ 'RO^%'EQ_\ /-/^^5_P
MHHH /+C_ .>:?]\K_A1Y<?\ SS3_ +Y7_"BB@ \N/_GFG_?*_P"%'EQ_\\T_
M[Y7_  HHH /+C_YYI_WRO^%'EQ_\\T_[Y7_"BB@ \N/_ )YI_P!\K_A1Y<?_
M #S3_OE?\*** #RX_P#GFG_?*_X4>7'_ ,\T_P"^5_PHHH /+C_YYI_WRO\
MA1Y<?_/-/^^5_P *** #RX_^>:?]\K_A1Y<?_/-/^^5_PHHH /+C_P">:?\
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M_GFG_?*_X4>7'_SS3_OE?\*** #RX_\ GFG_ 'RO^%'EQ_\ /-/^^5_PHHH
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M]\K_ (4>7'_SS3_OE?\ "BB@ \N/_GFG_?*_X4>7'_SS3_OE?\*** #RX_\
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(@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !' 00# 2(  A$! Q$!_\0
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M_P""S?P<_:3GG\&?%&"T^#?Q%M[ W\46HWX'AS6+:UQNN;35KT 8)Y.?IGD
M?,G[5_\ P7T\.?#_ ,6ZEX)_9T\":=\0I-+O[G2]0\;^)[_[#X<^T69XN=)^
MQY-[B^(R>YY 7.!^3/\ P5J_8O\ "G['GQX\/M\.(I]-^&OQ.TS4-<\,Z-;&
MZ/\ PC^I6=P+6[M+6Z[6)5@P#8;:5.#D5]X_\$8/^"=_PF^+G@#5/VC_ (T>
M&]/\7PIXMU#0O!/AS4<_V%_Q)K4?:]=U:TX%Z3G/.>!T.*]2OPAX5Y-E]?Q
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M"DO[-^K^'?#>J77V6Z^(OA_P;JO@[5=!)P/],\.ZUBPUOW_LX^AK]ZOVO?\
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M^'_VM-;U_P"+OQEM;O6/A1X3NAI=KHAENX+?QYXG)%X;J[NQUL=-&?[4'4L
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MY1/^&"O!@V_\S9XP/'_85QD\=*_.7_@XU_Y#'[-7_7/QC_.RK]'O^"&N?^&
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M'^>:%)(!/^>:!7UY];V_#S_X<C\I/O=\9S[=>G^>>>M(D$:#"#'OU_SFI2<
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EW;O<^K_)1.-H_G1117+[&#U:=WJ]>KU?YFMHK3DAII\*Z:'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !J 88# 2(  A$! Q$!_\0
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M?P)^&?C#XJ>,#L\,>%]&_M"_$'WN.._UZ^F.1G-?F;\,/^"V?['OQ0\<>#_
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M&8OV>4QG.UY*#E"$IV=Y.+491BFK.]G=M)V/ZDRK#/ZK#Z_\3C&ZZJ7+&_\
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M+G R<#_ZW\Z7PB^#/Q-^/'C*V\*_"7PKKGC_ ,8:I=?;]9O?^0K]C '_ -<
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MPW_P3?\ A7^P[I^O7/@F\N?$?C#Q!:BVNO%&L'DZ?G(!VYZ]\'GD$8Z^#?\
M!<[Q+X)TW_@FS\<(?&L^G6W]IC3[#PG9WAS]KUG^WEQQ^!_PYX_.,QSK+\1Q
MG.KDT?\ A+J:3C&+49)QDDW!)1ND[N3BG:][V/WW@?#YQ0R>,<X=Y)6\]EM>
M[W/M[QG\7?%.J_LX>"OVAOAK9G7[D>$]/\<7_A\\_P!O:0="+:J!Q_",8Z<8
M[Y->F? ;XY>%?CY\,]"\?>#[^WN;#5,?VG9@DG0K_ SI9]"#[MQ@]3@>0?\
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M_D\G]H;_ +&S4/Y&OM/H_?\ (XS)?].E\]:A\%X[W^K9=IM)7^^/EN?U3?\
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M6)7O34DM+^]-2UO;1>\GKW2/QCC+@''9UQ7EV<X;:+3;UM[K3_),_:73)/\
MB7V'3R?LNG_4?_6. /6M+[5VQ^^S[XZ?3_Z^:@MT"0^3Y0\G_CVZ\XY].V?U
M--\N>/SL?ZG!QQSZ?Y/_ .NOQ&34L7F$M;-N2OVDV_RD?L^&DXX7+HM.Z24E
MT;246_G;L?SD_P#!Q5-#_P */^%$.<S_ /"97_X_*.N>O^3]/QL_X(]S0Q_M
M\?#+[*;C[.=&UC[5[=NHZ?X<C.!7]>W[9'[$?PK_ &W/">D>#_B;-J%M;>&+
M\7^C7EGW. ,]1TP!_3%?.G[*O_!(3]GO]D[XGP_%KP?J/B/6_$]I:XM?[4(P
M/R)/U'7Z8R/VS(O$'A_!^'4^&&I/-)*HMG=\_.K7MI\22;VMY'X]GW F>8OQ
M"CQ$K?V6K-+3I;6W39Z>9^L?1/8)_(5_"O\ \%JS%'^WOXU-_P 9T71S:BWQ
MWT#/3C\1VK^ZEUG 'DQ%_7L!7Y9_M@?\$E_V?/VR?'%O\2O&TFN:)XO%A]@N
M+S1VZC'4YQC!!&,D=#GFOE_#KB3+>&.(GC\QNX<LDK)R=^:Z=ETMIMO]Y]%Q
M]PWF?$W#RP&"2NDM[)Z6757Z7/@#_@W5F_XM7\:L;O)_X3/3\>=UY5@..WXG
MODXYK^E023 8'3_/O7P)^Q/^P7\,?V&/#/B;PY\.]4US5X?$]U_:%U/K!_ C
M@D=^QYR./3[TMX)AGSNYY_+V.!T_/UKR.-,WR[B#B3,LXPOPS<6DU).UK/3U
MZ/;M='N<%Y/F7#_#V7X#%6O'1[:;?-;?/>Y'/<'[*_FCD9'.><Y'_P"ODX [
MXK_.Z_X*'31?\-F?M#PS?]#EJ']<GM[_ .>G^B.8_.CN?R[].O./RK\7/C]_
MP1%_9M^/WQ4\8_%O6_$'BW3?$/CN[^W:Q9V>W^RB>> ,_P \=L#O7T'AEQEE
MO!V<3Q>);M.'+9)OI/7;KSKOT/G_ !-X3S/B;#+#X57::>EKK57\UMY=S._X
M(+76[]C"UM?.%S'!XLUG[+S@]L=.^1R<\_E7[A?],QGMS^.3^GOG^=?+G[*W
M[,_@;]DWX4Z+\(? /VV70=+N#=?;[T M=[BIY*D@G(&<'''&1C/T_P!\>U?'
M<49I2SGB/,LPPRLL94E)-]G;7M_D?7<-9?B<FX>R[ XG5QBD]-59+3\/Q^_Y
MY_:JQ_PH#XP[\^5_P@7BC/T_LP^GX_K7^;+J7DQ27^-0M[DW'B34/],S_P!1
M[]1GIVK_ $\/%OA>P\7^']8\-ZI$)=*\0Z/K&CW6><KJ^ >W;J.P..U?A3-_
MP;Z?LNS^);_6_P#A*_&XMKS6?[9.C9_XE8/IU_KV.,U]WX;<;9;PS',L+C;^
M^FMGORN*T6ZU7=+R/S;Q&X'Q_$V/R['89.RDKZ/3E:?;LO0_3K]@F/\ XQ$^
M"*9QCP;HX&>1T']2<]:^E_&7A/1_&GAO5_#?B&U@NM"UO3#IFL6<YZV&TC![
M#J3SWQZ<9_PO^&^@_"OP1X8^'_AN'[-H7A'3UT^T7."0N3^A8DGTXXXSW12;
M9F;G'/&/\.G/..W-?F>/QKKYUF.886ZO5E4CK9W=1SBUMJM-=_,_5,ORZV2Y
M?D^+U7)RR5O[O*[K[]^^FQ_!%_P4?_8 \?\ ['_Q0\0ZWI7A[4-;^"WBB_\
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M6J\K591M>"O:,;:\S3Z]4?C%+PPXCHPC23=HZ:7M^":Z'Z24?ZOVQ^O^.?\
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M?\%$OACX/_;$\*_L;WGA[Q)-XP\46 NK76,9TKWYZ_X'Z$'>_;G_ &\?AO\
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MF4],MGISGT?]ISX*67[0_P"P_P")OAI=1?:;K5/A4MSI?/\ S%](T(A?S8L
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M?9_#VF$'.=,T\YZGH ??\C^@ KYN_;(U2VT?]G#XMW-_]G^RV_@363=&X/\
ML]_IQCC'KBO(-+_X*2?L8V>B6%S=?'[P/;#^S-/M1]LU CC&!GKW)].QR>:_
M(C_@H7^W_8_MH:)_PQ[^Q1_;'C_Q/X\NO[/\6^-]'M =)TS1^X!P"<]R<=!Q
MZ^3E648I<1.MB$XQ55R=U9)0J2G?5I:\J2LW\2>R9Z&;9OAL9P[' 9=\7)&+
M[WY$GH]5J_(]._X-X-&U"U_9]^*>M3"X^PZK\1]9-IYG!^74KXGUY !SQ_\
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M.P'3J?PKJ?!?_!,#]BGX=^*-'\8>%?@YI&F>(/#]_P#VCI=YGI?8^]TP<_\
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4X-ZN5V]V]?U/7225DK);):(__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
